
<html lang="en"     class="pb-page"  data-request-id="3c024d16-5b30-42de-ae37-9b1a6733819e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.6b01568;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2017.60.issue-6"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Identification of Non-Nucleoside Inhibitors of the Respiratory Syncytial Virus Polymerase Complex" /></meta><meta name="dc.Creator" content="Alberto  Jiménez-Somarribas" /></meta><meta name="dc.Creator" content="Shuli  Mao" /></meta><meta name="dc.Creator" content="Jeong-Joong  Yoon" /></meta><meta name="dc.Creator" content="Marco  Weisshaar" /></meta><meta name="dc.Creator" content="Robert M.  Cox" /></meta><meta name="dc.Creator" content="Jose R.  Marengo" /></meta><meta name="dc.Creator" content="Deborah G.  Mitchell" /></meta><meta name="dc.Creator" content="Zachary P.  Morehouse" /></meta><meta name="dc.Creator" content="Dan  Yan" /></meta><meta name="dc.Creator" content="Ivan  Solis" /></meta><meta name="dc.Creator" content="Dennis C.  Liotta" /></meta><meta name="dc.Creator" content="Michael G.  Natchus" /></meta><meta name="dc.Creator" content="Richard K.  Plemper" /></meta><meta name="dc.Description" content="Respiratory syncytial virus (RSV) represents a threat to infants, the elderly, and the immunocompromised. RSV entry blockers are in clinical trials, but escape mutations challenge their potential. ..." /></meta><meta name="Description" content="Respiratory syncytial virus (RSV) represents a threat to infants, the elderly, and the immunocompromised. RSV entry blockers are in clinical trials, but escape mutations challenge their potential. ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 13, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01568" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01568" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01568" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01568" /></link>
        
    
    

<title>Identification of Non-Nucleoside Inhibitors of the Respiratory Syncytial Virus Polymerase Complex | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01568" /></meta><meta property="og:title" content="Identification of Non-Nucleoside Inhibitors of the Respiratory Syncytial Virus Polymerase Complex" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0022.jpeg" /></meta><meta property="og:description" content="Respiratory syncytial virus (RSV) represents a threat to infants, the elderly, and the immunocompromised. RSV entry blockers are in clinical trials, but escape mutations challenge their potential. In search of RSV inhibitors, we have integrated a signature resistance mutation into a recombinant RSV virus and applied the strain to high-throughput screening. Counterscreening of candidates returned 14 confirmed hits with activities in the nano- to low-micromolar range. All blocked RSV polymerase activity in minigenome assays. Compound 1a (GRP-74915) was selected for development based on activity (EC50 = 0.21 μM, selectivity index (SI) 40) and scaffold. Resynthesis confirmed the potency of the compound, which suppressed viral RNA synthesis in infected cells. However, metabolic testing revealed a short half-life in the presence of mouse hepatocyte fractions. Metabolite tracking and chemical elaboration combined with 3D-quantitative structure–activity relationship modeling yielded analogues (i.e., 8n: EC50 = 0.06 μM, SI 500) that establish a platform for the development of a therapeutic candidate." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01568"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01568">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01568&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01568&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01568&amp;href=/doi/10.1021/acs.jmedchem.6b01568" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2305-2325</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01578" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b01615" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of Non-Nucleoside Inhibitors of the Respiratory Syncytial Virus Polymerase Complex</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alberto++Jim%C3%A9nez-Somarribas">Alberto Jiménez-Somarribas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shuli++Mao">Shuli Mao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeong-Joong++Yoon">Jeong-Joong Yoon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marco++Weisshaar">Marco Weisshaar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+M.++Cox">Robert M. Cox</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jose+R.++Marengo">Jose R. Marengo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Deborah+G.++Mitchell">Deborah G. Mitchell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zachary+P.++Morehouse">Zachary P. Morehouse</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dan++Yan">Dan Yan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ivan++Solis">Ivan Solis</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dennis+C.++Liotta">Dennis C. Liotta</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-7736-7113" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+G.++Natchus">Michael G. Natchus</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard+K.++Plemper">Richard K. Plemper</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-2034-2107" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Emory Institute for Drug Development, Emory University, Atlanta, Georgia 30329, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Institute for Biomedical Sciences, Georgia State University, Atlanta, Georgia 30303, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Chemistry, Emory University, Atlanta, Georgia 30322, United States</span></div><div class="corresp-info"><strong>*</strong>Petit Science Center/Ste 712, Institute for Biomedical Sciences, Georgia State University, 100 Piedmont Ave., Atlanta, GA 30303. Phone: 404-413-3579. E-mail: <a href="/cdn-cgi/l/email-protection#2153514d444c514453614652540f444554"><span class="__cf_email__" data-cfemail="5022203c353d203522103723257e353425">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01568&amp;href=/doi/10.1021%2Facs.jmedchem.6b01568" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2305–2325</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 28, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>26 October 2016</li><li><span class="item_label"><b>Published</b> online</span>13 March 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 March 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01568" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01568</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2305%26pageCount%3D21%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAlberto%2BJim%25C3%25A9nez-Somarribas%252C%2BShuli%2BMao%252C%2BJeong-Joong%2BYoon%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D6%26contentID%3Dacs.jmedchem.6b01568%26title%3DIdentification%2Bof%2BNon-Nucleoside%2BInhibitors%2Bof%2Bthe%2BRespiratory%2BSyncytial%2BVirus%2BPolymerase%2BComplex%26numPages%3D21%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2325%26publicationDate%3DMarch%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01568"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1320</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">8</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01568" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of Non-Nucleoside Inhibitors of the Respiratory Syncytial Virus Polymerase Complex&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Alberto&quot;,&quot;last_name&quot;:&quot;Jiménez-Somarribas&quot;},{&quot;first_name&quot;:&quot;Shuli&quot;,&quot;last_name&quot;:&quot;Mao&quot;},{&quot;first_name&quot;:&quot;Jeong-Joong&quot;,&quot;last_name&quot;:&quot;Yoon&quot;},{&quot;first_name&quot;:&quot;Marco&quot;,&quot;last_name&quot;:&quot;Weisshaar&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;M. Cox&quot;},{&quot;first_name&quot;:&quot;Jose&quot;,&quot;last_name&quot;:&quot;R. Marengo&quot;},{&quot;first_name&quot;:&quot;Deborah&quot;,&quot;last_name&quot;:&quot;G. Mitchell&quot;},{&quot;first_name&quot;:&quot;Zachary&quot;,&quot;last_name&quot;:&quot;P. Morehouse&quot;},{&quot;first_name&quot;:&quot;Dan&quot;,&quot;last_name&quot;:&quot;Yan&quot;},{&quot;first_name&quot;:&quot;Ivan&quot;,&quot;last_name&quot;:&quot;Solis&quot;},{&quot;first_name&quot;:&quot;Dennis&quot;,&quot;last_name&quot;:&quot;C. Liotta&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;G. Natchus&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;K. Plemper&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;2305-2325&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01568&quot;},&quot;abstract&quot;:&quot;Respiratory syncytial virus (RSV) represents a threat to infants, the elderly, and the immunocompromised. RSV entry blockers are in clinical trials, but escape mutations challenge their potential. In search of RSV inhibitors, we have integrated a signature resistance mutation into a recombinant RSV virus and applied the strain to high-throughput screening. Counterscreening of candidates returned 14 confirmed hits with activities in the nano- to low-micromolar range. All blocked RSV polymerase activity in minigenome assays. Compound 1a (GRP-74915) was selected for development based on activity (EC50 = 0.21 μM, selectivity index (SI) 40) and scaffold. Resynthesis confirmed the potency of the compound, which suppressed viral RNA synthesis in infected cells. However, metabolic testing revealed a short half-life in the presence of mouse hepatocyte fractions. Metabolite tracking and chemical elaboration combined with 3D-quantitative structure–activity relationship modeling yielded analogues (i.e., 8n: EC50 = 0.06 μ&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01568&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01568" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01568&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01568" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01568&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01568" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01568&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01568&amp;href=/doi/10.1021/acs.jmedchem.6b01568" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01568" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01568" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01568%26sid%3Dliteratum%253Aachs%26pmid%3D28245119%26genre%3Darticle%26aulast%3DJim%25C3%25A9nez-Somarribas%26date%3D2017%26atitle%3DIdentification%2Bof%2BNon-Nucleoside%2BInhibitors%2Bof%2Bthe%2BRespiratory%2BSyncytial%2BVirus%2BPolymerase%2BComplex%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D6%26spage%3D2305%26epage%3D2325%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291430" title="Infectious diseases">Infectious diseases</a>,</li><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a>,</li><li><a href="/action/doSearch?ConceptID=292143" title="Metabolism">Metabolism</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/jmcmar.2017.60.issue-6/20170323/jmcmar.2017.60.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Respiratory syncytial virus (RSV) represents a threat to infants, the elderly, and the immunocompromised. RSV entry blockers are in clinical trials, but escape mutations challenge their potential. In search of RSV inhibitors, we have integrated a signature resistance mutation into a recombinant RSV virus and applied the strain to high-throughput screening. Counterscreening of candidates returned 14 confirmed hits with activities in the nano- to low-micromolar range. All blocked RSV polymerase activity in minigenome assays. Compound <b>1a</b> (GRP-74915) was selected for development based on activity (EC<sub>50</sub> = 0.21 μM, selectivity index (SI) 40) and scaffold. Resynthesis confirmed the potency of the compound, which suppressed viral RNA synthesis in infected cells. However, metabolic testing revealed a short half-life in the presence of mouse hepatocyte fractions. Metabolite tracking and chemical elaboration combined with 3D-quantitative structure–activity relationship modeling yielded analogues (i.e., <b>8n</b>: EC<sub>50</sub> = 0.06 μM, SI 500) that establish a platform for the development of a therapeutic candidate.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14471" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14471" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A member of the recently established pneumovirus family of negative stranded nonsegmented RNA viruses,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> respiratory syncytial virus (RSV) is the leading cause of infant hospitalization due to viral infections in the United States and is responsible for the majority of fatalities due to respiratory infectious diseases of children less than one year of age.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The risk of progressing to severe RSV disease is highest during primary infection of infants, but reinfections with RSV can occur throughout life.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Whereas disease is typically less severe at reinfection, RSV constitutes a major clinical threat to the elderly and the immunocompromised.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">RSV is a highly contagious airborne pathogen that spreads through the respiratory route. Initial infection of airway epithelia cells is followed by viral spread from the nasopharynx to the lower airways that can impair respiratory function.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> Frequently observed with acute virus infections are immunopathogenic effects, such that disease symptoms are predominantly a consequence of the host immune response to infection rather than induced by the pathogen directly.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Since viral titers are typically already immune-controlled when the infection becomes fully symptomatic, the available time window is often too narrow for efficacious therapeutic intervention with acute viral disease. However, severe and life-threatening RSV disease is characterized by the spread of infection to the lower respiratory tract. Although the connection between initial viral load and progression to lower respiratory infection remains poorly understood, clinical studies have identified viral load as correlated with increased disease severity in adult volunteers.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> In RSV-infected hospitalized children under the age of two, higher viral loads on the third day after hospitalization were linked to an increased requirement for intensive care and progression to respiratory failure.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> These studies suggest that efficacious therapeutics given early to hospitalized children may improve downstream morbidity and reduce immunopathology, opening a time window for therapeutic disease management.</div><div class="NLM_p">Ribavirin is currently the only licensed drug approved for the treatment of RSV infection, but toxicity liabilities and limited efficacy undermine its clinical importance.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> Recent anti-RSV drug discovery campaigns have predominantly focused on two targets areas, the viral entry machinery and the RSV RNA-dependent RNA polymerase (RdRp) complex. Of eight small molecule drug candidates that were advanced to testing in primate models of RSV infection and/or clinical trials, six target the viral fusion protein, preventing viral entry, while only two block viral RNA synthesis.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Currently most advanced developments are the nucleoside analogue inhibitor ALS-8176 (<b>2</b>)<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and the entry inhibitor GS-5806 (<b>3</b>),<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) which are both orally available and decrease viral load and disease symptoms in phase II clinical trials.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0001.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. RSV inhibitors currently in phase II clinical trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Despite a high structural variety among the different small-molecule RSV entry inhibitors that were subjected to advanced development, point mutations in either one of two microdomains of the F protein, residues 392–401 and 486–489, induce robust viral escape from inhibition by all of these compounds.<a onclick="showRef(event, 'ref12 ref15'); return false;" href="javascript:void(0);" class="ref ref12 ref15">(12, 15)</a> This unusual RSV pan-resistance phenotype to entry inhibition does not necessarily coincide with viral attenuation since we noted that a pan-resistant RSV recombinant remained as pathogenic in a mouse model of RSV disease as the corresponding parent strain.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> If this finding equally extends to the human host, broad clinical implementation may result in the induction of preexisting resistance in circulating strains as observed with the adamantes used for the treatment of influenza A virus (IAV) infections. Because of the development of widespread resistance from 2002 to 2006, the CDC advises against the use of adamantanes for influenza therapy.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a></div><div class="NLM_p">Guided by the past experience that pan-resistance-sensitive RSV entry inhibitors emerge readily in HTS campaigns, we have in recent work developed an innovative HTS design that counterselects against identifying additional chemical scaffolds sensitive to pan-resistance by including a signature resistance mutation into a recombinant RSV reporter strain<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> that also features a fusion protein derived from the line19 RSV isolate.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> For automated detection of replication, this recombinant recRSV-A2-L19F<sub>D489E</sub>-fireSMASh strain expresses a firefly luciferase reporter from an additional transcription unit that is linked to an engineered small-molecule assisted shut off (SMASh) domain,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> which significantly boosts the dynamic range of the assay, allowing effective assay miniaturization to a 384-well plate format. Used in a coinfection approach with a recombinant IAV reporter strain harboring nanoluciferase, this strategy supports the simultaneous identification of RSV-specific, IAV-specific, and broad-spectrum hit candidates in a single well setting.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p last">Here, we describe the implementation of this screening protocol against a 50,640-entry, open discovery library with the goal to identify novel scaffolds with anti-RSV activity. On the basis of the design of the infection protocol, we anticipated identifying predominantly inhibitors of early and intermediate stages of the viral life cycle, such as a new entry-inhibitor class insensitive to pan-resistance and RdRp blockers, while the discovery of compounds targeting late stages of viral replication such as virion assembly and egress was less favored. Having validated hit candidates through direct and orthogonal counterscreens and initial mechanistic characterization, we tested the developmental potential of a confirmed novel hit class through synthetic exploration of the scaffold and 3D-QSAR development. This work establishes a foundation for our program to develop much-needed next generation RSV therapeutics.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45852" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45852" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Screening and Hit Identification</h3><div class="NLM_p">The primary HTS screen was carried out in a single replicate in 384-well plate format, using a final compound concentration in the assay plates of 5 μM. Target viruses were IAV-WSN-nanoLuc and recRSV-A2-L19F<sub>D489E</sub>-fireSMASh, which carried the signature D489E mutation mediating pan-resistance against currently developed RSV entry inhibitors.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><div class="NLM_p">For automated identification of primary hit candidates, we applied two complementary statistical methods: (i) raw values imported into the MScreen package<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> were automatically normalized for positive and negative controls present in 32 replicates each on every test plate and % inhibition by plate, scaled across all plates present in the campaign, calculated; and (ii) we determined control-independent robust z scores by plate,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> followed by scaling of values derived from each plate against the full campaign. Hit candidate cutoff values were arbitrarily set to ≥75% inhibition and robust z scores ≥4.5. Plotting of robust z scores as a function of % inhibition identified 180 compounds that met both hit identification targets and were selected for confirmation retesting (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0002.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Primary HTS and counterscreening for hit discovery. (A) Primary hit identification. Assay plates were analyzed using both control-dependent (% inhibition by plate) and independent (robust z-score) statistical approaches. Dashed lines represent hit cutoffs (75% inhibition and a z-score of >4.5, respectively), and red symbols denote hit candidates (180 total) selected for counterscreening. (B) Direct counter and cytotoxicity screens of the selected hit candidates against recRSV-A2-L19F<sub>D489E</sub>-fireSMASh. Confirmation plates were screened twice, and error bars depict the range. (C) Orthogonal dose–response counterscreens of 26 hit candidates selected (B) against recRSV-A2-L19F<sub>D489E</sub>-fireSMASh and recRSV-A2-L19F-renilla. EC<sub>50</sub> concentrations were determined through regression modeling. The solid line marks the parity of active concentrations against either target virus; the dashed line specifies the cutoff for further consideration (15-fold less potency against recRSV-A2-L19F-renilla than recRSV-A2-L19F<sub>D489E</sub>-fireSMASh). (D) RSV minigenome dose–response assay of the 14 confirmed compounds from C; red symbols. Regression curves are shown for each candidate, and symbols represent averages of relative minireplicon activities ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To verify hit candidates, we implemented a two-stage counterscreening strategy consisting of single concentration direct counter- and cytotoxicity screens in 384-well format and dose–response orthogonal counterscreens in 96-well format after sourcing of shortlisted compounds. Of the 180 compounds selected for the first stage of counterscreens, only 39 failed the direct counterscreen, corresponding to a false positive rate of 21.7% of the primary hit identification strategy (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B). We noted a relatively high frequency of cytotoxic compounds (defined as the metabolic activity of cells <70% of vehicle-exposed control) in this candidate pool of 41% when metabolic activity of uninfected cells was assessed after 48-h exposure to the different hit candidates. This distribution likely reflected that the primary hit pool included both RSV-specific and broad-spectrum myxovirus blockers since a large proportion of the cytotoxic candidates originated not surprisingly from the broad-spectrum pool.</div><div class="NLM_p">Of the remaining 67 candidates, a total of 26 with acceptable first-pass toxicity profile were sourced after visual inspection of the chemical scaffolds and advanced to orthogonal dose–response counterscreens to triage reporter-interfering candidates. We tested each compound in triplicate against the original screening strain and a recRSV-A2-L19F-renilla luciferase recombinant that we have previously generated,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> capitalizing on the different protein structures and substrate chemistry between firefly and renilla luciferase<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> that make simultaneous interference of a candidate compound with both reporters unlikely. Active concentrations against each target RSV strain were calculated independently through four-parameter variable slope regression modeling and plotted as a function of each other (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>C). Fourteen compounds returned EC<sub>50</sub> concentrations with <15-fold difference of each other against either target virus, indicating potency against both RSV reporter strains and thus either suggesting inhibition of RSV replication rather than reporter interference or, in an inversion of the desired activity profile, dependence on the D489E-substitution for antiviral activity. This subset of 14 hit candidates was subsequently tested for inhibitory activity in a firefly luciferase reporter-based RSV minigenome assay that we have previously developed.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Remarkably, we observed in all cases dose-dependent inhibition of reporter expression, indicating interference of the confirmed hit scaffolds with activity of the RSV RdRp complex (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>D).</div><div class="NLM_p">In an independent second orthogonal counterscreen, we tested the ability of five selected candidates (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) to reduce virus load, using standard recRSV-A2-L19F and progeny virus titers as the assay readout (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A). Combined, this panel of primary and counterscreens was highly effective, returning five confirmed hits with active concentrations below 1 μM against a standard RSV target strain. On the basis of structure and amenability for synthetic modification, we next selected one of the confirmed hits, compound <b>1a</b>, for chemical hit-to-lead development. The compound was first resynthesized in-house using the procedure outlined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> to confirm chemical structure, purity, and bioactivity. Testing against the original screening strain recRSV-A2-L19F<sub>D489E</sub>-fireSMASh demonstrated active concentrations of the sourced and resynthesized material within a 4-fold range of each other (EC<sub>50</sub> = 0.84 μM (sourced) vs 0.21 μM (resynthesized), respectively), supporting the structural integrity of the original hit candidate (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B). The observed potency difference is likely due to the higher purity of the resynthesized (98.2%) compared to the sourced (≥90%) material. Parallel testing of resynthesized <b>1a</b> against two additional RNA viruses, vesicular stomatitis virus (VSV), which is like RSV, a member of the order <i>mononegavirales</i>, and influenza A virus A/WSN/1933 (H1N1), revealed the RSV specificity of the compound since neither of these pathogens was inhibited by <b>1a</b> (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B). These results underscore that anti-RSV activity of the compound is not due to the underlying unspecific cytotoxicity and/or interference of the <b>1a</b> with host cell polymerases.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0003.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of confirmed hits.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0004.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Progeny virus yield-based dose–response assay of five selected candidates from the subpanel shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>C (red symbols) against recRSV-A2-L19F. Virus titers were determined through TCID<sub>50</sub> titration. Symbols represent averages of two repeats ± range, regression curves and calculated EC<sub>50</sub> values are shown. Compounds tested were <b>1a</b>, <b>4</b>, <b>5</b>, <b>6</b>, and <b>7</b>. (B) Dose–response reporter assays against the recRSV-A2-L19F<sub>D489E</sub>-fireSMASh screening strain to compare the potency of resynthesized <b>1a</b> and the sourced material. Only resynthesized <b>1a</b> was tested against two distinct RNA viruses, vesicular stomatitis virus (VSV) and influenza A virus A/WSN/1933 (H1N1) (IAV). Symbols represent averages of three repeats ± SEM, and nonlinear (RSV) and linear (VSV, IAV) regression curves, each with 95% confidence intervals, and EC<sub>50</sub> values are shown. N/A, not applicable. (C) RT-qPCR assay to determine relative RSV N mRNA levels. Cells were infected with recRSV-A2-L19F (MOI 3.0) and incubated in the presence of a range of <b>1a</b> concentrations as specified, previously reported <b>2</b> (30 μM), or volume-equivalent of vehicle (DMSO) for 20 h. Values represent averages of three experiments, determined in duplicate each ± SD. Statistical variation was assessed through one-way ANOVA with Sidak’s multiple comparison post test (***, <i>P</i> < 0.001; **, <i>P</i> < 0.01; NS, not significant).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of Compounds <b>1a</b>–<b>1s</b> and Syntheses of Compounds <b>1t</b> and <b>1u</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) EDCI, HOBt, aniline, DMF, RT, 65%. (b) PhSH, Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, RT, 50%. (c) EDCI, HOBt, R<sup>1</sup>COOH, DMF, RT, 22–87%. (d) 3-methyl-2-furaldehyde, NaBH(OAc)<sub>3</sub>, AcOH, DMA, 60 °C, 13%. (e) furan-2-sulfonyl chloride, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to RT, 58%.</p></p></figure><div class="NLM_p last">To furthermore assess the consistency of the MOA profile, we employed reverse transcription qPCR as an independent alternative approach to minigenome assays to compare relative levels of viral mRNA synthesized by the RSV polymerase complex in the presence or absence of inhibitor as exemplified by reference compound <b>2</b> (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>C). Consistent with the minireplicon data obtained with the sourced material, resynthesized <b>1a</b> reduced the relative amount of RSV N protein-encoding mRNA in infected cells after 20-h exposure to the compound. The inhibitory effect was dose-dependent, and statistically significant reductions were observed when <b>1a</b> concentrations exceeded 1 μM. Taken together, these results demonstrate the suitability of the recently developed pan-resistant recRSV-A2-L19F<sub>D489E</sub>-fireSMASh strain for automated drug discovery. The presence of the resistance mutation has shifted the hit pool of the drug discovery campaign described here toward inhibitors of the viral polymerase complex, illuminating that the pan-resistance mechanism apparently is challenging to overcome by small molecule entry inhibitors.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Structure–Activity Relationship Development</h3><div class="NLM_p">Upon selection of <b>1a</b> as a starting point for hit-to-lead development, we sought to synthetically explore this scaffold with a primary goal of establishing a structure–activity relationship (SAR) as a platform for pharmacophore-informed lead development. In addition to maximizing antiviral potency and selectivity, a thorough understanding of the underlying SAR will be essential for meaningful attempts to synthetically address pharmacologic liabilities that may emerge during development. A second goal of the initial synthetic campaign was to eliminate potential metabolically labile groups wherever possible at the earliest stage of hit-to-lead development.</div><div class="NLM_p">Before initiating in-house synthesis, we used the ChemNavigator similarity search application and SciFinder’s similarity search function<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> to search for commercially available analogues of <b>1a</b>. Disappointingly, however, the commercial source compounds showed little promise to yield interpretable information due to the presence of multiple scaffold modifications in each available analogue. We therefore opted to launch a traditional SAR campaign that divided the scaffold into three specific regions (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A–C) and concentrated synthetic efforts on probing each of these sections individually through the introduction of singular modifications. Bioactivity results of our serial query of each of these regions are summarized in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> for molecule sections <b>A</b>, <b>B</b>, and <b>C</b>, respectively.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0005.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. SAR strategy of hit compound <b>1a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. RSV Inhibitory (EC<sub>50</sub>) and Cytotoxic (CC<sub>50</sub>) Concentrations and Selectivity Indices of <b>1a</b> and Analogues Featuring Modifications of Section <b>A</b>, Tested on BEAS-2B Human Respiratory Cells<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0016.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0017.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">The highest concentration assessed for potency calculation was 10 μM and for cytotoxicity assessment 90 μM. Active concentrations were calculated through four-parameter variable slope regression modeling; values in parentheses specify 95% confidence intervals. ND: not determined.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. RSV Inhibitory (EC<sub>50</sub>) and Cytotoxic (CC<sub>50</sub>) Concentrations and Selectivity Indices (SI) of <b>1a</b> Analogues Featuring Modifications of Section C<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0018.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0019.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Testing and analysis were carried out as specified for <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. RSV Inhibitory (EC<sub>50</sub>) and Cytotoxic (CC<sub>50</sub>) Concentrations and Selectivity Indices (SI) of <b>1a</b> Analogues Featuring Modifications of Section B or Modifications of Multiple Sections<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0020.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Testing and analysis were carried out as specified for <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>.</p></div></div><div></div></div><div class="NLM_p">As outlined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, coupling of compound <b>10</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> with aniline, followed by removal of the <i>o-</i>nosyl protecting group with thiophenol and cesium carbonate provided amine <b>12</b>. Coupling this compound with the corresponding carboxylic acids gave access to final compounds <b>1a</b>–<b>1s</b> in low to good yields. Compound <b>1t</b> was prepared via reductive amination of 3-methyl-2-furaldehyde with amine <b>12</b>. The synthesis of compound <b>1u</b> was achieved through the reaction of amine <b>12</b> and furan-2-sulfonyl chloride under standard sulfonylation conditions.</div><div class="NLM_p">Compounds <b>8a</b>–<b>8o</b> were prepared according to the general synthesis outlined in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Amine <b>14</b> was prepared by removing of the <i>o-</i>nosyl group from compound <b>13</b>.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Coupling of <b>14</b> and 3-methylfuran-2-carboxylic acid,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> followed by hydrolysis of the ethyl ester moiety with sodium hydroxide afforded carboxylic acid <b>16</b>. Coupling <b>16</b> with the corresponding amines gave access to final compounds <b>8a</b>–<b>8o</b> in low to moderate yields.</div><figure id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Synthesis of Compounds <b>8a</b>–<b>8o</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) PhSH, Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, RT, 66%. (b) EDCI, HOBt, 3-methylfuran-2-carboxylic acid, DMF, RT, 90%. (c) 3 N NaOH, MeOH/THF, then aq. HCl, RT, 95%. (d) EDCI, HOBt, R<sup>3</sup>R<sup>4</sup>NH, DMF, or HATU, DIPEA, DMF, RT, 12–74%.</p></p></figure><div class="NLM_p">As described in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, conversion of carboxylic acid <b>16</b> into the corresponding Weinreb amide <b>17</b>, followed by treatment with benzylmagnesium chloride provided compound <b>8p</b>. Conversion of carboxylic acid <b>16</b> into a mixed carbonic acid anhydride, followed by reduction with sodium borohydride afforded alcohol <b>18</b>.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Treatment with mesyl chloride and displacement of the resulting mesylate group with aniline provided compound <b>8q</b>.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><figure id="sch3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0010.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Syntheses of Compounds <b>8p</b> and <b>8q</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeNH(OMe)·HCl, EDCI, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 41%. (b) BnMgCl, THF, 0 °C to RT, 25%. (c) IBCF, NMM, THF, 0 °C, then aq. NaBH<sub>4</sub>, 0 °C, 41%. (d) MsCl, Et<sub>3</sub>N, THF, 0 °C. (e) aniline, Et<sub>3</sub>N, THF, 20% (2 steps).</p></p></figure><div class="NLM_p">Sulfonamide <b>8r</b> was prepared in six steps from compound <b>10</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Carbamate <b>19</b> was prepared via a Curtius rearrangement starting from carboxylic acid <b>10</b>. Boc deprotection provided amine <b>20</b>, which in turn was converted into sulfonyl chloride <b>21</b> through a modified Sandmeyer reaction.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> Formation of sulfonanilide <b>22</b> under standard sulfonylation conditions, followed by deprotection of the <i>o-</i>nosyl group with thiophenol and cesium carbonate, provided amine <b>23</b>. This compound was then coupled with 3-methylfuran-2-carboxylic acid to give final compound <b>8r</b>.</div><figure id="sch4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0011.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compound <b>8r</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DPPA, Et<sub>3</sub>N, <i>t-</i>BuOH/toluene/1,2-dichloroethane 1.5:1.5:1, RT to reflux, 32%. (b) HCl/dioxane, then NaHCO<sub>3</sub>, RT, 99%. (c) NaNO<sub>2</sub>/aq. HCl, then CuSO<sub>4</sub>, SO<sub>2</sub>, AcOH/water, −10 °C to RT, 36%. (d) PhNH<sub>2</sub>, Et<sub>3</sub>N, THF, RT, 84%. (e) PhSH, Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, RT, 79%. (f) EDCI, HOBt, 3-methylfuran-2-carboxylic acid, DMF, RT, 76%.</p></p></figure><div class="NLM_p">Compounds <b>8s</b> and <b>8t</b> were prepared in three steps from compound <b>20</b> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). Treatment of this compound with benzoyl chloride and benzenesulfonyl chloride afforded the corresponding benzamide <b>24</b> and sulfonamide <b>26</b>, which were treated with thiophenol and cesium carbonate to remove the <i>o-</i>nosyl groups. The resulting unprotected azepines <b>25</b> and <b>27</b> were coupled with 3-methylfuran-2-carboxylic acid to provide the final compounds <b>8s</b> and <b>8t</b>, respectively.</div><figure id="sch5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0012.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Syntheses of Compounds <b>8s</b> and <b>8t</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BzCl, DIPEA, THF, 0 °C to RT, 90%. (b) PhSO<sub>2</sub>Cl, DIPEA, THF, 0 °C to RT, quant. (c) PhSH, Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, RT, 75%–quant. (d) EDCI, HOBt, 3-methylfuran-2-carboxylic acid, DMF, RT, 29–68%.</p></p></figure><div class="NLM_p">As shown in <a class="ref internalNav" href="#sch6" aria-label="Schemes 6">Schemes 6</a> and <a class="ref internalNav" href="#sch7" aria-label="7">7</a>, compounds <b>9a</b> and <b>9b</b> were prepared in three steps from known compounds <b>28</b><a onclick="showRef(event, 'ref26 ref32'); return false;" href="javascript:void(0);" class="ref ref26 ref32">(26, 32)</a> and <b>31</b>.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Coupling with 3-methylfuran-2-carboxylic acid, followed by hydrolysis of the ethyl esters provided carboxylic acids <b>30</b> and <b>33</b>, respectively. These compounds were coupled with aniline to provide the corresponding final compounds <b>9a</b> and <b>9b</b>.</div><figure id="sch6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0013.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Compound <b>9a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) EDCI, HOBt, 3-methylfuran-2-carboxylic acid, DMF, RT, 65%. (b) NaOH, H<sub>2</sub>O/MeOH/THF, then aq. HCl, RT. (c) EDCI, HOBt, aniline, DMF, RT, 54% (2 steps).</p></p></figure><figure id="sch7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0014.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Compound <b>9b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HATU, Et<sub>3</sub>N, 3-methylfuran-2-carboxylic acid, CH<sub>2</sub>Cl<sub>2</sub>, RT, 22%. (b) LiOH, H<sub>2</sub>O/MeOH/THF, then aq. HCl, RT. (c) HATU, DIPEA, aniline, DMF, RT, 15% (2 steps).</p></p></figure><div class="NLM_p">As shown in <a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>, compound <b>9c</b> was prepared in a similar manner to that described above for compounds <b>1a</b>–<b>1s</b>. Coupling of carboxylic acid <b>10</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> with <i>o-</i>fluoroaniline afforded anilide <b>34</b>. Removal of the <i>o-</i>nosyl group, followed by coupling with furan-2-carboxylic acid gave final compound <b>9c</b>.</div><figure id="sch8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0015.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Compound <b>9c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) EDCI, HOBt, <i>o-</i>fluoroaniline, DMF, RT, 65%. (b) PhSH, Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, RT, 55%. (c) EDCI, HOBt, furan-2-carboxylic acid, DMF, RT, 59%.</p></p></figure><div class="NLM_p">Given the known potential for metabolic liabilities associated with furan groups,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> we first turned our attention to section <b>A</b> of the scaffold with a goal of finding a suitable alternative (see <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Direct replacement with alternate heterocycles such as thiophene <b>1c</b>, pyrroles <b>1d</b> and <b>1e</b>, oxazole <b>1q</b>, isoxazole <b>1r</b>, benzofuran <b>1i</b>, and pyrimidine <b>1s</b>, resulted in complete loss of potency. We therefore narrowed the scope of modification and concentrated on alteration of substituents on the furan ring that might offer increases in potency, selectivity index, and/or metabolic stability. We found, however, that this region of the molecule was very sensitive to manipulation since all of these changes substantially reduced bioactivity. For example, removal of the furanyl-C3-methyl group (<b>1b</b>) resulted in a drastic loss of activity (EC<sub>50</sub> = 7.1 μM). Similarly, relocation of the methyl group to the 4-furanyl (<b>1o</b>) and 5-furanyl (<b>1p</b>) positions led to loss of activity, suggesting that substitution at the 3 position is required for activity. This was reinforced by the bioactivity results obtained for the 3,4-dimethyl (<b>1l</b>), 3,5-dimethyl (<b>1m</b>), and 4,5-dimethyl (<b>1n</b>) compounds, of which only <b>1n</b> lacked antiviral activity. We next sought to define the scope of modification and functional diversity that could be accommodated at the C3 position. Replacement of the 3-methyl with a 3-chloro substituent gave slightly less active <b>1f</b> (EC<sub>50</sub> = 0.76 μM and CC<sub>50</sub> = 30 μM). We also replaced the methyl with phenyl (<b>1h</b>) and incorporated the C3 carbon into a fused 5-membered ring (<b>1g</b>). However, the EC<sub>50</sub> of <b>1g</b> was reduced to approximately 10 μM, and <b>1h</b> lacked appreciable inhibitory activity. Finally, the replacement of the C3-methyl group with trifluoromethyl (<b>1j</b>) and ethyl (<b>1k</b>) groups had both negative impacts on the potency, revealing a very narrow tolerance range to C3 substitutions in section <b>A</b>. Turning our attention to the carboxamide group in section <b>A</b>, we obtained comparable results. We substituted the carbonyl bond for either CH<sub>2</sub> (<b>1t</b>) or SO<sub>2</sub> (<b>1u</b>), but in both cases the resulting compounds experienced a complete loss of bioactivity. Motivated by this limited window of opportunity for modifications in section <b>A</b>, we next examined section <b>C</b> of the scaffold.</div><div class="NLM_p">In parallel with our initial strategy toward probing section <b>A</b>, we again sampled the effect on bioactivity of different heteroaromatic rings, altered substitutions on the phenyl ring, and modified linkers other than the amide bond (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Two pyrimidine ring analogues were synthesized and tested (<b>8m</b> and <b>8o</b>). However, <b>8m</b> lacked inhibitory activity (EC<sub>50</sub> > 10 μM), and <b>8o</b> likewise experienced a drop in potency, albeit less pronounced than that seen for <b>8m</b> (EC<sub>50</sub> = 1.5 μM). We then substituted the aromatic ring with different groups on a variety of positions, such as <i>o</i>-F and <i>p</i>-F (<b>8c</b>), <i>o</i>-Me (<b>8d</b>), <i>o</i>-F (<b>8g</b>), <i>o</i>-OMe (<b>8j</b>), <i>m</i>-Me (<b>8e</b>), <i>m</i>-F (<b>8h</b>), <i>m</i>-OMe (<b>8k</b>), <i>p</i>-Me (<b>8f</b>), <i>p</i>-F(<b>8i</b>), <i>p</i>-OMe (<b>8l</b>), and <i>o</i>-Cl and <i>p</i>-F (<b>8n</b>). Several compounds of this panel showed improved inhibitory activity compared to that of hit compound <b>1a</b>; for instance, compounds <b>8c</b> (EC<sub>50</sub> = 0.06 μM), <b>8g</b> (EC<sub>50</sub> = 0.05 μM), and <b>8n</b> (EC<sub>50</sub> = 0.06 μM) all returned an approximately 4-fold improvement in antiviral potency. The SI was acceptable (SI > 20) in most cases with some values well above 100; however, there was no apparent correlation with structure that allowed for predictive design around this parameter.</div><div class="NLM_p">Encouraged by these promising results, we assessed the sensitivity of <b>8g</b> to phase I liver oxidation by incubating them with mouse S9 hepatocyte subcellular fractions to determine if the metabolic stability was suitable to support efficacy testing in the mouse model of RSV infection.<a onclick="showRef(event, 'ref15 ref19'); return false;" href="javascript:void(0);" class="ref ref15 ref19">(15, 19)</a> Unfortunately, the half-life of compound <b>8g</b> coincubated with mouse S9 fractions was only 11 min, and the compound hydrolyzed rapidly even in the absence of cofactors (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.6b01568/suppl_file/jm6b01568_si_001.pdf" class="ext-link">Supporting Information</a>). Interestingly, the half-life against human S9 liver fractions was much higher (7 h) suggesting that the metabolic stability of this compound, and possibly others in the series, in humans may be sufficient to support advancement toward clinical develoment.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Aqueous Solubility for Selected Compounds at Various pH Values<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0021.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Detailed solubility and metabolism procedures are in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a></p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">Tested against mouse liver microsomes.</p></div></div><div></div></div><div class="NLM_p">In order to develop a rational plan to address the observed metabolic liability in mice, we assessed the metabolites that arose from the exposure of <b>1a</b> to mouse liver microsomes (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01568/suppl_file/jm6b01568_si_001.pdf" class="ext-link">Supporting Information</a> for detailed protocols and results). The half-life was 15 min both with and without the presence of cofactors. Given that amidases do not require cofactors for activity, amide hydrolysis was postulated to be the primary metabolic pathway. Analytical standards of the two most likely metabolites (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, compound <b>12</b>; <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>, compound <b>16</b>) were then prepared, and <b>16</b> was the only compound identified as a metabolic product of <b>1a</b> by mouse liver microsomes, thus implicating the anilinic amide as the primary site for hydrolysis (amide bond b in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). The evidence also suggests that amide bond a is stable and not labile to hydrolytic cleavage.</div><figure id="fig6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0006.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Amide bonds in compound <b>1a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As a follow-up experiment, the anilinic nitrogen in <b>1a</b> was replaced with a methylene to provide <b>8p</b> and eliminate the possibility of amide hydrolysis of amide bond b The calculated half-life remained short (20 min) in the presence of cofactors, but the parent remained intact after 2 h when incubated in the presence of mouse liver microsomes without cofactors. CYP-mediated oxidative metabolism was therefore implicated as a competing metabolic pathway. We then incubated <b>8p</b> at a higher concentration (80 μM) in order to elucidate the primary metabolites and determine potential sites for oxidative metabolism. Proposed metabolites and biotransformations are listed in <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a> (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01568/suppl_file/jm6b01568_si_001.pdf" class="ext-link">Supporting Information</a> for a detailed rationale for this analysis). The core ring system and the phenyl ring were implicated as primary sites for oxidative metabolism, and much of our SAR strategy was accordingly directed toward modifications at these sites.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Major Metabolites of <b>8p</b> by Mouse Liver Microsomes and Proposed Biotransformations<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">metabolite</th><th class="colsep0 rowsep0" align="center">retention time (min)</th><th class="colsep0 rowsep0" align="center"><i>m</i>/<i>z</i> (Δ Da)</th><th class="colsep0 rowsep0" align="center">proposed biotransformation</th><th class="colsep0 rowsep0" align="center">proposed site of biotransformation</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">M1</td><td class="colsep0 rowsep0" align="left">7.0</td><td class="colsep0 rowsep0" align="left">556 (+192)</td><td class="colsep0 rowsep0" align="left">glucuronide of M3</td><td class="colsep0 rowsep0" align="left">phenyl ring hydroxyl</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">M2</td><td class="colsep0 rowsep0" align="left">9.7</td><td class="colsep0 rowsep0" align="left">396 (+32)</td><td class="colsep0 rowsep0" align="left">(di)hydroxylation/<i>N</i>-oxide(s)</td><td class="colsep0 rowsep0" align="left">pyrazole ring</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">M3</td><td class="colsep0 rowsep0" align="left">10.1</td><td class="colsep0 rowsep0" align="left">380 (+16)</td><td class="colsep0 rowsep0" align="left">monohydroxylation</td><td class="colsep0 rowsep0" align="left">phenyl ring</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">M4</td><td class="colsep0 rowsep0" align="left">10.6</td><td class="colsep0 rowsep0" align="left">380 (+16)</td><td class="colsep0 rowsep0" align="left">monohydroxylation or <i>N</i>-oxide</td><td class="colsep0 rowsep0" align="left">pyrazole ring</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">parent</td><td class="colsep0 rowsep0" align="left">12.9</td><td class="colsep0 rowsep0" align="left">364 (MH<sup>+</sup>)</td><td class="colsep0 rowsep0" align="left">parent</td><td class="colsep0 rowsep0" align="left">N/A</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Detailed procedure is in <a href="/doi/suppl/10.1021/acs.jmedchem.6b01568/suppl_file/jm6b01568_si_001.pdf" class="ext-link">Supporting Information</a></p></div></div></div><div class="NLM_p">Two additional analogues were designed specifically to substitute the amide bond b for a metabolically more stable alternative. This effort produced compounds that feature a CH<sub>2</sub> substitution (<b>8q</b>) and an SO<sub>2</sub> replacement (<b>8r</b>). Encouragingly, compounds <b>8p</b> and, albeit to a lesser degree, <b>8q</b> maintained antiviral activity (EC<sub>50</sub> = 0.07 μM and 0.5 μM, respectively). Despite the successful replacement of amide bond b, however, compound <b>8p</b> yielded only a 2-fold improvement in half-life (20 min) compared to <b>8g</b> when incubated with mouse S9 subcellular fractions. Several other compounds were assessed with modifications on the aromatic ring, but none was successful in addressing the high rate of metabolism by mouse liver S9 fractions, likely rendering them unsuitable for use in mouse models of RSV infection. However, the longer half-life in human liver S9 fractions and the acceptable aqueous solubility observed with several compounds tested (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>) support further investigation with this series for possible advancement toward use in humans.</div><div class="NLM_p">Our third target for SAR development was section <b>B</b> of the hit scaffold, the central 5–7 fused ring system (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). To explore the amenability of this section to substitution, we altered the size and nature of the system. Replacing the 7-membered ring with a 6-membered ring (compound <b>9a</b>) completely eliminated antiviral activity (EC<sub>50</sub> > 10 μM). In addition, substitution of the pyrazole ring for a pyrrole moiety (compound <b>9b</b>) reduced potency, although modest antiviral activity was still observed (EC<sub>50</sub> = 3.19 μM).</div><div class="NLM_p last">Several representatives of each analogues set were tested for aqueous solubility (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>) including <b>1a</b>, <b>8g</b>, <b>8p</b>, and <b>8n</b>. Poor solubility at concentrations exceeding approximately 50 μM interfered with cytotoxicity testing in several cases. The solubility showed minimal dependence on pH. We did not focus on aqueous solubility as a selection criterion because the observed solubilities are on the lower end of what are typically considered acceptable. However, we recognize that detailed preformulation studies may be required before compounds of this type can be advanced in development.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> QSAR Model Building</h3><div class="NLM_p">To extract a graphical summary of the nascent SAR that may serve as a framework for future chemical development of the scaffold, we generated 3D-QSAR models using the AutoGPA module<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> embedded in the MOE software package.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><div class="NLM_p">Ranking of 147 automatically generated initial pharmacophore models identified a superior representation that showed acceptable predictive capacity (<i>q</i><sup>2</sup> = 0.7552) when evaluated against a test set of six compounds selected from the pool of bioactives (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>). This top-scoring model fully reflected our initial impression that both the central region B and in particular section <b>A</b> of the scaffold are sterically highly controlled and unaccepting of bulkier substitutions. The predicted allowable space contour map is most relaxed around section <b>C</b>, which accurately represents our experience that a number of analogues of the second series demonstrate consistent or improved inhibitory activity. Highlighted by the red and blue contours in the model, the presence of electron donating groups in section <b>A</b> and electron acceptance by the C region are predicted to be a key feature of ligand docking.</div><figure id="fig7" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0007.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Pharmacophore modeling. (A) AutoGPA-based 3D-QSAR model, shown from two rotational angels. Orange and green spheres represent aromatic and hydrophobic centers, respectively. The allowable space model is shown in gray, and electrostatically active portions are in red and blue. Areas of steric constrain (yellow) and freedom (solid green) are marked. (B) Correlation between the predicted and observed pIC50 values for the training (19 compounds) and test (6 compounds) sets. Model statistics are shown in the graph.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76626" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76626" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this study, we have implemented an open screening campaign against a novel RSV reporter virus carrying a signature pan-resistance mutation that mediates viral escape from known RSV entry inhibitors. A panel of automated direct and orthogonal counterscreens centered on recombinant RSV strains with distinct reporter technology expedited the identification of 14 confirmed hits, corresponding to an overall hit discovery rate in this campaign of approximately 0.028%. Mechanistic characterization through minigenome reporter assays monitoring RSV RdRp activity suggested that all of these confirmed compounds interfere with activity of the RSV polymerase machinery. In the case of <b>1a</b>, this observation was corroborated by quantitation of the relative viral N mRNA level in virus infected cells. Although this particular screen was limited to a moderate size library of 50,640 compounds, an entirely RdRp-centric hit activity profile is in our experience unusual for drug screens against RSV since small-molecule entry inhibitors emerge readily in anti-RSV campaigns. On the basis of the available data set alone, we cannot definitely address whether it may be feasible in principle to overcome RSV pan-resistance through a new generation of small molecule entry blockers. However, the noticeable absence of this usually prominent hit class from our pool of confirmed candidates indicates that the threshold against efficient inhibition of the entry machinery of this mutant RSV strain must be considerably increased. This finding is consistent with the notion that pan-resistance likely represents a composite phenotype, arising from a blend of primary resistance and kinetic, secondary escape from entry inhibition.<a onclick="showRef(event, 'ref15 ref36'); return false;" href="javascript:void(0);" class="ref ref15 ref36">(15, 36)</a> It remains to be seen whether structure-guided optimization of currently existing, pan-resistance-sensitive scaffolds will illuminate a path toward overcoming viral escape, but the outcome of our HTS campaign provides little encouragement. Ultimately, therapeutic targeting of the viral RdRp complex may represent the more fruitful strategy toward developing anti-RSV therapeutics with a lasting clinical impact.</div><div class="NLM_p">Compound <b>1a</b> was selected for SAR development based on initial potency, absence of obvious chemical liabilities, and potential for chemical elaboration. Although resistance profiles have not yet been generated for this compound class, quantitation of relative viral RNA levels synthesized in the presence of compound in a one-step replication cycle confirmed inhibition of RdRp complex activity. The 3D-QSAR model best summarizes the insight gained from our initial chemical elaboration efforts. Without knowledge of the binding site or docking pose of the hit compound, it was the primary goal of the initial synthetic efforts to establish a basic framework of the underlying SAR profile. Consequently, synthesis was directed toward appreciating the basic impact of structural modifications on antiviral potency and cytotoxicity. Three major conclusions can be drawn from the resulting data set: (i) The section <b>A</b> portion of the molecule, bearing the furanyl amide, was highly sensitive to modification. A diverse set of substitutions were made that contributed modest electronic and/or steric alterations, and all resulted in moderate to catastrophic losses in antiviral potency, suggesting that this region likely stands in close-range interaction with the RdRp target. Fortunately, data generated from <i>in vitro</i> metabolism studies showed that this portion of the molecule was not sensitive to either amide hydrolysis or oxidative metabolism. We therefore refrained from further modification of this substructure and turned our attention to section <b>B</b>, bearing the phenyl amide moiety, which was found to be sensitive to both types of metabolic attack.</div><div class="NLM_p">(ii) Importantly, the central amide linker presented as partially amenable to modification, providing a basis to probe its contribution to metabolic instability. While several modifications designed to address hydrolytic cleavage of the amide linker resulted in loss of activity including N-methylation (<b>8a</b>), inversion of the amide group (<b>8s</b>), and isosteric substitution as a sulfonamide (<b>8r</b> and <b>8t</b>), others retained sufficient activity to remain viable as potential tools for the development of more metabolically stable analogues. These included conversion of the amide to a ketone (<b>8p</b>) and alkylamine (<b>8q</b>). However, a detailed analysis of the metabolites emerging from the exposure of <b>8p</b> to mouse microsomes revealed that even though the hydrolytic cleavage issue had been circumvented, oxidative metabolism was occurring both on the core ring structure and on the aromatic ring. Initial attempts to modify the core bicyclic ring structure compromised antiviral potency.</div><div class="NLM_p">(iii) Substitutions on the aromatic ring were well-tolerated, indicating a considerable degree of structural freedom at this position, which argues against a direct engagement of the target by this substructure. Accordingly, we explored several iterations at the ortho- and para-positions in order to block the most common sites of oxidative metabolism. This exercise yielded compounds <b>8i</b>, <b>8l</b>, and <b>8n</b>, which revealed that both positions accept substituents that can block oxidative metabolism, retain nanomolar potency, and provide acceptable SI’s.</div><div class="NLM_p last">On the basis of this QSAR-driven insight, we intend to next launch a comprehensive lead optimization program to identify an analogue that is suitable for efficacy testing in the mouse model of RSV infection before ultimately advancing to formal development.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10058" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10058" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Cells and Viruses</h3><div class="NLM_p last">Human carcinoma (HEp-2, ATCC CCL-23), human bronchial epithelial (BEAS-2B, ATCC CRL-9609), human embryonic kidney (293T, ATCC CRL-3216), and Madin Darby canine kidney (MDCK, ATCC CCL-34) cells were maintained at 37 °C and 5% CO<sub>2</sub> in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 7.5% fetal bovine serum. Cell lines were obtained directly from the ATCC. Cell lines are replaced with cryo-preserved low-passage stocks after approximately 20–30 passages in culture. All cell lines in culture in the laboratory are routinely screened for mycoplasma contaminations on a biannual basis. GeneJuice (EMD) was used for all transient transfection reactions. IAV stocks were grown on MDCK cells, while all RSV stocks were propagated on HEp-2 cells inoculated at a multiplicity of infection (MOI) of 0.01 pfu/cell. Infected cells were kept for 16 h at 37 °C, followed by incubation at 32 °C for five to 7 days. Cell-associated progeny virus was released through one freeze/thaw cycle and titers determined by TCID<sub>50</sub> titration on HEp-2 cells. Asunaprevir (ASV) was obtained from Santa Cruz Biotechnology. When included, ASV was added at the time of virus infection. For purification of virus screening stocks, progeny virions in culture supernatants (IAV stocks) or released through one freeze/thaw cycle from infected cells (RSV stocks) were cleared (4,000<i>g</i> for 20 min at 4 °C), then pelleted (60,000<i>g</i> for 30 min at 4 °C). The pelleted material was resuspended in TNE buffer (50 mM Tris/Cl at pH 7.2, 10 mM EDTA) and purified through a 20/60% one-step sucrose gradient in TNE buffer (100,000<i>g</i> for 90 min at 4 °C). Virions were harvested from the gradient intersection.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> High-Throughput Screening</h3><div class="NLM_p last">Screening libraries were sourced from the ChemBridge collections and dissolved in DMSO to 10 mM concentration in 96-well master plates and stored at −80 °C. The MScreen software package<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> was used for electronic compound management, HTS data storage, and data analysis. Inventoried libraries were reformatted into barcoded 384-well daughter plates using a Nimbus liquid handler (Hamilton Robotics) with multichannel pipetting head. Sixty-four wells on each 384-well stock plate were reserved for positive and negative controls, located in the outermost columns and arranged in a checkerboard pattern. For screening, BEAS-2B cells (3.5 × 103/well) were injected in 30 μL/well into barcoded white wall/clear bottom 384-well plates using a MultiFlo automated dispenser (BioTek) equipped with dual 10-μL peristaltic pump manifolds, collected (150<i>g</i> for 90 s at 25 °C), and incubated for 14 h at 37 °C and 5% CO<sub>2</sub>. Compound was added to a final concentration of 5 μM (20 nL/well) using a high-density pin tool (V&P Scientific) attached to the pipetting head of the Nimbus liquid handler, followed by coinfection with recRSV A2-L19FD489E-fireSMASh (MOI = 0.1) and recIAV WSN-NanoLuc (MOI = 0.02) in 10 μL/well using the MultiFlo dispenser unit, spin collection (150<i>g</i> for 90 s at 25 °C), and incubation for 40 h at 37 °C and 5% CO<sub>2</sub>. Final vehicle (DMSO) concentration was 0.05%. Barcodes of source and assay plates were automatically detected and recorded by the Nimbus unit at the time of stamping. Using a stacker unit with integrated barcode reader (Biotek) attached to an H1 synergy plate reader, plates were automatically loaded, dual-Glo substrates (15 μL/well each) injected, and bioluminescence recorded after a 3 min lag time for each well and substrate. Readouts were automatically saved by plate barcode and imported into the MScreen IT environment.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Data Analysis and Hit Identification</h3><div class="NLM_p last">Normalized relative values were automatically calculated in the MScreen package by subtracting from each value the average of the plate vehicle controls, followed by dividing the results by the difference between the means of plate vehicle positive and negative controls. Robust z-scores were calculated as follows: <span class="NLM_inline-formula"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/jm-2016-01568k_m001.gif" alt="" /></img></span> and MAD(S<sub>all</sub>) = 1.4826 × medain (|S<sub>i</sub> – medain(S<sub>all</sub>)|). Hit candidates were defined as compounds showing ≥75% inhibition of normalized signal intensity against either viral target or both and a robust z-score ≥4.5.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Counterscreening Campaigns</h3><div class="NLM_p last">For single concentrations direct counter- and cytotoxicity screens, hit candidates were automatically picked into a single 384-well plate and stamped against recRSV-L19FD489E-fireSMASh grown on BEAS-2B cells. Reporter signals were recorded as outlined above, but only control well-dependent % inhibition calculated due to the high number of positives present on the confirmation plates. All confirmation plates were tested twice in independent repeats. To determine cell viability, the PrestoBlue substrate (life technologies) was added after 48 h of incubation of uninfected but compound treated cells at 37 °C (5 μL/well) and top-read fluorescence (excitation at 560 nm, emission at 590 nm, and instrument gain of 85) recorded after incubation for 90 min at 37 °C using the H1 synergy plate reader. For dose–response counterscreens, serial 3-fold compound dilutions were prepared in three repeats in 96-well plates using the Nimbus liquid handler. BEAS-2B cells (1.5 × 104 cells/well) were plated in 96-well plates, serial dilutions transferred to the cell plates using the liquid handler, and cells infected with recRSV-A2-L19FD489E-fireSMASh (MOI = 0.1) or recRSV-A2-L19F-renilla (MOI = 0.1). Each plate contained negative and positive control wells in four replicates each, and raw data of all dose–response screens were analyzed according to the formula % inhibition = (<i>X</i><sub>Sample</sub> – <i>X</i><sub>Min</sub>)/(<i>X</i><sub>Max</sub> – <i>X</i><sub>Min</sub>) × 100 with <i>X</i><sub>Min</sub> representing the average of the positive and <i>X</i><sub>Max</sub> the average of the negative control wells. Four-parameter variable slope regression was applied to determine 50% active (EC<sub>50</sub>) concentrations. For virus yield assays, cells were infected in a 12-well plate format with recRSV-A2-L19F-mKate expressing a far-red fluorescent protein<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> at an MOI of 0.05 particles/cell in the presence of serial compound dilutions and incubated at 37 °C. Cell-associated progeny virions were harvested 48 h postinfection, released as described, and virus titers in each sample determined through TCID<sub>50</sub> titration.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Minigenome Reporter Assays</h3><div class="NLM_p last">For minireplicon assays, an RSV firefly luciferase minigenome construct under the control of the constitutive RNA pol I promoter (pHH-RSV-repl-firefly) was used that we have previously described.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> 293T cells were cotransfected with this minigenome and plasmids pRSV-L, pRSV-M2-1, pRSV-N, and pRSV-P, respectively, under CMV promoter control. Test compounds were added in serial dilutions and luciferase reporter activities determined 40–44 h post-transfection.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Reverse Transcription QPCR</h3><div class="NLM_p last">Cells were infected with recRSV-A2-L19F-mKate (MOI = 3 particles/cell) and incubated in the presence of different <b>1a</b> concentrations ranging from 0.1 to 10 μM, 30 μM of the nucleoside-analogue RSV RdRp inhibitor <b>2</b><sup>13</sup>, or vehicle (DMSO) for control at 37 °C. Twenty hours postinfection, total RNA was prepared from all wells using a QIAcube automated extractor and the RNeasy Mini Kit (Qiagen), and subjected to reverse transcription using Superscript III Reverse Transcriptase and oligo-dT primer of first strand synthesis. Real-time reactions were carried out using an Applied Biosystems 7500 Fast real-time PCR system, PowerUp Sybr Green Master mix (Thermo-Fisher scientific), and primer pairs specific for a fragment in the RSV N open reading frame or human GAPDH, respectively. Melting curves were generated for each primer pair to verify amplification of a single product. To calculate ΔΔCT values, CT values obtained for each sample were normalized for GAPDH as reference and then ΔCT values of inhibitor treated samples normalized for the DMSO-treated controls. Final quantification was based on three independent experiments in which each treatment condition and RT primer setting were assessed in duplicate.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> QSAR Model Building</h3><div class="NLM_p last">All energy minimization, conformation searches, and model building were performed by MOE 2015 × 10<sup>35</sup>. The AutoGPA module<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> embedded in MOE was used to develop 3D-QSAR models. For model building, 25 structures were chosen that showed various inhibitory activities, ranging in EC<sub>50</sub> concentration from 0.01 to 30 μM. This panel was divided into a training set (19 entries compounds <b>1a</b>, <b>1c</b>, <b>1f</b>, <b>1g</b>, <b>1l</b>, <b>1m</b>, <b>8a</b>, <b>8b</b>, <b>8c</b>, <b>8d</b>, <b>8f</b>, <b>8g</b>, <b>8h</b>, <b>8i</b>, <b>8j</b>, <b>8k</b>, <b>8l</b>, <b>8o</b>, and <b>8q</b>) and a test set (6 entries; compounds <b>1b</b>, <b>8e</b>, <b>8n</b>, <b>8p</b>, <b>9b</b>, and <b>9c</b>). Prior to input, EC<sub>50</sub> values were converted to pIC<sub>50</sub> (−log10(EC<sub>50</sub>)), compounds then drawn and energy minimized under the Merck molecular force field 94X (MMFF94X). Conformational alternatives of each compound were generated using the conformational search function of the AutoGPA package. A total of 983 and 351 conformations were generated for the training and test sets, respectively, which were then aligned and assigned pharmacophore properties. AutoGPA identified common features and created 147 initial pharmacophore models based on the training set. Employing the CoMFA algorithm,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> all molecules were placed in a 3D grid box with 2 Å separation, and electrostatic and steric interaction energies between each molecule were calculated. An sp3 carbon atom probe evaluated the allowable space and molecular field surrounding the compounds. Subsequently, a partial-least-squares analysis was performed to analyze the relationship between grid potential fields and inhibitory activity to create the AutoGPA-based 3D-QSAR. The test set subsequently provided analogues with known bioactivity to evaluate the predictive capacity of the model.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Statistical Analysis</h3><div class="NLM_p last">The MScreen, Excel, and Prism 7 (GraphPad) software packages were used for data analysis. To determine antiviral potency, EC<sub>50</sub> concentrations were determined from dose–response data sets through four parameter variably slope regression modeling using the Prism package. The statistical significance of differences between groups was assessed through one-way analysis of variance (ANOVA) in combination with Sidak’s multiple comparison post-test. Experimental uncertainties are identified by error bars, representing standard deviations (SD) or standard error of the mean (SEM) as specified in figure legends.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Procedure for Aqueous Solubility</h3><div class="NLM_p last">The compounds and an internal control were dissolved in 100% DMSO to obtain a stock concentration of 30 mg/mL. The 30 mg/mL stock solution was serially diluted (concentration profile: 30, 20, 15, 10, 7.5, 5, 2.5, 1.25, 0.63, 0.31, and 0.15 mg/mL) in test tubes with 100% DMSO. The concentration profile was transferred to 96 well microplates and serially diluted to a final DMSO (EMD) concentration of 1% and a final drug concentration 300, 200, 150, 100, 75, 50, 25, 12, 6, 3, and 1.5 μg/mL with phosphate buffered saline, pH 7.4, (Sigma). Compounds that are pH dependent were assayed at pH 3 and 5 in addition to pH 7.4. Citrate buffer was the diluent used for pH 3 and 5. Microplates were incubated for 90 min at ambient temperature. Laser nephelometry (NEPHELOstar, BMG Lab Technologies), measuring forward scattered light, was used to determine the point at which the solute began to precipitate out of solution.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Metabolic Stability Study</h3><div class="NLM_p last">Compounds were incubated in triplicate with mouse or human S9 hepatocyte subcellular fractions or microsomes (XenoTech/BioreclamationIVT, 0.5 mg total protein) at final concentrations of 1 μM for metabolic stability or 80 μM for metabolite ID, with the necessary cofactors for phase I oxidations and phase II glucuronide conjugation. Incubations were performed in 13 × 100 mm glass culture tubes. Samples were placed in a water bath shaker set at 37 °C and shaken at 150 rpm. Positive controls consisted of 1 μM verapamil (phase I) and 175 μM 7-hydroxycoumarin (phase II) and were run in parallel to test system for competency. Negative controls (without cofactors) were also run to access noncytochrome-P450 metabolism. A negative control containing no microsomes was run to assess chemical stability. Aliquots of 100 μL were taken at the following time-points: 0, 15, 30, 60, and 120 min; and only at 0 and 120 min for the negative controls. These aliquots were mixed with 400 μL of a suitable organic internal standard solution (ISTD) in 1.7 mL conical polypropylene microcentrifuge tubes. Subsamples plus ISTD from each time point were vortexed for about 10 s and then centrifuged for 2 min at 13,000 rpm. Supernatants were decanted into 2 mL of LC vials and analyzed by LC-MS full-scan and/or LC-MS. For metabolite ID samples, after 2 h of incubation the whole sample was quenched with acidified acetonitrile, and the organic solvent was evaporated under a gentle nitrogen stream prior analysis. Half-life (<i>t</i><sub>1/2</sub>) was estimated by plotting the natural logarithm of % parent vs time and obtaining the slope of the line. Assuming first-order kinetics, the elimination rate constant, <i>k</i>, is the negative (−) of the slope of the plot (ln % parent vs time). Half-life (<i>t</i><sub>1/2</sub>) (min) = −0.693/ (slope).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Chemistry</h3><div class="NLM_p">Unless otherwise noted, all materials were obtained from commercial suppliers and used without purification. Dry organic solvents, packaged under nitrogen in septum sealed bottles, were purchased from EMD Millipore and Sigma-Aldrich Co. Reactions were monitored using EMD silica gel 60 F<sub>254</sub> TLC plates or using an Agilent 1200 series HPLC system with a diode array detector and an Agilent 6120 quadrupole MS detector. Compound purification was accomplished by liquid chromatography on a Teledyne Isco CombiFlash RF+ flash chromatography system. <sup>1</sup>H NMR and <sup>19</sup>F spectra were recorded on an Agilent NMR spectrometer (400 MHz) at room temperature. Chemical shifts are reported in ppm relative to CDCl<sub>3</sub> (7.26) or CD<sub>3</sub>OD (3.31). The residual shifts were taken as internal references and reported in parts per million (ppm). All target compounds in this article appear as two or more distinct rotamers on the NMR time scale; accordingly, the <sup>13</sup>C NMR spectra were complex and not interpretable. Data were therefore not included. Purities of all compounds were determined by high-performance liquid chromatography (HPLC), using an Agilent 1200 HPLC system with a Zorbax Eclipse XDB C18 column (4.6 × 50 mm, 3.5 μm) at 254 nm, and 0.1% formic acid in MeOH (solvent A) and 0.1% formic acid in water (solvent B) solvent mixtures, at 1 mL/min. Method A: 5 min, 60% solvent A/40% solvent B to 95% solvent A/5% solvent B; method B: 8 min, 60% solvent A/40% solvent B to 95% solvent A/5% solvent B; method C: 5 min, 70% solvent A/30% solvent B to 95% solvent A/5% solvent B. The HRMS experiments were performed with a Thermo LTQ-FTMS, using a nanospray source.</div><div id="sec4_11_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 5-((2-Nitrophenyl)sulfonyl)-<i>N</i>-phenyl-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>11</b>)</h4><div class="NLM_p last">To a solution of HOBt (367 mg, 2.72 mmol), EDCI (521 mg, 2.72 mmol), and aniline (207 μL, 2.27 mmol) in DMF (11 mL) was added 5-((2-nitrophenyl)sulfonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxylic acid (<b>10</b>)<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (830 mg, 2.27 mmol) in one portion. The reaction was stirred for 72 h and diluted with water (100 mL), and the aqueous phase was extracted with EtOAc (3 × 75 mL). The combined organic phases were washed with brine (50 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The residue was purified via flash chromatography (SiO<sub>2</sub>, 25 to 70% EtOAc in hexanes) to give <b>11</b> (654 mg, 1.48 mmol, 65% yield) as a light yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.58 (s, 1H), 8.03–7.96 (m, 1H), 7.74–7.59 (m, 5H), 7.40–7.32 (m, 2H), 7.15–7.07 (m, 1H), 6.81 (s, 1H), 4.60 (s, 2H), 4.49–4.43 (m, 2H), 3.80–3.72 (m, 2H), 2.17–2.05 (m, 2H). MS (ESI) [M + H]<sup>+</sup>: 442.0.</div></div><div id="sec4_11_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> <i>N</i>-Phenyl-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>12</b>)</h4><div class="NLM_p last">To a suspension of 5-((2-nitrophenyl)sulfonyl)-<i>N</i>-phenyl-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide <b>11</b> (0.87 g, 1.971 mmol) and cesium carbonate (1.284 g, 3.94 mmol) in acetonitrile (20 mL) was added a solution of thiophenol (0.405 mL, 3.94 mmol) in acetonitrile (1 mL). The reaction was stirred at RT for 4 h and concentrated under vacuum. The residue was suspended in CH<sub>2</sub>Cl<sub>2</sub>, filtered through a cotton plug, and purified via flash chromatography (SiO<sub>2</sub>, 0 to 4% MeOH in CH<sub>2</sub>Cl<sub>2</sub>, <i>R</i><sub>f</sub> = 0.25, 5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to give <b>12</b> (250 mg, 0.975 mmol, 50% yield) as a white crystalline solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.66 (s, 1H), 7.69–7.64 (m, 2H), 7.37–7.30 (m, 2H), 7.12–7.06 (m, 1H), 6.66 (s, 1H), 4.45–4.35 (m, 2H), 3.92 (s, 2H), 3.24–3.17 (m, 2H), 1.92–1.81 (m, 2H). MS (ESI) [M + H]<sup>+</sup>: 257.1.</div></div><div id="sec4_11_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Synthesis of 5-(3-Methylfuran-2-carbonyl)-<i>N</i>-phenyl-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>1a</b>)</h4><div class="NLM_p last">To a solution of HOBt (89 mg, 0.66 mmol), EDCI (126 mg, 0.66 mmol), and <i>N</i>-phenyl-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>12</b>) (140 mg, 0.55 mmol) in DMF (5.4 mL) was added 3-methylfuran-2-carboxylic acid (69 mg, 0.55 mmol) in one portion. The reaction was stirred for 24 h. The reaction mixture was partitioned between EtOAc (50 mL) and water (50 mL), and the aqueous phase was extracted with EtOAc (2 × 50 mL). The combined organic phases were washed with brine (50 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and purified via flash chromatography (SiO<sub>2</sub>, 40 to 60% EtOAc in hexanes, <i>R</i><sub>f</sub> = 0.2, 60% EtOAc in hexanes) to give <b>1a</b> (111 mg, 0.30 mmol, 56% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.64 (s, 1H), 7.66 (d, <i>J</i> = 7.8 Hz, 2H), 7.41–7.30 (br s, 1H, overlapped), 7.34 (t, <i>J</i> = 7.9 Hz, 2H), 7.10 (t, <i>J</i> = 7.4 Hz, 1H), 6.77 (br s, 1H), 6.34 (d, 1H), 4.84 (s, 2H), 4.55–4.45 (m, 2H), 4.05–3.93 (m, 2H), 2.27 (s, 3H), 2.13 (br s, 2H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>21</sub>N<sub>4</sub>O<sub>3</sub>, 365.16082; found, 365.16077. HPLC purity: 98.2% (method A).</div></div><div id="sec4_11_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Synthesis of Compounds <b>1b</b>–<b>1s</b></h4><div class="NLM_p last">Compounds <b>1b</b>–<b>1s</b> were prepared by employing a procedure similar to that described for compound <b>1a</b>, with <i>N</i>-phenyl-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>12</b>) and the corresponding carboxylic acid.</div></div><div id="sec4_11_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 5-(Furan-2-carbonyl)-<i>N</i>-phenyl-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>1b</b>)</h4><div class="NLM_p last">Compound <b>1b</b> was obtained as a white solid in 66% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.63 (s, 1H), 7.66 (m, 2H), 7.54 (br s, 1H), 7.37–7.31 (m, 2H), 7.14–7.08 (m, 2H), 6.81 (br s, 1H), 6.50 (dd, <i>J</i> = 3.5, 1.8 Hz, 1H), 4.93 (br s, 2H), 4.57–4.47 (m, 2H), 4.07 (br s, 2H), 2.19–2.09 (br m, 2H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>19</sub>N<sub>4</sub>O<sub>3</sub>, 351.14517; found, 351.14511. HPLC purity: 96.9% (method A).</div></div><div id="sec4_11_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 5-(3-Methylthiophene-2-carbonyl)-<i>N</i>-phenyl-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>1c</b>)</h4><div class="NLM_p last">Compound <b>1c</b> was obtained as a white solid in 57% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.63 (s, 1H), 7.74–7.62 (m, 2H), 7.39–7.31 (m, 2H), 7.28 (d, <i>J</i> = 5.0 Hz, 1H), 7.15–7.07 (m, 1H), 6.85 (d, <i>J</i> = 5.0 Hz, 1H), 6.67 (br s, 1H), 4.68 (br s, 2H), 4.55–4.47 (m, 2H), 3.94 (br s, 2H), 2.15 (s, 3H), 2.13–2.01 (br m, 2H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>19</sub>N<sub>4</sub>O<sub>3</sub>, 351.14517; found, 351.14511. HPLC purity: 98.8% (method A).</div></div><div id="sec4_11_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 5-(3-Methyl-1<i>H</i>-pyrrole-2-carbonyl)-<i>N</i>-phenyl-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>1d</b>)</h4><div class="NLM_p last">Compound <b>1d</b> was obtained as a white solid in 87% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD/CDCl<sub>3</sub> 1:1) δ 7.67–7.59 (m, 2H), 7.37–7.27 (m, 2H), 7.13–7.07 (m, 1H), 6.74 (d, <i>J</i> = 2.6 Hz, 1H), 6.64 (br s, 1H), 6.00–5.97 (m, 1H), 4.72 (br s, 2H, overlapped with HOD signal), 4.57–4.48 (m, 1H), 3.94 (t, <i>J</i> = 5.4 Hz, 2H), 2.10 (s, 3H), 2.06–1.98 (m, 2H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>22</sub>N<sub>5</sub>O<sub>2</sub>, 364.17680; found, 364.17609. HPLC purity: 95.7% (method B).</div></div><div id="sec4_11_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 5-(1,3-Dimethyl-1<i>H</i>-pyrrole-2-carbonyl)-<i>N</i>-phenyl-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>1e</b>)</h4><div class="NLM_p last">Compound <b>1e</b> was obtained as a white solid in 68% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.62 (s, 1H), 7.66 (d, <i>J</i> = 7.9 Hz, 2H), 7.34 (t, <i>J</i> = 7.6 Hz, 3H), 7.10 (t, <i>J</i> = 7.2 Hz, 2H), 6.56 (s, 1H), 5.91 (s, 1H), 4.95 (br s, 1H), 4.68–4.14 (br m, 4H), 3.34 (s, 3H), 2.16–1.85 (br m, 2H, overlapped), 2.06 (s, 3H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + Na]<sup>+</sup> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>5</sub>O<sub>2</sub>Na, 400.17440; found, 400.17435. HPLC purity: 99.2% (method A).</div></div><div id="sec4_11_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 5-(3-Chlorofuran-2-carbonyl)-<i>N</i>-phenyl-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>1f</b>)</h4><div class="NLM_p last">Compound <b>1f</b> was obtained as a white solid in 62% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.63 (s, 1H), 7.70–7.63 (m, 2H), 7.52–7.39 (br m, 1H), 7.34 (t, <i>J</i> = 7.9 Hz, 2H), 7.10 (t, <i>J</i> = 7.4 Hz, 1H), 6.95–6.58 (br m, 1H), 6.51 (br s, 1H), 4.78 (s, 2H), 4.54–4.46 (m, 2H), 3.97 (br s, 2H), 2.16–2.08 (br m, 2H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>18</sub>N<sub>4</sub>O<sub>3</sub>Cl, 385.10619; found, 385.10609. HPLC purity: 98.6% (method A).</div></div><div id="sec4_11_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 5-(5,6-Dihydro-4<i>H</i>-cyclopenta[<i>c</i>]furan-1-carbonyl)-<i>N</i>-phenyl-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>1g</b>)</h4><div class="NLM_p last">Compound <b>1g</b> was obtained as a white solid in 59% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.62 (s, 1H), 7.75–7.58 (m, 2H), 7.38–7.28 (m, 2H), 7.17–7.04 (m, 2H), 6.81 (br s, 1H), 4.96 (br s, 2H), 4.60–4.42 (m, 2H), 4.07 (br s, 2H), 2.82 (t, <i>J</i> = 7.3 Hz, 2H), 2.62 (td, <i>J</i> = 7.3, 1.4 Hz, 2H), 2.36 (p, <i>J</i> = 7.4 Hz, 2H), 2.16–2.06 (br m, 2H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>23</sub>N<sub>4</sub>O<sub>3</sub>Cl, 391.17647; found, 391.17641. HPLC purity: 99.2% (method A).</div></div><div id="sec4_11_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> <i>N</i>-Phenyl-5-(3-phenylfuran-2-carbonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>1h</b>)</h4><div class="NLM_p last">Compound <b>1h</b> was obtained as a white solid in 86% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.59 (br s, 1H), 7.67 (br d, <i>J</i> = 7.9 Hz, 2H), 7.51 (br s, 1H), 7.42 (d, <i>J</i> = 7.5 Hz, 2H), 7.36–7.20 (m, 5H), 7.15–7.06 (m, 1H), 6.91 (br s, 0.5 H), 6.66 (br s, 1H), 6.45 (br s, 0.5H), 4.81 (br s, 1H), 4.49 (br s, overlapped, 1H), 4.42 (br s, 2H), 3.99 (br s, 1H), 3.63 (br s, 1H), 2.12 (br s, 1H), 1.78 (br s, 1H), 1.62 (s, 3H). MS (ESI) [M + H]<sup>+</sup>: HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>25</sub>H<sub>23</sub>N<sub>4</sub>O<sub>3</sub>, 427.17647; found, 427.17677. HPLC purity: 98.9% (method A).</div></div><div id="sec4_11_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 5-(3-Methylbenzofuran-2-carbonyl)-<i>N</i>-phenyl-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>1i</b>)</h4><div class="NLM_p last">Compound <b>1i</b> was obtained as a white solid in 79% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.64 (br s, 1H), 7.70–7.65 (m, 2H), 7.63–7.58 (m, 1H), 7.48–7.38 (br m, 1H), 7.38–7.28 (m, 3H), 7.14–7.08 (m, 1H), 6.98–6.69 (br m, 1H), 4.87 (s, 2H), 4.60–4.50 (m, 2H), 4.13–3.99 (br m, 2H), 2.46 (s, 3H), 2.25–2.15 (br m, 2H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + Na]<sup>+</sup> calcd for C<sub>24</sub>H<sub>22</sub>N<sub>4</sub>O<sub>3</sub>Na, 437.15841; found, 437.15927. HPLC purity: 98.6% (method C).</div></div><div id="sec4_11_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>N</i>-Phenyl-5-(3-(trifluoromethyl)furan-2-carbonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>1j</b>)</h4><div class="NLM_p last">Compound <b>1j</b> was obtained as a white solid in 22% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.62 (br s, 1H), 7.70–7.62 (m, 2H), 7.55 (br s, 0.5H, overlapped), 7.46 (br s, 0.5H, overlapped), 7.40–7.28 (m, 2H), 7.15–7.06 (m, 1H), 6.90 (br s, 0.5H), 6.71 (br s, 0.5H, overlapped), 6.67 (br s, 0.5H, overlapped), 6.58 (br s, 0.5H), 4.82 (br s, 1H), 4.60 (br s, 1H), 4.55–4.46 (m, 2H), 4.03 (br s, 1H), 3.74 (br s, 1H), 2.12 (br s, 2H). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −58.3 (s), −58.4 (s). Note: the <sup>1</sup>H and <sup>19</sup>F NMR spectra reveal the presence of two rotamers. HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>18</sub>N<sub>4</sub>O<sub>3</sub>F<sub>3</sub>, 419.13255; found, 419.13254. HPLC purity: 89.0% (method B).</div></div><div id="sec4_11_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 5-(3-Ethylfuran-2-carbonyl)-<i>N</i>-phenyl-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>1k</b>)</h4><div class="NLM_p last">Compound <b>1k</b> was obtained as a white solid in 77% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.62 (s, 1H), 7.72–7.62 (m, 2H), 7.39 (br s, 1H, overlapped), 7.40–7.29 (m, 2H), 7.16–7.05 (m, 1H), 6.76 (br s, 1H), 6.41 (d, <i>J</i> = 1.8 Hz, 1H), 4.83 (s, 2H), 4.56–4.47 (m, 2H), 4.04–3.94 (m, 2H), 2.71 (q, <i>J</i> = 7.6 Hz, 2H), 2.21–2.07 (m, 2H), 1.15 (t, <i>J</i> = 7.6 Hz, 3H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>4</sub>O<sub>3</sub>, 379.17646; found, 379.17636. HPLC purity: 99.5% (method B).</div></div><div id="sec4_11_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 5-(3,4-Dimethylfuran-2-carbonyl)-<i>N</i>-phenyl-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>1l</b>)</h4><div class="NLM_p last">Compound <b>1l</b> was obtained as a white solid in 45% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.63 (s, 1H), 7.68–7.64 (m, 2H), 7.38–7.29 (m, 2H), 7.19 (br s, 1H), 7.13–7.06 (m, 1H), 6.75 (br s, 1H), 4.84 (br s, 2H), 4.55–4.44 (m, 2H), 4.06–3.92 (m, 2H), 2.18 (s, 3H), 2.15–2.08 (br m, 2H), 1.95 (d, <i>J</i> = 1.0 Hz, 3H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>4</sub>O<sub>3</sub>, 379.17647; found, 379.17634. HPLC purity: 98.9% (method C).</div></div><div id="sec4_11_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 5-(3,5-Dimethylfuran-2-carbonyl)-<i>N</i>-phenyl-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>1m</b>)</h4><div class="NLM_p last">Compound <b>1m</b> was obtained as a white solid in 68% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.63 (s, 1H), 7.69–7.63 (m, 2H), 7.38–7.29 (m, 2H), 7.13–7.06 (m, 1H), 6.76 (br s, 1H), 5.95 (s, 1H), 4.84 (br s, 1H), 4.54–4.44 (m, 1H), 4.04–3.93 (m, 2H), 2.32 (br s, 3H), 2.22 (s, 3H), 2.16–2.07 (m, 2H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>4</sub>O<sub>3</sub>, 379.17647; found, 379.17648. HPLC purity: 97.4% (method C).</div></div><div id="sec4_11_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 5-(4,5-Dimethylfuran-2-carbonyl)-<i>N</i>-phenyl-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>1n</b>)</h4><div class="NLM_p last">Compound <b>1n</b> was obtained as a white solid in 54% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.63 (s, 1H), 7.69–7.63 (m, 2H), 7.37–7.31 (m, 2H), 7.14–7.06 (m, 1H), 6.88 (br s, 1H), 6.79 (br s, 1H), 4.92 (br s, 2H), 4.53–4.48 (m, 2H), 4.04 (br s, 2H), 2.30 (s, 1H), 2.16–2.07 (br m, 1H), 1.96 (br s, 1H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>4</sub>O<sub>3</sub>, 379.17647; found, 379.17645. HPLC purity: 97.9% (method C).</div></div><div id="sec4_11_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 5-(4-Methylfuran-2-carbonyl)-<i>N</i>-phenyl-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>1o</b>)</h4><div class="NLM_p last">Compound <b>1o</b> was obtained as a white solid in 76% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.63 (s, 1H), 7.68–7.64 (m, 2H), 7.37–7.29 (m, 2H), 7.28 (br s, overlapped, 1H), 7.13–7.07 (m, 1H), 6.95 (s, 1H), 6.79 (br s, 1H), 4.92 (br s, 2H), 4.54–4.47 (m, 2H), 4.05 (br s, 2H), 2.15–2.07 (br m, 2H), 2.05 (s, 3H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>21</sub>N<sub>4</sub>O<sub>3</sub>, 365.16082; found, 365.16147. HPLC purity: 96.4% (method A).</div></div><div id="sec4_11_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 5-(5-Methylfuran-2-carbonyl)-<i>N</i>-phenyl-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>1p</b>)</h4><div class="NLM_p last">Compound <b>1p</b> was obtained as a white solid in 54% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.63 (s, 1H), 7.68–7.62 (m, 2H), 7.37–7.30 (m, 2H), 7.12–7.07 (m, 1H), 6.99 (d, <i>J</i> = 3.3 Hz, 1H), 6.79 (br s, 1H), 6.11–6.07 (m, 1H), 4.90 (br s, 2H), 4.56–4.41 (m, 2H), 4.04 (br s, 2H), 2.39 (s, 3H), 2.18–2.04 (br m, 2H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>21</sub>N<sub>4</sub>O<sub>3</sub>, 365.16082; found, 365.16074. HPLC purity: 98.7% (method A).</div></div><div id="sec4_11_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 5-(4-Methylisoxazole-5-carbonyl)-<i>N</i>-phenyl-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>1q</b>)</h4><div class="NLM_p last">Compound <b>1q</b> was obtained as a white solid in 65% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.61 (s, 1H), 8.18 (s, 0.44 H), 8.16 (s, 0.56H), 7.69–7.63 (m, 2H), 7.40–7.29 (m, 2H), 7.14–7.08 (m, 1H), 6.91 (br s, 0.56H), 6.68 (br s, 0.44H), 4.85 (d, <i>J</i> = 8.6 Hz, 1H), 4.58–4.50 (br m, 2H), 4.10–3.98 (m, 0.88H), 4.02–3.92 (m, 1.12H), 2.21 (s, 3H), 2.13 (s, 2H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>20</sub>N<sub>5</sub>O<sub>3</sub>, 366.15607; found, 366.15601. HPLC purity: 98.7% (method A).</div></div><div id="sec4_11_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 5-(4-Methyloxazole-5-carbonyl)-<i>N</i>-phenyl-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>1r</b>)</h4><div class="NLM_p last">Compound <b>1r</b> was obtained as a white solid in 81% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.63 (s, 1H), 7.94–7.74 (br m, 1H), 7.68–7.59 (m, 2H), 7.36–7.26 (m, 2H), 7.13–7.03 (m, 1H), 6.91–6.60 (br m, 1H), 4.78 (br s, 2H), 4.52–4.43 (m, 2H), 4.05–3.89 (m, 2H), 2.40 (s, 3H), 2.04–2.04 (br m, 2H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>20</sub>N<sub>5</sub>O<sub>3</sub>, 366.15607; found, 366.15582. HPLC purity: 98.5% (method A).</div></div><div id="sec4_11_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> <i>N</i>-Phenyl-5-(pyrimidine-4-carbonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>1s</b>)</h4><div class="NLM_p last">Compound <b>1s</b> was obtained as a light yellow solid in 64% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.32 (d, <i>J</i> = 1.4 Hz, 0.5H), 9.23 (d, <i>J</i> = 1.4 Hz, 0.5H), 8.93 (d, <i>J</i> = 5.1 Hz, 0.5H), 8.90 (d, <i>J</i> = 5.1 Hz, 0.5H), 8.62 (br s, 1H, overlapped), 8.61 (br s, 1H, overlapped), 7.70–7.62 (m, 2.5H), 7.60 (dd, <i>J</i> = 5.1, 1.4 Hz, 0.5H), 7.39–7.31 (m, 2H), 7.15–7.07 (m, 1H), 6.94 (s, 0.5H), 6.45 (s, 0.5H), 4.93 (s, 1H), 4.87 (s, 1H), 4.60–4.49 (m, 2H), 4.14–4.05 (m, 1H), 3.97–3.88 (m, 1H), 2.21–2.12 (br m, 2H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>19</sub>N<sub>6</sub>O<sub>2</sub>, 363.15640; found, 363.15688. HPLC purity: 99.0% (method A).</div></div><div id="sec4_11_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 5-((3-Methylfuran-2-yl)methyl)-<i>N</i>-phenyl-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>1t</b>)</h4><div class="NLM_p last">To a solution of <i>N</i>-phenyl-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>12</b>) (100 mg, 0.39 mmol) in DMA (2.6 mL) were added 3-methylfuran-2-carbaldehyde (107 mg, 0.98 mmol) and acetic acid (67 μL, 1.2 mmol). The mixture was stirred for 10 min, and then NaBH(OAc)<sub>3</sub> (273 mg, 1.3 mmol) was added in one portion. The reaction was heated at 60 °C for 8 h, allowed to cool down to RT, and diluted with sat. aq. NaHCO<sub>3</sub> (50 mL). The aqueous phase was extracted with EtOAc (3 × 50 mL), and the combined organic phases were washed with brine (50 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under vacuum. The residue was purified via flash chromatography (SiO<sub>2</sub>, 20 to 60% EtOAc in hexanes, <i>R</i><sub>f</sub> = 0.20, 60% EtOAc in hexanes) to afford <b>1t</b> (18 mg, 0.051 mmol, 13% yield) as a light yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.66 (s, 1H), 7.68 (d, <i>J</i> = 7.7 Hz, 3H), 7.38–7.32 (m, 2H), 7.31 (d, <i>J</i> = 1.8 Hz, 1H), 7.13–7.07 (m, 1H), 6.68 (s, 1H), 6.20 (d, <i>J</i> = 1.8 Hz, 1H), 4.44–4.33 (m, 2H), 3.85 (s, 2H), 3.54 (s, 2H), 3.18–3.09 (m, 2H), 1.95 (s, 3H), 1.95–1.89 (m, 2H, overlapped). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>23</sub>N<sub>4</sub>O<sub>2</sub>, 351.18155; found, 351.18135. HPLC purity: 99.5% (method A).</div></div><div id="sec4_11_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 5-(Furan-2-ylsulfonyl)-<i>N</i>-phenyl-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>1u</b>)</h4><div class="NLM_p last">To a solution of <i>N</i>-phenyl-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>12</b>) (50 mg, 0.20 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) at 0 °C, under argon, were added DIPEA (51 μL, 0.20 mmol) and furan-2-sulfonyl chloride (36 mg, 0.22 mmol). The reaction was stirred overnight and quenched with sat. aq. NaHCO<sub>3</sub> (50 mL). The aqueous phase was extracted with EtOAc (3 × 50 mL), and the combined organic phases were washed with brine (50 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under vacuum. The residue was purified via flash chromatography (SiO<sub>2,</sub> 20 to 60% EtOAc in hexanes, <i>R</i><sub>f</sub> = 0.2, 60% EtOAc in hexanes) to afford <b>1u</b> (44 mg, 0.11 mmol, 58% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.57 (s, 1H), 7.72–7.60 (m, 2H), 7.41–7.29 (m, 3H), 7.16–7.06 (m, 1H), 6.96–6.93 (m, 1H), 6.68 (s, 1H), 6.43–6.40 (m, 1H), 4.56 (s, 2H), 4.45–4.36 (m, 2H), 3.85–3.73 (m, 2H), 1.95–2.05 (br m, 2H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>19</sub>N<sub>4</sub>O<sub>4</sub>S, 387.11215; found, 387.11227. HPLC purity: 99.2% (method A).</div></div><div id="sec4_11_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> Ethyl 5,6,7,8-Tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxylate (<b>14</b>)</h4><div class="NLM_p last">Compound <b>14</b> was prepared from 5-((2-nitrophenyl)sulfonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxylate (<b>13</b>)<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> by employing a procedure similar to that described for compound <b>12</b>. It was isolated in 66% yield as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.60 (s, 1H), 4.49–4.44 (m, 1H), 4.37 (q, <i>J</i> = 7.1 Hz, 2H), 3.91 (s, 2H), 3.23–3.17 (m, 1H), 1.90–1.79 (m, 2H), 1.37 (t, <i>J</i> = 7.1 Hz, 2H). MS (ESI) [M + H]<sup>+</sup>: 210.1.</div></div><div id="sec4_11_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Ethyl 5-(3-Methylfuran-2-carbonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxylate (<b>15</b>)</h4><div class="NLM_p last">To a solution of HOBt (275 mg, 2.04 mmol), EDCI (390 mg, 2.04 mmol), and ethyl 5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxylate <b>14</b> (355 mg, 1.70 mmol) in DMF (8.5 mL) was added 3-methylfuran-2-carboxylic acid (214 mg, 1.70 mmol) in one portion. The reaction was stirred for 24 h. The reaction mixture was partitioned between EtOAc (50 mL) and water (50 mL), and the aqueous phase was extracted with EtOAc (2 × 50 mL). The combined organic phases were washed with brine (50 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The residue was purified via flash chromatography (SiO<sub>2</sub>, 20 to 60% EtOAc in hexanes, <i>R</i><sub>f</sub> = 0.1, 50% EtOAc in hexanes) to give ethyl 5-(3-methylfuran-2-carbonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxylate (<b>15</b>) (485 mg, 1.53 mmol, 90% yield) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.33 (br s, 1H), 6.71 (br s, 0H), 6.32 (br s, 1H), 4.80 (br s, 2H), 4.59–4.49 (m, 2H), 4.35 (q, <i>J</i> = 7.1 Hz, 2H), 4.03–3.92 (m, 2H), 2.24 (s, 3H), 2.14–2.04 (m, 2H), 1.35 (t, <i>J</i> = 7.1 Hz, 3H). MS (ESI) [M + H]<sup>+</sup>: 318.1.</div></div><div id="sec4_11_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 5-(3-Methylfuran-2-carbonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxylic Acid (<b>16</b>)</h4><div class="NLM_p last">To a solution of ethyl 5-(3-methylfuran-2-carbonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxylate (<b>15</b>) (0.444 g, 1.40 mmol) in 4:1 THF/MeOH (14 mL) was added 3 N NaOH (1.87 mL, 5.60 mmol), and the resulting solution was stirred for 2 h, concentrated to dryness, and suspended in water (25 mL). The aqueous phase was extracted with diethyl ether (3 × 10 mL), acidified to pH 3 with 1 N HCl, and extracted with EtOAc (3 × 10 mL). The combined EtOAc layers were rinsed with brine (10 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated to provide <b>16</b> (385 mg, 1.33 mmol, 95% yield) as an amorphous white solid. The material was used in the following step without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.36 (br s, 1H), 6.78 (br s, 1H), 6.34 (s, 1H), 4.83 (br s, 2H), 4.64–4.49 (br m, 2H), 4.07–3.92 (br m, 2H), 2.26 (s, 3H), 2.17–2.05 (br m, 2H). MS (ESI) [M + H]<sup>+</sup>: 290.1.</div></div><div id="sec4_11_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>N</i>-Methyl-5-(3-methylfuran-2-carbonyl)-<i>N</i>-phenyl-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>8a</b>)</h4><div class="NLM_p last">To a solution of 5-(3-methylfuran-2-carbonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxylic acid (<b>16</b>) (75 mg, 0.26 mmol), HOBt (42 mg, 0.31 mmol), and EDCI (60 mg, 0.31 mmol) in DMF (1.3 mL) was added <i>N</i>-methylaniline (28 μL, 0.26 mmol) in one portion. The reaction was stirred for 24 h and partitioned between EtOAc (50 mL) and water (50 mL), and the aqueous phase was extracted with EtOAc (2 × 50 mL). The combined organic phases were washed with brine (50 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and purified via flash chromatography (SiO<sub>2</sub>, 35 to 100% EtOAc in hexanes, <i>R</i><sub>f</sub> = 0.05, 60% EtOAc in hexanes) to give <b>8a</b> (30 mg, 0.079 mmol, 31% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.37–7.22 (m, 4H), 7.17–7.07 (m, 2H), 6.30 (d, <i>J</i> = 1.8 Hz, 1H), 5.54 (br s, 1H), 4.57 (br s, 2H), 4.46–4.34 (br m, 2H), 3.93–3.85 (m, 2H), 3.44 (br s, 3H), 2.22 (s, 3H), 1.98 (br s, 2H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>4</sub>O<sub>3</sub>, 379.17647; found, 379.17617. HPLC purity: 97.9% (method A).</div></div><div id="sec4_11_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> Synthesis of Compounds <b>8b</b>–<b>8n</b></h4><div class="NLM_p last">Compounds <b>8b</b>–<b>8n</b> were prepared by employing a procedure similar to that described for compound <b>8a</b>, with 5-(3-methylfuran-2-carbonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxylic acid (<b>16</b>) and the corresponding amine.</div></div><div id="sec4_11_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> <i>N</i>-Benzyl-5-(3-methylfuran-2-carbonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>8b</b>)</h4><div class="NLM_p last">Compound <b>8b</b> was obtained as a white solid in 15% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.47–7.20 (m, 5H), 7.19–7.05 (br m, 1H), 6.71 (br s, 1H), 6.33 (d, <i>J</i> = 1.7 Hz, 1H), 4.81 (br s, 2H), 4.60 (s, 1H), 4.58 (s, 1H), 4.46–4.38 (m, 2H), 4.00–3.92 (m, 2H), 2.26 (s, 3H), 2.12–2.03 (br m, 2H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>4</sub>O<sub>3</sub>, 379.17647; found, 379.17626. HPLC purity: 94.7% (method A).</div></div><div id="sec4_11_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> <i>N</i>-(2,4-Difluorophenyl)-5-(3-methylfuran-2-carbonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>8c</b>)</h4><div class="NLM_p last">Compound <b>8c</b> was obtained as a white solid in 55% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.78 (s, 1H), 8.45–8.36 (m, 1H), 7.36 (br s, 1H), 6.92–6.84 (m, 2H), 6.77 (br s, overlapped, 1H), 6.34 (d, <i>J</i> = 1.4 Hz, 1H), 4.84 (s, 2H), 4.55–4.48 (m, 2H), 4.05–3.94 (m, 2H), 2.27 (s, 3H), 2.18–2.09 (br m, 2H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>4</sub>O<sub>3</sub>, 379.17647; found, 379.17626. HPLC purity: 96.5% (method C).</div></div><div id="sec4_11_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 5-(3-Methylfuran-2-carbonyl)-<i>N</i>-(<i>o</i>-tolyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>8d</b>)</h4><div class="NLM_p last">Compound <b>8d</b> was obtained as a white solid in 52% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.59 (s, 1H), 7.52 (br m, 1H), 7.45 (d, <i>J</i> = 8.4 Hz, 1H), 7.37 (br s, 1H), 7.22 (t, <i>J</i> = 7.8 Hz, 1H), 6.92 (d, <i>J</i> = 7.5 Hz, 1H), 6.76 (br s, 1H), 6.34 (d, <i>J</i> = 1.7 Hz, 1H), 4.84 (br s, 2H), 4.55–4.45 (m, 2H), 4.04–3.94 (m, 2H), 2.35 (s, 3H), 2.27 (s, 3H), 2.21–2.04 (br m, 2H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>4</sub>O<sub>3</sub>, 379.17647; found, 379.17638. HPLC purity: 99.2% (method A).</div></div><div id="sec4_11_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 5-(3-Methylfuran-2-carbonyl)-<i>N</i>-(<i>m</i>-tolyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>8e</b>)</h4><div class="NLM_p last">Compound <b>8e</b> was obtained as a light yellow solid in 62% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.60 (s, 1H), 8.10 (d, <i>J</i> = 8.0 Hz, 1H), 7.38 (br s, 1H), 7.25–7.16 (m, 2H), 7.05 (td, <i>J</i> = 7.4, 1.3 Hz, 1H), 6.78 (br s, 1H), 6.35 (d, <i>J</i> = 1.8 Hz, 1H), 4.85 (s, 2H), 4.59–4.46 (m, 2H), 4.06–3.95 (m, 2H), 2.35 (s, 3H), 2.28 (s, 3H), 2.20–2.09 (br m, 1H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>4</sub>O<sub>3</sub>, 379.17647; found, 379.17633. HPLC purity: 97.4% (method A).</div></div><div id="sec4_11_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 5-(3-Methylfuran-2-carbonyl)-<i>N</i>-(<i>p</i>-tolyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>8f</b>)</h4><div class="NLM_p last">Compound <b>8f</b> was obtained as a white solid in 64% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.57 (s, 1H), 7.59–7.49 (m, 2H), 7.37 (br s, 1H), 7.14 (d, <i>J</i> = 8.2 Hz, 2H), 6.76 (br s, 1H), 6.34 (d, <i>J</i> = 1.7 Hz, 1H), 4.84 (br s, 2H), 4.55–4.44 (m, 2H), 4.05–3.92 (br m, 2H), 2.32 (s, 3H), 2.27 (s, 3H), 2.18–2.08 (br m, 2H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>4</sub>O<sub>3</sub>, 379.17647; found, 379.17689. HPLC purity: 97.5% (method A).</div></div><div id="sec4_11_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> <i>N</i>-(2-Fluorophenyl)-5-(3-methylfuran-2-carbonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>8g</b>)</h4><div class="NLM_p last">Compound <b>8g</b> was obtained as a white solid in 52% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.91 (s, 1H), 8.47 (td, <i>J</i> = 8.1, 1.7 Hz, 1H), 7.38 (br s, 1H), 7.20–6.97 (m, 3H), 6.78 (br s, 1H), 6.35 (d, <i>J</i> = 1.4 Hz, 1H), 4.85 (br s, 2H), 4.59–4.48 (m, 2H), 4.14–3.89 (m, 2H), 2.28 (s, 3H), 2.21–2.08 (br m, 2H). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ – 131.3 (s). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>20</sub>N<sub>4</sub>O<sub>3</sub>F, 379.15140; found, 379.15114. HPLC purity: 97.7% (method A).</div></div><div id="sec4_11_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> <i>N</i>-(3-Fluorophenyl)-5-(3-methylfuran-2-carbonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>8h</b>)</h4><div class="NLM_p last">Compound <b>8h</b> was obtained as a yellow solid in 62% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.68 (s, 1H), 7.67–7.60 (m, 1H), 7.37 (br s, 1H), 7.32–7.27 (m, 2H), 6.90–6.69 (m, 2H), 6.35 (d, <i>J</i> = 1.7 Hz, 1H), 4.85 (s, 2H), 4.59–4.47 (m, 2H), 4.09–3.94 (m, 2H), 2.27 (s, 3H), 2.18–2.09 (br m, 2H). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ – 111.61 (s). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>20</sub>N<sub>4</sub>O<sub>3</sub>F, 379.15140; found, 379.15150. HPLC purity: 97.0% (method A).</div></div><div id="sec4_11_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> <i>N</i>-(4-Fluorophenyl)-5-(3-methylfuran-2-carbonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>8i</b>)</h4><div class="NLM_p last">Compound <b>8i</b> was obtained as a white solid in 53% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.61 (s, 1H), 7.68–7.56 (m, 2H), 7.37 (br s, 1H), 7.09–6.96 (m, 2H), 6.77 (s, 1H), 6.35 (d, <i>J</i> = 1.7 Hz, 1H), 4.85 (s, 2H), 4.62–4.41 (m, 2H), 4.07–3.96 (m, 2H), 2.27 (s, 3H), 2.20–2.08 (br m, 2H). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ – 118.6 (s). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>20</sub>N<sub>4</sub>O<sub>3</sub>F, 379.15140; found, 379.15204. HPLC purity: 98.7% (method A).</div></div><div id="sec4_11_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> <i>N</i>-(2-Methoxyphenyl)-5-(3-methylfuran-2-carbonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>8j</b>)</h4><div class="NLM_p last">Compound <b>8j</b> was obtained as a white solid in 66% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.25 (br s, 1H), 8.50 (dd, <i>J</i> = 7.9, 1.7 Hz, 1H), 7.38 (br s, 1H), 7.05 (td, <i>J</i> = 7.8, 1.7 Hz, 1H), 6.98 (td, <i>J</i> = 7.7, 1.4 Hz, 1H), 6.90 (dd, <i>J</i> = 8.0, 1.4 Hz, 1H), 6.76 (br s, 1H), 6.34 (d, <i>J</i> = 1.4 Hz, 1H), 4.85 (br s, 2H), 4.58–4.46 (m, 2H), 4.04–3.97 (br m, 2H), 3.93 (s, 3H), 2.27 (s, 3H), 2.20–2.05 (br m, 2H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>4</sub>O<sub>4</sub>, 395.17138; found, 395.17109. HPLC purity: 99.1% (method A).</div></div><div id="sec4_11_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> <i>N</i>-(3-Methoxyphenyl)-5-(3-methylfuran-2-carbonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>8k</b>)</h4><div class="NLM_p last">Compound <b>8k</b> was obtained as a yellow solid in 62% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.63 (s, 1H), 7.47 (t, <i>J</i> = 2.2 Hz, 1H), 7.37 (br s, 1H), 7.22 (t, <i>J</i> = 8.1 Hz, 1H), 7.10 (ddd, <i>J</i> = 8.0, 2.0, 0.9 Hz, 1H), 6.77 (br s, 1H), 6.66 (ddd, <i>J</i> = 8.3, 2.5, 0.9 Hz, 1H), 6.34 (d, <i>J</i> = 1.8 Hz, 1H), 4.84 (s, 2H), 4.58–4.42 (m, 2H), 4.05–3.93 (m, 2H), 3.81 (s, 3H), 2.26 (s, 3H), 2.18–2.06 (br m, 2H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>4</sub>O<sub>4</sub>, 395.17138; found, 395.17125. HPLC purity: 98.6% (method A).</div></div><div id="sec4_11_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> <i>N</i>-(4-Methoxyphenyl)-5-(3-methylfuran-2-carbonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>8l</b>)</h4><div class="NLM_p last">Compound <b>8l</b> was obtained as a white solid in 74% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.53 (br s, 1H), 7.63–7.50 (m, 2H), 7.37 (br s, 1H), 6.94–6.84 (m, 2H), 6.76 (br s, 1H), 6.35 (d, <i>J</i> = 1.7 Hz, 1H), 4.85 (br s, 2H), 4.59–4.43 (m, 2H), 4.06–3.93 (m, 2H), 3.80 (s, 3H), 2.27 (s, 3H), 2.21–2.06 (m, 2H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>23</sub>N<sub>4</sub>O<sub>4</sub>, 395.17138; found, 395.17141. HPLC purity: 98.7% (method A).</div></div><div id="sec4_11_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 5-(3-Methylfuran-2-carbonyl)-<i>N</i>-(pyrimidin-5-yl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>8m</b>)</h4><div class="NLM_p last">Compound <b>8m</b> was obtained as a light yellow solid in 15% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.15 (s, 2H), 8.98 (s, 1H), 8.68 (br s, 1H), 7.38 (br s, 1H), 6.81 (br s, 1H), 6.36 (d, <i>J</i> = 1.7 Hz, 1H), 4.86 (s, 2H), 4.64–4.43 (m, 2H), 4.11–3.95 (br m, 2H), 2.28 (s, 3H), 2.21.2.09 (br m, 1H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>19</sub>N<sub>6</sub>O<sub>3</sub>, 367.15131; found, 367.15111. HPLC purity: 97.2% (method A).</div></div><div id="sec4_11_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> <i>N</i>-(2-Chloro-4-fluorophenyl)-5-(3-methylfuran-2-carbonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>8n</b>)</h4><div class="NLM_p last">Compound <b>8n</b> was obtained as a white solid in 29% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.15 (s, 1H), 8.49 (dd, <i>J</i> = 9.2, 5.7 Hz, 1H), 7.37 (br s, 1H), 7.15 (dd, <i>J</i> = 8.1, 2.9 Hz, 1H), 7.02 (ddd, <i>J</i> = 9.2, 7.9, 2.9 Hz, 1H), 6.78 (br s, 1H), 6.35 (d, <i>J</i> = 1.5 Hz, 1H), 4.85 (s, 2H), 4.61–4.47 (m, 2H), 4.09–3.92 (br m, 2H), 2.27 (s, 3H), 2.21–2.08 (br m, 2H). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −117.1 (s). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>19</sub>N<sub>4</sub>O<sub>3</sub>ClF, 417.11242; found, 417.11213. HPLC purity: 97.8% (method C).</div></div><div id="sec4_11_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 5-(3-Methylfuran-2-carbonyl)-<i>N</i>-(pyrimidin-4-yl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>8o</b>)</h4><div class="NLM_p last">To a solution of 5-(3-methylfuran-2-carbonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxylic acid <b>16</b> (122 mg, 0.42 mmol), HATU (192 mg, 0.51 mmol), and DIPEA (176 μL, 1.01 mmol) in DMF (2.1 mL) was added pyrimidin-4-amine (120 mg, 1.265 mmol) in one portion. The reaction was stirred for 72 h and diluted with water (50 mL), and the aqueous phase was extracted with EtOAc (3 × 50 mL). The combined organic phases were washed with brine (50 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under vacuum. The residue was purified via flash chromatography (SiO<sub>2</sub>, 30 to 100% EtOAc in hexanes, <i>R</i><sub>f</sub> = 0.05, 60% EtOAc in hexanes) to afford <b>8o</b> (19 mg, 0.052 mmol, 12% yield) as a light yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.37 (s, 1H), 8.90 (s, 1H), 8.64 (br d, <i>J</i> = 5.8 Hz, 1H), 8.29 (d, <i>J</i> = 5.5 Hz, 1H), 7.37 (br s, 1H), 6.81 (br s, 1H), 6.35 (d, <i>J</i> = 1.7 Hz, 1H), 4.85 (br s, 2H), 4.62–4.41 (m, 2H), 4.07–3.98 (m, 2H), 2.27 (s, 3H), 2.20–2.08 (br m, 2H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>19</sub>N<sub>6</sub>O<sub>3</sub>, 367.15131; found, 367.15112. HPLC purity: 96.1% (method A).</div></div><div id="sec4_11_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> <i>N</i>-Methoxy-<i>N</i>-methyl-5-(3-methylfuran-2-carbonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>17</b>)</h4><div class="NLM_p last">To a solution of 5-(3-methylfuran-2-carbonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxylic acid (<b>16</b>) (85 mg, 0.29 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) were added EDCI (56 mg, 0.29 mmol), <i>N,O</i>-dimethylhydroxylamine hydrochloride (32 mg, 0.32 mmol), and triethylamine (41 μL, 0.29 mmol). The reaction was stirred overnight and diluted with water (100 mL), and the aqueous phase was extracted with EtOAc (3 × 50 mL). The combined organic layers were washed with brine (50 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The residue was purified via flash chromatography (SiO<sub>2</sub>, 1 to 5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>, <i>R</i><sub>f</sub> = 0.1, 5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>), to afford <b>17</b> (40 mg, 0.120 mmol, 41% yield) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.31 (s, 1H), 6.63 (br s, 1H), 6.29 (d, <i>J</i> = 1.7 Hz, 1H), 4.78 (s, 2H), 4.58–4.40 (m, 2H), 3.98–3.90 (m, 2H), 3.67 (s, 3H), 3.35 (s, 3H), 2.21 (s, 3H), 2.13–1.99 (m, 2H). MS (ESI) [M + H]<sup>+</sup>: 333.1.</div></div><div id="sec4_11_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 1-(5-(3-Methylfuran-2-carbonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepin-2-yl)-2-phenylethanone (<b>8p</b>)</h4><div class="NLM_p last">To a solution of <i>N</i>-methoxy-<i>N</i>-methyl-5-(3-methylfuran-2-carbonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>17</b>) (40 mg, 0.12 mmol) in THF (1.2 mL), under argon, at 0 °C, was added benzylmagnesium chloride (963 μL, 0.963 mmol) (1.0 M in 2-methyltetrahydrofuran), and the reaction was allowed to warm to RT and stirred for 1 h at this temperature. The reaction was quenched with sat. aq. NH<sub>4</sub>Cl (10 mL) and diluted with water (40 mL), and the aqueous phase was extracted with EtOAc (3 × 50 mL). The combined organic layers were washed with brine (50 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated, and the residue was purified via flash chromatography (SiO<sub>2</sub>, 20 to 60% EtOAc in hexanes, <i>R</i><sub>f</sub> = 0.25, 60% EtOAc in hexanes) to provide <b>8p</b> (11 mg, 0.030 mmol, 25% yield) as a light yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.39–7.17 (m, 6H), 6.68 (br s, 1H), 6.33 (d, <i>J</i> = 1.7 Hz, 1H), 4.80 (s, 2H), 4.59–4.49 (m, 2H), 4.26 (s, 2H), 4.04–3.95 (m, 2H), 2.26 (s, 3H), 2.18–2.10 (br m, 2H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>22</sub>N<sub>3</sub>O<sub>3</sub>, 364.16557; found, 364.16580. HPLC purity: 95.4% (method C).</div></div><div id="sec4_11_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> (2-(Hydroxymethyl)-7,8-dihydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepin-5(6<i>H</i>)-yl)(3-methylfuran-2-yl)methanone (<b>18</b>)</h4><div class="NLM_p last">To a solution of 5-(3-methylfuran-2-carbonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxylic acid (<b>16</b>) (200 mg, 0.69 mmol) and 4-methylmorpholine (76 μL, 0.69 mmol) in THF (14 mL) under argon, at 0 °C, was added isobutyl chloroformate (90 μL, 0.69 mmol). The reaction was stirred for 30 min, filtered through Celite into a flask containing a solution of NaBH<sub>4</sub> (262 mg, 6.9 mmol) in water (14 mL) at 0 °C, and stirred for 2 h at this temperature. The reaction was quenched with AcOH (1.6 mL, 28 mmol) and allowed to warm to RT. The aqueous phase was extracted with EtOAc (3 × 25 mL), and the combined organic phases were washed with brine (25 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The residue was purified via flash chromatography (SiO<sub>2</sub>, 40 to 100% EtOAc in hexanes) to provide <b>18</b> (78 mg, 0.28 mmol, 41% yield) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.34 (br s, 1H), 6.34 (d, <i>J</i> = 1.9 Hz, 1H), 6.20 (br s, 1H), 4.78 (s, 2H), 4.62 (s, 2H), 4.48–4.40 (m, 2H), 4.02–3.92 (m, 2H), 2.27 (s, 3H), 2.13–2.06 (br m, 2H). MS (ESI) [M + H]<sup>+</sup>: 276.1.</div></div><div id="sec4_11_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> (3-Methylfuran-2-yl)(2-((phenylamino)methyl)-7,8-dihydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepin-5(6<i>H</i>)-yl)methanone (<b>8q</b>)</h4><div class="NLM_p last">To a solution of (2-(hydroxymethyl)-7,8-dihydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepin-5(6<i>H</i>)-yl)(3-methylfuran-2-yl)methanone <b>18</b> (72 mg, 0.26 mmol) and triethylamine (73 μL, 0.52 mmol) in THF (1.3 mL), under argon, at 0 °C was added methanesulfonyl chloride (30 μL, 0.39 mmol) in one portion. The reaction was stirred for 2 h, diluted with MeOH (2 mL) and concentrated to dryness. The residue was taken up in dry toluene (2 mL) and concentrated to dryness (2×). According to <sup>1</sup>H NMR, the residue contained a 4:1 mixture of (5-(3-methylfuran-2-carbonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepin-2-yl)methylmethanesulfonate and the starting material. The mixture was dissolved in dry THF and used in the next step without further purification. To the resulting solution, under argon, at RT, were added aniline (72 μL, 0.78 mmol) and triethylamine (109 μL, 0.78 mmol). The reaction was stirred overnight at RT and diluted with water (50 mL). The aqueous phase was extracted with EtOAc (3 × 25 mL), and the combined organic phases were washed with brine (50 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under vacuum. The residue was separated via flash chromatography (SiO<sub>2</sub>, 0 to 5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to provide a partially purified product, which was purified via flash chromatography (SiO<sub>2</sub>, 20 to 70% EtOAc in hexanes, <i>R</i><sub>f</sub> = 0.25, 2% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to give <b>8q</b> (18 mg, 0.051 mmol, 20% yield) as an amorphous white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.32–7.29 (m, 1H), 7.21–7.13 (m, 2H), 6.73–6.69 (m, overlapped, 1H), 6.69–6.64 (m, overlapped, 2H), 6.33–6.32 (m, 1H), 6.28–5.97 (br m, 1H), 4.75 (s, 2H), 4.47–4.40 (m, 2H), 4.25 (s, 2H), 4.00–3.91 (m, 2H), 2.26 (s, 3H), 2.14–2.06 (br m, 2H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>23</sub>N<sub>4</sub>O<sub>2</sub>, 351.18155; found, 351.18195. HPLC purity: 98.9% (method A).</div></div><div id="sec4_11_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> <i>tert</i>-Butyl (5-((2-nitrophenyl)sulfonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepin-2-yl)carbamate (<b>19</b>)</h4><div class="NLM_p last">To a solution of 5-((2-nitrophenyl)sulfonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxylic acid (<b>10</b>) (121 mg, 0.33 mmol) in toluene/<i>tert</i>-butanol/1,2-dichloroethane 3:3:2 (1.6 mL) were added triethylamine (92 μL, 0.66 mmol) and diphenyl phosphorazidate (93 μL, 0.43 mmol). The reaction was stirred overnight at RT, and then refluxed for 8 h and allowed to warm to RT. The reaction was diluted with water (25 mL) and extracted with EtOAc (3 × 25 mL), and the combined organic phases were washed with brine (25 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The residue was purified via flash chromatography (SiO<sub>2</sub>, 0 to 50% EtOAc in hexanes) to afford <b>19</b> (41 mg, 0.094 mmol, 32% yield) as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.00–7.95 (m, 1H), 7.73–7.57 (m, 3H), 6.98 (s, 1H), 6.45 (br s, 1H), 4.51 (s, 2H), 4.29–4.20 (m, 2H), 3.75–3.62 (m, 2H), 2.04–1.96 (br m, 2H), 1.50 (s, 9H). MS (ESI) [M + H]<sup>+</sup>: 438.1.</div></div><div id="sec4_11_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 5-((2-Nitrophenyl)sulfonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepin-2-amine (<b>20</b>)</h4><div class="NLM_p last"><i>tert</i>-Butyl (5-((2-nitrophenyl)sulfonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepin-2-yl)carbamate <b>19</b> (600 mg, 1.37 mmol) was suspended in a 4 M solution of HCl in dioxane (8.6 mL, 34 mmol) at RT. The reaction was stirred overnight and diluted with water (50 mL), and sat. aq. NaHCO<sub>3</sub> was added to adjust the pH to 8. The aqueous phase was extracted with EtOAc (3 × 50 mL), and the combined organic phases were washed with brine (50 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under vacuum. The residue was purified via flash chromatography (SiO<sub>2</sub>, 0 to 5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to afford <b>20</b> (457 mg, 1.36 mmol, 99% yield) as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.00–7.92 (m, 1H), 7.74–7.58 (m, 3H), 5.62 (s, 1H), 4.46 (s, 2H), 4.28–4.07 (m, 2H), 3.66–3.61 (m, 2H), 2.61 (br s, 2H), 2.05–1.91 (m, 2H). MS (ESI) [M + H]<sup>+</sup>: 338.1.</div></div><div id="sec4_11_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 5-((2-Nitrophenyl)sulfonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-sulfonyl chloride (<b>21</b>)</h4><div class="NLM_p last">A solution of sodium nitrite (98 mg, 1.4 mmol) in water (1 mL) was added to a solution of 5-((2-nitrophenyl)sulfonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepin-2-amine (<b>20</b>) (457 mg, 1.35 mmol) in AcOH/conc. HCl/water 2:1:1 (6 mL) at −10 °C. The mixture was stirred for 30 min and then added to a suspension of copper(II) sulfate (43 mg, 0.27 mmol) in AcOH (5 mL) saturated with sulfur dioxide. The reaction was stirred for 1 h at −10 °C, allowed to warm to room temperature and diluted with water (50 mL). The pH of was adjusted to 7 with LiOH, and the mixture was diluted with water (50 mL). The aqueous phase was extracted with EtOAc (3 × 50 mL), and the combined organic phases were washed with water (25 mL) and brine (50 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under vacuum. The residue was purified via flash chromatography (SiO<sub>2</sub>, 20 to 60% EtOAc in hexanes) to afford <b>21</b> (205 mg, 0.487 mmol, 36% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.05–8.00 (m, 1H), 7.79–7.61 (m, 3H), 6.85 (s, 1H), 4.62 (s, 2H), 4.60–4.54 (m, 2H), 3.77–3.70 (m, 2H), 2.20–2.12 (m, 1H). MS (ESI) [M + H]<sup>+</sup>: 421.0.</div></div><div id="sec4_11_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 5-((2-Nitrophenyl)sulfonyl)-<i>N</i>-phenyl-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-sulfonamide (<b>22</b>)</h4><div class="NLM_p last">To a solution of 5-((2-nitrophenyl)sulfonyl)-5,6,7,8-tetrahydro-4H-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-sulfonyl chloride <b>21</b> (100 mg, 0.24 mmol) and aniline (27 μL, 0.29 mmol) in THF (1.2 mL) was added triethylamine (132 μL, 0.95 mmol) in one portion. The reaction was stirred under argon for 16 h and diluted with water (50 mL). The aqueous phase was extracted with EtOAc (3 × 25 mL), and the combined organic phases were washed with brine (25 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under vacuum. The residue was purified via flash chromatography (SiO<sub>2</sub>, 25 to 70% EtOAc in hexanes) to afford <b>22</b> (95 mg, 0.20 mmol, 84% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.94–7.89 (m, 1H), 7.69–7.65 (m, 3H), 7.63–7.56 (m, 2H), 7.31–7.25 (m, 2H), 7.17–7.11 (m, 3H), 6.53 (s, 1H), 4.51 (s, 2H), 4.46–4.39 (m, 2H), 3.72–3.64 (m, 2H), 2.06–1.99 (m, 2H). MS (ESI) [M + H]<sup>+</sup>: 478.0.</div></div><div id="sec4_11_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> <i>N</i>-Phenyl-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-sulfonamide (<b>23</b>)</h4><div class="NLM_p last">Compound <b>23</b> was prepared from 5-((2-nitrophenyl)sulfonyl)-<i>N</i>-phenyl-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-sulfonamide <b>22</b> by employing a procedure similar to that described for compound <b>12</b>. It was obtained as a colorless oil in 79% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.67 (s, 1H), 7.28–7.15 (m, 3H), 7.12–7.02 (m, 3H), 6.47 (br s, 1H, overlapped), 6.36 (s, 1H), 4.45–4.25 (m, 2H), 3.82 (s, 2H), 3.24–3.06 (m, 1H), 1.87–1.68 (m, 2H). MS (ESI) [M + H]<sup>+</sup>: 293.1.</div></div><div id="sec4_11_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 5-(3-Methylfuran-2-carbonyl)-<i>N</i>-phenyl-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-sulfonamide (<b>8r</b>)</h4><div class="NLM_p last">Compound <b>8r</b> was prepared by employing a procedure similar to that for compound <b>1a</b>, with 3-methylfuran-2-carboxylic acid and <i>N</i>-phenyl-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-sulfonamide (<b>23</b>). It was obtained as a white solid in 76% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.28 (br s, 1H), 7.26–7.20 (m, 2H), 7.17–7.12 (m, 1H), 7.12–7.06 (m, 1H), 6.83 (s, 1H), 6.49 (br s, 1H), 6.34–6.33 (m, 1H), 4.73 (s, 2H), 4.54–4.44 (m, 2H), 4.02–3.92 (m, 2H), 2.25 (s, 3H), 2.13–2.02 (br m, 2H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>21</sub>N<sub>4</sub>O<sub>4</sub>S, 401.12780; found, 401.12790. HPLC purity: 98.2% (method A).</div></div><div id="sec4_11_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> <i>N</i>-(5-((2-Nitrophenyl)sulfonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepin-2-yl)benzamide (<b>24</b>)</h4><div class="NLM_p last">To a solution of 5-((2-nitrophenyl)sulfonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepin-2-amine (<b>20</b>) (136 mg, 0.403 mmol) and DIPEA (351 μL, 2.02 mmol) in THF (4.03 mL) at 0 °C, was added a solution of benzoyl chloride (70 μL, 0.60 mmol) in THF (4.03 mL). The reaction was stirred overnight and quenched with water (50 mL), and the aqueous phase was extracted with EtOAc (3 × 33 mL). The combined organic layers were washed with brine (33 mL), dried (sodium sulfate), filtered, and concentrated under vacuum. The residue was purified via flash chromatography (SiO<sub>2</sub>, 0 to 100% EtOAc in hexanes), to give <b>24</b> (161 mg, 0.365 mmol, 90% yield) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.93–8.58 (br m, 1H), 8.05–7.99 (m, 1H), 7.89–7.80 (m, 2H), 7.74–7.51 (m, 4H), 7.51–7.39 (m, 2H), 6.85 (s, 1H), 4.59–4.52 (br m, 1H), 4.26–4.15 (m, 2H), 3.78–3.62 (br m, 2H), 1.99 (brs, 2H). MS (ESI) [M + H]<sup>+</sup>: 442.0.</div></div><div id="sec4_11_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> <i>N</i>-(5,6,7,8-Tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepin-2-yl)benzamide (<b>25</b>)</h4><div class="NLM_p last">Compound <b>25</b> was prepared from <i>N</i>-(5-((2-nitrophenyl)sulfonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepin-2-yl)benzamide (<b>24</b>) by employing a procedure similar to that described for compound <b>12</b>. It was obtained as a colorless oil in quantitative yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.11–8.95 (br m, 1H), 7.88–7.82 (m, 2H), 7.57–7.49 (m, 1H), 7.48–7.40 (m, 2H), 6.71 (s, 1H), 4.17–4.09 (m, 2H), 3.89 (s, 2H), 3.21–3.12 (m, 2H), 1.83–1.64 (m, 2H, overlapped with HOD signal). MS (ESI) [M + H]<sup>+</sup>: 257.1.</div></div><div id="sec4_11_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> <i>N</i>-(5-(3-Methylfuran-2-carbonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepin-2-yl)benzamide (<b>8s</b>)</h4><div class="NLM_p last">Compound <b>8s</b> was prepared by employing a procedure similar to that for compound <b>1a</b>, with 3-methylfuran-2-carboxylic acid and <i>N</i>-(5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepin-2-yl)benzamide (<b>25</b>). It was obtained as a white solid in 29% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.76 (s, 1H), 7.90–7.83 (m, 2H), 7.59–7.51 (m, 1H), 7.50–7.41 (m, 2H), 7.39 (br s, 1H), 6.82 (br s, 1H), 6.35 (d, <i>J</i> = 1.7 Hz, 1H), 4.82 (s, 2H), 4.36–4.27 (m, 2H), 4.00–3.93 (m, 2H), 2.28 (s, 3H), 2.13–2.03 (br m, 2H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>21</sub>N<sub>4</sub>O<sub>3</sub>, 365.16082; found, 365.16051. HPLC purity: 98.6% (method B).</div></div><div id="sec4_11_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> <i>N</i>-(5-((2-Nitrophenyl)sulfonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepin-2-yl)benzenesulfonamide (<b>26</b>)</h4><div class="NLM_p last">To a solution of 5-((2-nitrophenyl)sulfonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepin-2-amine (<b>20</b>) (105 mg, 0.31 mmol) and DIPEA (270 μL, 1.55 mmol) in THF (3 mL) at 0 °C, under Ar, was added benzenesulfonyl chloride (60 μL, 0.47 mmol). The reaction was stirred overnight, quenched with sat. aq. NH<sub>4</sub>Cl (25 mL), and the aqueous phase extracted with EtOAc (3 × 25 mL). The combined organic phases were washed with brine (25 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The residue was purified via flash chromatography (SiO<sub>2</sub>, 50 to 100% EtOAc in hexanes, <i>R</i><sub>f</sub> = 0.1 in 80% EtOAc in hexanes), to afford <b>26</b> (148 mg, 0.31 mmol, quantitative yield) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.56 (br s, 1H), 8.01–7.93 (m, 1H), 7.74–7.67 (m, 3H), 7.67–7.60 (m, 2H), 7.57–7.50 (m, 1H), 7.45–7.38 (m, 2H), 6.24 (s, 1H), 4.47 (s, 2H), 4.35–4.25 (m, 2H), 3.68–3.59 (m, 2H), 2.04–1.91 (m, 2H). MS (ESI) [M + H]<sup>+</sup>: 478.0.</div></div><div id="sec4_11_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> <i>N</i>-(5,6,7,8-Tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepin-2-yl)benzenesulfonamide (<b>27</b>)</h4><div class="NLM_p last">Compound <b>27</b> was prepared from <i>N</i>-(5-((2-nitrophenyl)sulfonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepin-2-yl)benzenesulfonamide (<b>26</b>), by employing a procedure similar to that described for compound <b>12</b>. It was obtained as a colorless oil in 74% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.73–7.67 (m, 2H), 7.55–7.49 (m, 1H), 7.38 (t, <i>J</i> = 7.7 Hz, 2H), 4.37–4.29 (m, 2H), 3.82 (s, 2H), 3.18–3.09 (m, 2H), 1.85–1.72 (m, 2H). MS (ESI) [M + H]<sup>+</sup>: 293.1.</div></div><div id="sec4_11_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> <i>N</i>-(5-(3-Methylfuran-2-carbonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepin-2-yl)benzenesulfonamide (<b>8t</b>)</h4><div class="NLM_p last">Compound <b>8t</b> was prepared by employing a procedure similar to that for compound <b>1a</b>, with 3-methylfuran-2-carboxylic acid and <i>N</i>-(5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepin-2-yl)benzenesulfonamide (<b>27)</b>. It was obtained as a white solid in 13% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.00 (br s, 1H), 7.75–7.60 (br m, 2H), 7.53–7.47 (m, 1H), 7.36 (t, <i>J</i> = 7.6 Hz, 2H), 6.35 (s, 1H), 6.19 (br s, 1H), 4.72 (s, 2H), 4.42–4.32 (m, 2H), 3.96–3.84 (m, 2H). 2.27 (s, 3H), 2.02 (br s, 2H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>21</sub>N<sub>4</sub>O<sub>4</sub>S, 401.12780; found, 401.12781. HPLC purity: 96.3% (method B).</div></div><div id="sec4_11_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> Ethyl 5-(3-Methylfuran-2-carbonyl)-4,5,6,7-tetrahydropyrazolo[1,5-<i>a</i>]pyrazine-2-carboxylate (<b>29</b>)</h4><div class="NLM_p last">Compound <b>29</b> was prepared by employing a procedure similar to that for compound <b>15</b>, with 3-methylfuran-2-carboxylic acid and ethyl 4,5,6,7-tetrahydropyrazolo[1,5-<i>a</i>]pyrazine-2-carboxylate (<b>28</b>).<a onclick="showRef(event, 'ref26 ref32'); return false;" href="javascript:void(0);" class="ref ref26 ref32">(26, 32)</a> It was obtained as a white solid in 65% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.39 (dd, <i>J</i> = 1.8, 0.5 Hz, 1H), 6.65 (s, 1H), 6.38 (dd, <i>J</i> = 1.8, 0.5 Hz, 1H), 4.40 (q, <i>J</i> = 7.1 Hz, 3H), 4.21–4.15 (m, 2H), 2.42 (s, 9H), 2.32 (s, 3H), 1.39 (t, <i>J</i> = 7.1 Hz, 3H). MS (ESI) [M + H]<sup>+</sup>: 304.1.</div></div><div id="sec4_11_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> 5-(3-Methylfuran-2-carbonyl)-<i>N</i>-phenyl-4,5,6,7-tetrahydropyrazolo[1,5-<i>a</i>]pyrazine-2-carboxamide (<b>9a</b>)</h4><div class="NLM_p last">To a solution of ethyl 5-(3-methylfuran-2-carbonyl)-4,5,6,7-tetrahydropyrazolo[1,5-<i>a</i>]pyrazine-2-carboxylate (<b>29</b>) (150 mg, 0.495 mmol) in THF/MeOH 4:1 (4.95 mL) was added 3 N NaOH (660 μL, 1.98 mmol), and the resulting solution was stirred for 2 h, concentrated to dryness, and suspended in water (25 mL). The aqueous phase was extracted with diethyl ether (3 × 10 mL), acidified to pH 3 with 1 N HCl, and extracted with EtOAc (3 × 10 mL). The combined organic phases were washed with brine (10 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated to provide 5-(3-methylfuran-2-carbonyl)-4,5,6,7-tetrahydropyrazolo[1,5-<i>a</i>]pyrazine-2-carboxylic acid (<b>30</b>) (116 mg, 0.421 mmol, 85% yield) as an amorphous white solid, which was used without further purification. MS (ESI) [M + H]<sup>+</sup>: 276.1. To a solution of the crude carboxylic acid <b>30</b>, HOBt (68 mg, 0.51 mmol), and EDCI (97 mg, 0.51 mmol) in DMF (2.10 mL) was added aniline (38 μL, 0.42 mmol) in one portion. The reaction was stirred for 24 h and partitioned between EtOAc (50 mL) and water (50 mL). The aqueous phase was extracted with EtOAc (2 × 50 mL), and the combined organic phases were washed with brine (50 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and purified via flash chromatography (SiO<sub>2</sub>, 20 to 50% EtOAc in hexanes, <i>R</i><sub>f</sub> = 0.30, 60% EtOAc in hexanes) to give <b>9a</b> (96 mg, 0.27 mmol, 54% yield from <b>29</b>) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.66 (s, 1H), 7.72–7.64 (m, 2H), 7.40 (d, <i>J</i> = 1.7 Hz, 1H), 7.39–7.30 (m, 2H), 7.16–7.07 (m, 1H), 6.70 (s, 1H), 6.39 (d, <i>J</i> = 1.7 Hz, 1H), 5.00 (br s, 2H), 4.38–4.31 (br m, 2H), 4.24–4.16 (br m, 2H), 2.33 (s, 3H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>19</sub>N<sub>4</sub>O<sub>3</sub>, 351.14517; found, 351.14597. HPLC purity: 96.0% (method A).</div></div><div id="sec4_11_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> Ethyl 2-(3-Methylfuran-2-carbonyl)-2,3,4,5-tetrahydro-1<i>H</i>-pyrrolo[1,2-<i>a</i>][1,4]diazepine-8-carboxylate (<b>32</b>)</h4><div class="NLM_p last">To a solution of ethyl 2,3,4,5-tetrahydro-1<i>H</i>-pyrrolo[1,2-<i>a</i>][1,4]diazepine-8-carboxylate (<b>31</b>)<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (320 mg, 1.54 mmol), HATU (701 mg, 1.84 mmol), and 3-methylfuran-2-carboxylic acid (233 mg, 1.84 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (15.4 mL) was added triethylamine (1.03 mL, 7.38 mmol). The reaction was stirred for 24 h and diluted with water (50 mL). The aqueous phase was extracted with EtOAc (3 × 33 mL), and the combined organic phases were washed with brine (50 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The residue was purified via flash chromatography (SiO<sub>2</sub>, 0 to 70% EtOAc in hexanes <i>R</i><sub>f</sub> = 0.4, 50% EtOAc in hexanes) to afford <b>32</b> (106 mg, 0.335 mmol, 22% yield) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.48–7.29 (br m, 1H), 7.24–7.21 (m, 1H), 6.66–6.39 (br m, 2H), 6.33 (s, 1H), 4.74 (br s, 2H), 4.23 (q, <i>J</i> = 7.1 Hz, 2H), 4.19–4.14 (m, 2H), 3.90 (s, 2H), 2.26 (s, 3H), 2.10–2.00 (br m, 2H), 1.30 (t, <i>J</i> = 7.1 Hz, 3H). MS (ESI) [M + H]<sup>+</sup>: 317.1.</div></div><div id="sec4_11_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> 2-(3-Methylfuran-2-carbonyl)-<i>N</i>-phenyl-2,3,4,5-tetrahydro-1<i>H</i>-pyrrolo[1,2-<i>a</i>][1,4]diazepine-8-carboxamide (<b>9b</b>)</h4><div class="NLM_p last">To a solution of ethyl 2-(3-methylfuran-2-carbonyl)-2,3,4,5-tetrahydro-1<i>H</i>-pyrrolo[1,2-<i>a</i>][1,4]diazepine-8-carboxylate (<b>32</b>) (0.100 g, 0.316 mmol) in THF/MeOH 4:1 (3.16 mL) was added 3 N LiOH (420 μL, 1.26 mmol), and the resulting solution was stirred for 6 days, concentrated to dryness, and the residue was suspended in water (25 mL). The aqueous phase was extracted with diethyl ether (3 × 10 mL), acidified to pH 3 with 1 N HCl, and extracted with EtOAc (3 × 10 mL). The combined EtOAc were washed with brine (10 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated to provide 2-(3-methylfuran-2-carbonyl)-2,3,4,5-tetrahydro-1<i>H</i>-pyrrolo[1,2-<i>a</i>][1,4]diazepine-8-carboxylic acid (<b>33</b>) (35 mg, 0.121 mmol, 38% yield) as an amorphous white solid, which was used without further purification. MS (ESI) [M + H]<sup>+</sup>: 289.1. To a solution of crude carboxylic acid <b>33</b>, HOBt (20 mg, 0.15 mmol), and EDCI (28 mg, 0.15 mmol) in DMF (607 μL) was added aniline (33 μL, 0.36 mmol) in one portion, and the reaction was stirred overnight. The reaction mixture was partitioned between EtOAc (50 mL) and water (50 mL), the aqueous phase was extracted with EtOAc (2 × 50 mL). The combined organic phases were rinsed with brine (50 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and separated via flash chromatography (SiO<sub>2</sub>, 0 to 5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>, <i>R</i><sub>f</sub> = 0.1, 2% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to afford <b>9b</b> (17 mg, 0.047 mmol, 15% yield from <b>32</b>) as a light tan solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.64–7.54 (m, 2H), 7.47–7.37 (br m, 1H, overlapped), 7.38–7.28 (m, 2H), 7.13–7.03 (m, 1H), 6.50–6.19 (br m, overlapped 1H), 6.34 (s, 1H), 4.76 (br s, 2H), 4.27–4.13 (m, 2H), 3.95 (br s, 2H), 2.27 (s, 3H), 2.12–2.01 (br m, 2H). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>22</sub>N<sub>3</sub>O<sub>3</sub>, 364.16557; found, 364.16620. HPLC purity: 97.3% (method A).</div></div><div id="sec4_11_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> <i>N</i>-(2-Fluorophenyl)-5-((2-nitrophenyl)sulfonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>34</b>)</h4><div class="NLM_p last">Compound <b>34</b> was prepared from 5-((2-nitrophenyl)sulfonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxylic acid (<b>10</b>) and <i>o-</i>fluoroaniline by employing a similar procedure to that described for compound <b>11</b>. It was isolated in 65% yield as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.92–8.81 (m, 1H), 8.47 (td, J = 8.1, 1.7 Hz, 1H), 8.02–7.95 (m, 1H), 7.76–7.59 (m, 3H), 7.21–6.98 (m, 3H), 6.82 (d, J = 0.6 Hz, 1H), 4.61 (s, 2H), 4.54–4.41 (m, 2H), 3.83–3.65 (m, 2H), 2.18–2.05 (m, 2H). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ – 131.4–131.5 (m). MS (ESI) [M + H]<sup>+</sup>: 460.0.</div></div><div id="sec4_11_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> <i>N</i>-(2-Fluorophenyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>35</b>)</h4><div class="NLM_p last">Compound <b>35</b> was prepared from <i>N</i>-(2-fluorophenyl)-5-((2-nitrophenyl)sulfonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>34</b>) by employing a procedure similar to that described for compound <b>12</b>. It was isolated in 56% yield as a white solid. <sup>1</sup>H NMR (400 MHz, Chloroform-<i>d</i>) δ 8.93 (s, 1H), 8.49 (td, <i>J</i> = 8.1, 1.7 Hz, 1H), 7.20–6.95 (m, 4H), 6.68 (s, 1H), 4.49–4.40 (m, 2H), 3.95 (s, 2H), 3.28–3.18 (m, 2H), 1.96–1.84 (m, 2H). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ – 131.4 – 131.5 (m). MS (ESI) [M + H]<sup>+</sup>: 275.1.</div></div><div id="sec4_11_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> <i>N</i>-(2-Fluorophenyl)-5-(furan-2-carbonyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>9c</b>)</h4><div class="NLM_p last">Compound <b>9c</b> was prepared by employing a similar procedure to that for compound <b>1a</b> with furan-2-carboxylic acid and <i>N</i>-(2-fluorophenyl)-5,6,7,8-tetrahydro-4<i>H</i>-pyrazolo[1,5-<i>a</i>][1,4]diazepine-2-carboxamide (<b>35</b>). It was obtained as a white solid in 59% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.88 (s, 1H), 8.44 (td, <i>J</i> = 8.1, 1.7 Hz, 1H), 7.51 (br s, 1H), 7.17–6.97 (m, 4H), 6.79 (br s, 1H), 6.53–6.41 (m, 1H), 4.89 (br s, 2H), 4.59–4.37 (m, 2H), 4.04 (br s, 2H), 2.16–2.04 (br m, 2H). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ – 131.0–131.6 (s). HRMS–ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>18</sub>N<sub>4</sub>O<sub>3</sub>F, 369.13575; found, 369.13572. HPLC purity: 99.2% (method A).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i98"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01568">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62523" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62523" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01568" class="ext-link">10.1021/acs.jmedchem.6b01568</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Detailed procedure for the metabolism study of <b>1a</b> and <b>8p</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01568/suppl_file/jm6b01568_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (MFS) for compounds presented in the article (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01568/suppl_file/jm6b01568_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01568/suppl_file/jm6b01568_si_001.pdf">jm6b01568_si_001.pdf (467.62 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01568/suppl_file/jm6b01568_si_002.csv">jm6b01568_si_002.csv (4.0 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b01568" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50531" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50531" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard K. Plemper</span> - <span class="hlFld-Affiliation affiliation">Institute
for Biomedical Sciences, Georgia State University, Atlanta, Georgia 30303, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2034-2107" title="Orcid link">http://orcid.org/0000-0003-2034-2107</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b2c0c2ded7dfc2d7c0f2d5c1c79cd7d6c7"><span class="__cf_email__" data-cfemail="e795978b828a978295a7809492c9828392">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alberto Jiménez-Somarribas</span> - <span class="hlFld-Affiliation affiliation">Emory
Institute for Drug Development, Emory University, Atlanta, Georgia 30329, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shuli Mao</span> - <span class="hlFld-Affiliation affiliation">Emory
Institute for Drug Development, Emory University, Atlanta, Georgia 30329, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeong-Joong Yoon</span> - <span class="hlFld-Affiliation affiliation">Institute
for Biomedical Sciences, Georgia State University, Atlanta, Georgia 30303, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marco Weisshaar</span> - <span class="hlFld-Affiliation affiliation">Institute
for Biomedical Sciences, Georgia State University, Atlanta, Georgia 30303, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert M. Cox</span> - <span class="hlFld-Affiliation affiliation">Institute
for Biomedical Sciences, Georgia State University, Atlanta, Georgia 30303, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jose R. Marengo</span> - <span class="hlFld-Affiliation affiliation">Emory
Institute for Drug Development, Emory University, Atlanta, Georgia 30329, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deborah G. Mitchell</span> - <span class="hlFld-Affiliation affiliation">Emory
Institute for Drug Development, Emory University, Atlanta, Georgia 30329, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zachary P. Morehouse</span> - <span class="hlFld-Affiliation affiliation">Institute
for Biomedical Sciences, Georgia State University, Atlanta, Georgia 30303, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dan Yan</span> - <span class="hlFld-Affiliation affiliation">Institute
for Biomedical Sciences, Georgia State University, Atlanta, Georgia 30303, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ivan Solis</span> - <span class="hlFld-Affiliation affiliation">Institute
for Biomedical Sciences, Georgia State University, Atlanta, Georgia 30303, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dennis C. Liotta</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Emory University, Atlanta, Georgia 30322, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7736-7113" title="Orcid link">http://orcid.org/0000-0002-7736-7113</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael G. Natchus</span> - <span class="hlFld-Affiliation affiliation">Emory
Institute for Drug Development, Emory University, Atlanta, Georgia 30329, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d219e6187-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i99">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11120" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11120" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported, in part, by public health service grants AI071002 and HD079327 from the NIH/NIAID and NIH/NICHD (to R.K.P.). We thank R. T. Jacob for IT support. The MScreen software package was kindly provided by the Center for Chemical Genomics of the University of Michigan under a license agreement by the University of Michigan Office of Technology Transfer. JChem was used for structure database management, search, and prediction (JChem 6.2, 2014, ChemAxon (<a href="http://www.chemaxon.com" class="extLink">http://www.chemaxon.com</a>)), and Marvin was employed for drawing, displaying, and characterizing chemical structures, substructures, and reactions (Marvin 14.9.22.0, 2014, ChemAxon (<a href="http://www.chemaxon.com" class="extLink">http://www.chemaxon.com</a>)).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i100" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i100"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i101" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i101"> Abbreviations Used</h2><tr><td class="NLM_term">ATCC</td><td class="NLM_def"><p class="first last">American Type Culture Collection</p></td></tr><tr><td class="NLM_term">ANOVA</td><td class="NLM_def"><p class="first last">analysis of variance</p></td></tr><tr><td class="NLM_term">CC<sub>50</sub></td><td class="NLM_def"><p class="first last">50% cytotoxic concentration</p></td></tr><tr><td class="NLM_term">Ct value</td><td class="NLM_def"><p class="first last">cycle threshold value</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N,N-</i>diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s modified Eagle’s medium</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">DPPA</td><td class="NLM_def"><p class="first last">diphenyl phosphorazidate</p></td></tr><tr><td class="NLM_term">EC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal effective concentration</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last"><i>N</i>-(3-(dimethylamino)propyl)-<i>N</i>′-ethylcarbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">GAPDH</td><td class="NLM_def"><p class="first last">glyceraldehyde 3-phosphate dehydrogenase</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last"><i>N</i>-[(dimethylamino)-1<i>H</i>-1,2,3-triazolo-[4,5-<i>b</i>]pyridin-1-ylmethylene]-<i>N</i>-methylmethanaminium hexafluorophosphate <i>N</i>-oxide</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">1-hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">IAV</td><td class="NLM_def"><p class="first last">influenza A virus</p></td></tr><tr><td class="NLM_term">IBCF</td><td class="NLM_def"><p class="first last"><i>iso-</i>butyl chloroformate</p></td></tr><tr><td class="NLM_term">ITSD</td><td class="NLM_def"><p class="first last">internal standard</p></td></tr><tr><td class="NLM_term">NMM</td><td class="NLM_def"><p class="first last"><i>N-</i>methylmorpholine</p></td></tr><tr><td class="NLM_term">Ns</td><td class="NLM_def"><p class="first last">2-nitrobenzenesulfonyl</p></td></tr><tr><td class="NLM_term">qPCR</td><td class="NLM_def"><p class="first last">real-time polymerase chain reaction</p></td></tr><tr><td class="NLM_term">RdRp</td><td class="NLM_def"><p class="first last">RNA-dependent RNA polymerase</p></td></tr><tr><td class="NLM_term">RSV</td><td class="NLM_def"><p class="first last">respiratory syncytial virus</p></td></tr><tr><td class="NLM_term">RSV N</td><td class="NLM_def"><p class="first last">RSV nucleocapsid protein</p></td></tr><tr><td class="NLM_term">RSV P</td><td class="NLM_def"><p class="first last">RSV phosphoprotein</p></td></tr><tr><td class="NLM_term">RSV M2-1</td><td class="NLM_def"><p class="first last">RSV matrix protein 2-1</p></td></tr><tr><td class="NLM_term">RSV L</td><td class="NLM_def"><p class="first last">RSV large protein</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">standard deviation</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr><tr><td class="NLM_term">SI</td><td class="NLM_def"><p class="first last">selectivity index</p></td></tr><tr><td class="NLM_term">TCID<sub>50</sub></td><td class="NLM_def"><p class="first last">median tissue culture infective dose</p></td></tr><tr><td class="NLM_term">VSV</td><td class="NLM_def"><p class="first last">vesicular stomatitis virus</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i102">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60058" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60058" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 38 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Afonso, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amarasinghe, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banyai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basler, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bavari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bejerman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blasdell, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briand, F. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briese, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukreyev, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calisher, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clawson, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietzgen, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolnik, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domier, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durrwald, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dye, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easton, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebihara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farkas, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freitas-Astua, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Formenty, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fouchier, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghedin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodin, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyndman, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitajima, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobinger, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurath, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenardon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroy, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longdon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maisner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muhlberger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Netesov, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowotny, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paweska, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randall, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rima, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rota, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubbenstroth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwemmle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smither, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenglein, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terregino, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tesh, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomonaga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tordo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Towner, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasilakis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbeek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volchkov, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl-Jensen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetzel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitfield, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuen, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, J. H.</span><span> </span><span class="NLM_article-title">Taxonomy of the order mononegavirales: Update 2016</span> <span class="citation_source-journal">Arch. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">2351</span><span class="NLM_x">–</span> <span class="NLM_lpage">2360</span><span class="refDoi"> DOI: 10.1007/s00705-016-2880-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1007%2Fs00705-016-2880-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=27216929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADC%252BC28XosVSqu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2016&pages=2351-2360&author=C.+L.+Afonsoauthor=G.+K.+Amarasingheauthor=K.+Banyaiauthor=Y.+Baoauthor=C.+F.+Baslerauthor=S.+Bavariauthor=N.+Bejermanauthor=K.+R.+Blasdellauthor=F.+X.+Briandauthor=T.+Brieseauthor=A.+Bukreyevauthor=C.+H.+Calisherauthor=K.+Chandranauthor=J.+Chengauthor=A.+N.+Clawsonauthor=P.+L.+Collinsauthor=R.+G.+Dietzgenauthor=O.+Dolnikauthor=L.+L.+Domierauthor=R.+Durrwaldauthor=J.+M.+Dyeauthor=A.+J.+Eastonauthor=H.+Ebiharaauthor=S.+L.+Farkasauthor=J.+Freitas-Astuaauthor=P.+Formentyauthor=R.+A.+Fouchierauthor=Y.+Fuauthor=E.+Ghedinauthor=M.+M.+Goodinauthor=R.+Hewsonauthor=M.+Horieauthor=T.+H.+Hyndmanauthor=D.+Jiangauthor=E.+W.+Kitajimaauthor=G.+P.+Kobingerauthor=H.+Kondoauthor=G.+Kurathauthor=R.+A.+Lambauthor=S.+Lenardonauthor=E.+M.+Leroyauthor=C.+X.+Liauthor=X.+D.+Linauthor=L.+Liuauthor=B.+Longdonauthor=S.+Martonauthor=A.+Maisnerauthor=E.+Muhlbergerauthor=S.+V.+Netesovauthor=N.+Nowotnyauthor=J.+L.+Pattersonauthor=S.+L.+Payneauthor=J.+T.+Paweskaauthor=R.+E.+Randallauthor=B.+K.+Rimaauthor=P.+Rotaauthor=D.+Rubbenstrothauthor=M.+Schwemmleauthor=M.+Shiauthor=S.+J.+Smitherauthor=M.+D.+Stengleinauthor=D.+M.+Stoneauthor=A.+Takadaauthor=C.+Terreginoauthor=R.+B.+Teshauthor=J.+H.+Tianauthor=K.+Tomonagaauthor=N.+Tordoauthor=J.+S.+Townerauthor=N.+Vasilakisauthor=M.+Verbeekauthor=V.+E.+Volchkovauthor=V.+Wahl-Jensenauthor=J.+A.+Walshauthor=P.+J.+Walkerauthor=D.+Wangauthor=L.+F.+Wangauthor=T.+Wetzelauthor=A.+E.+Whitfieldauthor=J.+T.+Xieauthor=K.+Y.+Yuenauthor=Y.+Z.+Zhangauthor=J.+H.+Kuhn&title=Taxonomy+of+the+order+mononegavirales%3A+Update+2016&doi=10.1007%2Fs00705-016-2880-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Taxonomy of the order Mononegavirales: update 2016</span></div><div class="casAuthors">Afonso, Claudio L.; Amarasinghe, Gaya K.; Banyai, Krisztian; Bao, Yiming; Basler, Christopher F.; Bavari, Sina; Bejerman, Nicolas; Blasdell, Kim R.; Briand, Francois-Xavier; Briese, Thomas; Bukreyev, Alexander; Calisher, Charles H.; Chandran, Kartik; Cheng, Jiasen; Clawson, Anna N.; Collins, Peter L.; Dietzgen, Ralf G.; Dolnik, Olga; Domier, Leslie L.; Durrwald, Ralf; Dye, John M.; Easton, Andrew J.; Ebihara, Hideki; Farkas, Szilvia L.; Freitas-Astua, Juliana; Formenty, Pierre; Fouchier, Ron A. M.; Fu, Yanping; Ghedin, Elodie; Goodin, Michael M.; Hewson, Roger; Horie, Masayuki; Hyndman, Timothy H.; Jiang, Daohong; Kitajima, Elliot W.; Kobinger, Gary P.; Kondo, Hideki; Kurath, Gael; Lamb, Robert A.; Lenardon, Sergio; Leroy, Eric M.; Li, Ci-Xiu; Lin, Xian-Dan; Liu, Lijiang; Longdon, Ben; Marton, Szilvia; Maisner, Andrea; Muhlberger, Elke; Netesov, Sergey V.; Nowotny, Norbert; Patterson, Jean L.; Payne, Susan L.; Paweska, Janusz T.; Randall, Rick E.; Rima, Bertus K.; Rota, Paul; Rubbenstroth, Dennis; Schwemmle, Martin; Shi, Mang; Smither, Sophie J.; Stenglein, Mark D.; Stone, David M.; Takada, Ayato; Terregino, Calogero; Tesh, Robert B.; Tian, Jun-Hua; Tomonaga, Keizo; Tordo, Noel; Towner, Jonathan S.; Vasilakis, Nikos; Verbeek, Martin; Volchkov, Viktor E.; Wahl-Jensen, Victoria; Walsh, John A.; Walker, Peter J.; Wang, David; Wang, Lin-Fa; Wetzel, Thierry; Whitfield, Anna E.; Xie, Jiatao; Yuen, Kwok-Yung; Zhang, Yong-Zhen; Kuhn, Jens H.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Virology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2351-2360</span>CODEN:
                <span class="NLM_cas:coden">ARVIDF</span>;
        ISSN:<span class="NLM_cas:issn">0304-8608</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag GmbH</span>)
        </div><div class="casAbstract">In 2016, the order Mononegavirales was emended through the addn. of two new families (Mymonaviridae and Sunviridae), the elevation of the paramyxoviral subfamily Pneumovirinae to family status (Pneumoviridae), the addn. of five free-floating genera (Anphevirus, Arlivirus, Chengtivirus, Crustavirus, and Wastrivirus), and several other changes at the genus and species levels.  This article presents the updated taxonomy of the order Mononegavirales as now accepted by the International Committee on Taxonomy of Viruses (ICTV).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJf1Zbq5k5fbVg90H21EOLACvtfcHk0liOOo1EWxbkHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosVSqu7Y%253D&md5=42c7698d6765f50874b7c6dc90d4f30a</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs00705-016-2880-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00705-016-2880-1%26sid%3Dliteratum%253Aachs%26aulast%3DAfonso%26aufirst%3DC.%2BL.%26aulast%3DAmarasinghe%26aufirst%3DG.%2BK.%26aulast%3DBanyai%26aufirst%3DK.%26aulast%3DBao%26aufirst%3DY.%26aulast%3DBasler%26aufirst%3DC.%2BF.%26aulast%3DBavari%26aufirst%3DS.%26aulast%3DBejerman%26aufirst%3DN.%26aulast%3DBlasdell%26aufirst%3DK.%2BR.%26aulast%3DBriand%26aufirst%3DF.%2BX.%26aulast%3DBriese%26aufirst%3DT.%26aulast%3DBukreyev%26aufirst%3DA.%26aulast%3DCalisher%26aufirst%3DC.%2BH.%26aulast%3DChandran%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DClawson%26aufirst%3DA.%2BN.%26aulast%3DCollins%26aufirst%3DP.%2BL.%26aulast%3DDietzgen%26aufirst%3DR.%2BG.%26aulast%3DDolnik%26aufirst%3DO.%26aulast%3DDomier%26aufirst%3DL.%2BL.%26aulast%3DDurrwald%26aufirst%3DR.%26aulast%3DDye%26aufirst%3DJ.%2BM.%26aulast%3DEaston%26aufirst%3DA.%2BJ.%26aulast%3DEbihara%26aufirst%3DH.%26aulast%3DFarkas%26aufirst%3DS.%2BL.%26aulast%3DFreitas-Astua%26aufirst%3DJ.%26aulast%3DFormenty%26aufirst%3DP.%26aulast%3DFouchier%26aufirst%3DR.%2BA.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DGhedin%26aufirst%3DE.%26aulast%3DGoodin%26aufirst%3DM.%2BM.%26aulast%3DHewson%26aufirst%3DR.%26aulast%3DHorie%26aufirst%3DM.%26aulast%3DHyndman%26aufirst%3DT.%2BH.%26aulast%3DJiang%26aufirst%3DD.%26aulast%3DKitajima%26aufirst%3DE.%2BW.%26aulast%3DKobinger%26aufirst%3DG.%2BP.%26aulast%3DKondo%26aufirst%3DH.%26aulast%3DKurath%26aufirst%3DG.%26aulast%3DLamb%26aufirst%3DR.%2BA.%26aulast%3DLenardon%26aufirst%3DS.%26aulast%3DLeroy%26aufirst%3DE.%2BM.%26aulast%3DLi%26aufirst%3DC.%2BX.%26aulast%3DLin%26aufirst%3DX.%2BD.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLongdon%26aufirst%3DB.%26aulast%3DMarton%26aufirst%3DS.%26aulast%3DMaisner%26aufirst%3DA.%26aulast%3DMuhlberger%26aufirst%3DE.%26aulast%3DNetesov%26aufirst%3DS.%2BV.%26aulast%3DNowotny%26aufirst%3DN.%26aulast%3DPatterson%26aufirst%3DJ.%2BL.%26aulast%3DPayne%26aufirst%3DS.%2BL.%26aulast%3DPaweska%26aufirst%3DJ.%2BT.%26aulast%3DRandall%26aufirst%3DR.%2BE.%26aulast%3DRima%26aufirst%3DB.%2BK.%26aulast%3DRota%26aufirst%3DP.%26aulast%3DRubbenstroth%26aufirst%3DD.%26aulast%3DSchwemmle%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DM.%26aulast%3DSmither%26aufirst%3DS.%2BJ.%26aulast%3DStenglein%26aufirst%3DM.%2BD.%26aulast%3DStone%26aufirst%3DD.%2BM.%26aulast%3DTakada%26aufirst%3DA.%26aulast%3DTerregino%26aufirst%3DC.%26aulast%3DTesh%26aufirst%3DR.%2BB.%26aulast%3DTian%26aufirst%3DJ.%2BH.%26aulast%3DTomonaga%26aufirst%3DK.%26aulast%3DTordo%26aufirst%3DN.%26aulast%3DTowner%26aufirst%3DJ.%2BS.%26aulast%3DVasilakis%26aufirst%3DN.%26aulast%3DVerbeek%26aufirst%3DM.%26aulast%3DVolchkov%26aufirst%3DV.%2BE.%26aulast%3DWahl-Jensen%26aufirst%3DV.%26aulast%3DWalsh%26aufirst%3DJ.%2BA.%26aulast%3DWalker%26aufirst%3DP.%2BJ.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.%2BF.%26aulast%3DWetzel%26aufirst%3DT.%26aulast%3DWhitfield%26aufirst%3DA.%2BE.%26aulast%3DXie%26aufirst%3DJ.%2BT.%26aulast%3DYuen%26aufirst%3DK.%2BY.%26aulast%3DZhang%26aufirst%3DY.%2BZ.%26aulast%3DKuhn%26aufirst%3DJ.%2BH.%26atitle%3DTaxonomy%2520of%2520the%2520order%2520mononegavirales%253A%2520Update%25202016%26jtitle%3DArch.%2520Virol.%26date%3D2016%26volume%3D161%26spage%3D2351%26epage%3D2360%26doi%3D10.1007%2Fs00705-016-2880-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Thompson, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shay, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weintraub, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brammer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuda, K.</span><span> </span><span class="NLM_article-title">Mortality associated with influenza and respiratory syncytial virus in the United States</span> <span class="citation_source-journal">J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span><span class="refDoi"> DOI: 10.1001/jama.289.2.179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1001%2Fjama.289.2.179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=12517228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A280%3ADC%252BD3s%252FhtFOntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2003&pages=179-186&author=W.+W.+Thompsonauthor=D.+K.+Shayauthor=E.+Weintraubauthor=L.+Brammerauthor=N.+Coxauthor=L.+J.+Andersonauthor=K.+Fukuda&title=Mortality+associated+with+influenza+and+respiratory+syncytial+virus+in+the+United+States&doi=10.1001%2Fjama.289.2.179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mortality associated with influenza and respiratory syncytial virus in the United States</span></div><div class="casAuthors">Thompson William W; Shay David K; Weintraub Eric; Brammer Lynnette; Cox Nancy; Anderson Larry J; Fukuda Keiji</div><div class="citationInfo"><span class="NLM_cas:title">JAMA</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">179-86</span>
        ISSN:<span class="NLM_cas:issn">0098-7484</span>.
    </div><div class="casAbstract">CONTEXT:  Influenza and respiratory syncytial virus (RSV) cause substantial morbidity and mortality.  Statistical methods used to estimate deaths in the United States attributable to influenza have not accounted for RSV circulation.  OBJECTIVE:  To develop a statistical model using national mortality and viral surveillance data to estimate annual influenza- and RSV-associated deaths in the United States, by age group, virus, and influenza type and subtype.  DESIGN, SETTING, AND POPULATION:  Age-specific Poisson regression models using national viral surveillance data for the 1976-1977 through 1998-1999 seasons were used to estimate influenza-associated deaths.  Influenza- and RSV-associated deaths were simultaneously estimated for the 1990-1991 through 1998-1999 seasons.  MAIN OUTCOME MEASURES:  Attributable deaths for 3 categories: underlying pneumonia and influenza, underlying respiratory and circulatory, and all causes.  RESULTS:  Annual estimates of influenza-associated deaths increased significantly between the 1976-1977 and 1998-1999 seasons for all 3 death categories (P<.001 for each category).  For the 1990-1991 through 1998-1999 seasons, the greatest mean numbers of deaths were associated with influenza A(H3N2) viruses, followed by RSV, influenza B, and influenza A(H1N1).  Influenza viruses and RSV, respectively, were associated with annual means (SD) of 8097 (3084) and 2707 (196) underlying pneumonia and influenza deaths, 36 155 (11 055) and 11 321 (668) underlying respiratory and circulatory deaths, and 51 203 (15 081) and 17 358 (1086) all-cause deaths.  For underlying respiratory and circulatory deaths, 90% of influenza- and 78% of RSV-associated deaths occurred among persons aged 65 years or older.  Influenza was associated with more deaths than RSV in all age groups except for children younger than 1 year.  On average, influenza was associated with 3 times as many deaths as RSV.  CONCLUSIONS:  Mortality associated with both influenza and RSV circulation disproportionately affects elderly persons.  Influenza deaths have increased substantially in the last 2 decades, in part because of aging of the population, underscoring the need for better prevention measures, including more effective vaccines and vaccination programs for elderly persons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4QBM7LTwlvHqj_yg7twvpfW6udTcc2eZJ88Qk6ogNXrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s%252FhtFOntA%253D%253D&md5=76dba2ff0597ae7dafd32c90820fa1f7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1001%2Fjama.289.2.179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.289.2.179%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DW.%2BW.%26aulast%3DShay%26aufirst%3DD.%2BK.%26aulast%3DWeintraub%26aufirst%3DE.%26aulast%3DBrammer%26aufirst%3DL.%26aulast%3DCox%26aufirst%3DN.%26aulast%3DAnderson%26aufirst%3DL.%2BJ.%26aulast%3DFukuda%26aufirst%3DK.%26atitle%3DMortality%2520associated%2520with%2520influenza%2520and%2520respiratory%2520syncytial%2520virus%2520in%2520the%2520United%2520States%26jtitle%3DJ.%2520Am.%2520Med.%2520Assoc.%26date%3D2003%26volume%3D289%26spage%3D179%26epage%3D186%26doi%3D10.1001%2Fjama.289.2.179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Collins, P. L.; Crowe, J. E.,  Jr.</span><span> </span><span class="NLM_article-title">Respiratory Syncytial Virus and Metapneumoviruses</span>. In  <span class="citation_source-book">Fields Virology</span>, <span class="NLM_edition">5</span>th ed.; <span class="NLM_contrib-group">Knipe, D. M.; Howley, P. M.</span>, Eds.; <span class="NLM_publisher-name">Lippincott, Williams, & Wilkins</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">2</span>, pp  <span class="NLM_fpage">1601</span><span class="NLM_x">–</span> <span class="NLM_lpage">1645</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=1601-1645&author=P.+L.+Collins&author=J.+E.+Croweauthor=D.+M.+Knipe&author=P.+M.+Howley&title=Fields+Virology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DP.%2BL.%26atitle%3DRespiratory%2520Syncytial%2520Virus%2520and%2520Metapneumoviruses%26btitle%3DFields%2520Virology%26aulast%3DKnipe%26aufirst%3DD.%2BM.%26pub%3DLippincott%252C%2520Williams%252C%2520%2526%2520Wilkins%26date%3D2007%26volume%3D2%26spage%3D1601%26epage%3D1645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Elliot, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, D. M.</span><span> </span><span class="NLM_article-title">Influenza and respiratory syncytial virus in the elderly</span> <span class="citation_source-journal">Expert Rev. Vaccines</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span><span class="refDoi"> DOI: 10.1586/14760584.7.2.249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1586%2F14760584.7.2.249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=18324893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A280%3ADC%252BD1c7mvFaguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=249-258&author=A.+J.+Elliotauthor=D.+M.+Fleming&title=Influenza+and+respiratory+syncytial+virus+in+the+elderly&doi=10.1586%2F14760584.7.2.249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Influenza and respiratory syncytial virus in the elderly</span></div><div class="casAuthors">Elliot Alex J; Fleming Douglas M</div><div class="citationInfo"><span class="NLM_cas:title">Expert review of vaccines</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">249-58</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Respiratory infections are one of the leading causes of morbidity and mortality worldwide: influenza and respiratory syncytial virus (RSV) are the predominant pathogens responsible.  Annual vaccination and the use of antiviral drugs provides both protection and treatment against influenza, particularly protecting those patients most at risk, including the elderly and individuals with chronic comorbidities.  Currently, there are extremely limited options in the protection against RSV infection, making those at-risk patients vulnerable to serious disease, complications and death.  This review focuses on recent trends in respiratory illness in the elderly, particularly focusing on the burden of influenza and RSV on hospitalizations and mortality.  We discuss the potential benefit of influenza vaccination on these outcomes, including the recent controversial debate over the effectiveness of influenza vaccination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRNyeSHlOW6MJPlX7E30qdzfW6udTcc2eZJ88Qk6ogNXrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7mvFaguw%253D%253D&md5=ef4849de4ad796c341cbcc8ef0eed2c6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1586%2F14760584.7.2.249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14760584.7.2.249%26sid%3Dliteratum%253Aachs%26aulast%3DElliot%26aufirst%3DA.%2BJ.%26aulast%3DFleming%26aufirst%3DD.%2BM.%26atitle%3DInfluenza%2520and%2520respiratory%2520syncytial%2520virus%2520in%2520the%2520elderly%26jtitle%3DExpert%2520Rev.%2520Vaccines%26date%3D2008%26volume%3D7%26spage%3D249%26epage%3D258%26doi%3D10.1586%2F14760584.7.2.249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Aherne, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bird, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Court, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQuillin, J.</span><span> </span><span class="NLM_article-title">Pathological changes in virus infections of the lower respiratory tract in children</span> <span class="citation_source-journal">J. Clin. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span><span class="refDoi"> DOI: 10.1136/jcp.23.1.7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1136%2Fjcp.23.1.7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=4909103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A280%3ADyaE3c7mtFaitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1970&pages=7-18&author=W.+Aherneauthor=T.+Birdauthor=S.+D.+Courtauthor=P.+S.+Gardnerauthor=J.+McQuillin&title=Pathological+changes+in+virus+infections+of+the+lower+respiratory+tract+in+children&doi=10.1136%2Fjcp.23.1.7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Pathological changes in virus infections of the lower respiratory tract in children</span></div><div class="casAuthors">Aherne W; Bird T; Court S D; Gardner P S; McQuillin J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical pathology</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-18</span>
        ISSN:<span class="NLM_cas:issn">0021-9746</span>.
    </div><div class="casAbstract">The pathological changes are described in 22 children with proven or suspected virus infection of the lower respiratory tract.  Two main patterns of disease were found: acute bronchiolitis and interstitial pneumonia.  Particular viruses were not specifically associated with particular histological changes.  The prime importance of the respiratory syncytial virus (RSV) as a cause of disease and death in young infants is again shown.  Structural lesions and clinical dysfunction correlate fairly well; in acute bronchiolitis the main lesion is epithelial necrosis when a dense plug is formed in the bronchiolar lumen leading to trapping air and other mechanical interference with ventilation: in interstitial pneumonia there is widespread inflammation and necrosis of lung parenchyma, and severe lesions of the bronchial and bronchiolar mucosa as well.  The implications of these structural changes for clinical management are discussed.  The possibility of a hypersensitivity reaction in the cot death syndrome is raised, mediated by a serum antibody-antigen-complement reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS01jf-M8Pu0zjk2McQZ6XmfW6udTcc2ebDfELQ5z5T8Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE3c7mtFaitg%253D%253D&md5=58dda7fdb25a55f6903d3ab2bb8b2aab</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1136%2Fjcp.23.1.7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjcp.23.1.7%26sid%3Dliteratum%253Aachs%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DBird%26aufirst%3DT.%26aulast%3DCourt%26aufirst%3DS.%2BD.%26aulast%3DGardner%26aufirst%3DP.%2BS.%26aulast%3DMcQuillin%26aufirst%3DJ.%26atitle%3DPathological%2520changes%2520in%2520virus%2520infections%2520of%2520the%2520lower%2520respiratory%2520tract%2520in%2520children%26jtitle%3DJ.%2520Clin.%2520Pathol.%26date%3D1970%26volume%3D23%26spage%3D7%26epage%3D18%26doi%3D10.1136%2Fjcp.23.1.7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Lugo, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nahata, M. C.</span><span> </span><span class="NLM_article-title">Pathogenesis and treatment of bronchiolitis</span> <span class="citation_source-journal">Clin. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=8095871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A280%3ADyaK3s3gtFyrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1993&pages=95-116&author=R.+A.+Lugoauthor=M.+C.+Nahata&title=Pathogenesis+and+treatment+of+bronchiolitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogenesis and treatment of bronchiolitis</span></div><div class="casAuthors">Lugo R A; Nahata M C</div><div class="citationInfo"><span class="NLM_cas:title">Clinical pharmacy</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">95-116</span>
        ISSN:<span class="NLM_cas:issn">0278-2677</span>.
    </div><div class="casAbstract">The pathogenesis, epidemiology, clinical features, sequelae, and treatment of bronchiolitis are reviewed.  Acute bronchiolitis is the most common severe lower-respiratory-tract infection of infancy.  During epidemics, more than 80% of cases may be caused by respiratory syncytial virus (RSV).  Although signs and symptoms may become severe, most infections are self-limited and improvement occurs within several days.  Approximately 1-2% of infants less than one year of age require hospitalization.  Generally, patients who develop severe, life-threatening RSV bronchiolitis are those with underlying cardiopulmonary disease, immunosuppression, bronchopulmonary dysplasia, or a history of premature birth.  In severe bronchiolitis, necrosis of the respiratory epithelium, excessive mucus production, and lymphocytic infiltration result in edema, dense plugs of debris, and subsequent bronchiolar obstruction.  IgE-mediated reactions and release of inflammatory mediators may result in exacerbation of acute obstruction and may contribute to chronic obstructive pulmonary dysfunction, a common sequela of bronchiolitis.  Patients hospitalized with bronchiolitis usually require supportive therapy and may require mechanical ventilation.  Based on recent data, a trial of aerosolized beta 2 agonists is warranted in all patients.  Systemic corticosteroids have not proved efficacious and have a limited role in the treatment of acute bronchiolitis.  Inhaled corticosteroids may be useful in reducing the severity of chronic wheezing that may follow acute bronchiolitis.  Ribavirin may be considered in patients with severe illness or in those at high risk for severe RSV disease.  Intravenous immune globulin may have a role in the treatment of lower-respiratory-tract infections involving RSV; however, since few studies have been performed in humans, it is not possible to determine its place in the treatment of bronchiolitis.  A trial of aerosolized beta 2 agonists is warranted in patients with bronchiolitis.  Ribavirin may be considered in patients with severe disease or those at high risk for severe disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQtslZVRRlDLI3yKPtYViAGfW6udTcc2ebDfELQ5z5T8Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s3gtFyrsw%253D%253D&md5=8daaba023aadc470f9d448b335b94d20</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLugo%26aufirst%3DR.%2BA.%26aulast%3DNahata%26aufirst%3DM.%2BC.%26atitle%3DPathogenesis%2520and%2520treatment%2520of%2520bronchiolitis%26jtitle%3DClin.%2520Pharm.%26date%3D1993%26volume%3D12%26spage%3D95%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Domachowske, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, H. F.</span><span> </span><span class="NLM_article-title">Respiratory syncytial virus infection: Immune response, immunopathogenesis, and treatment</span> <span class="citation_source-journal">Clin. Microbiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">298</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1128%2FCMR.12.2.298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10194461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A280%3ADyaK1M3ht1Smsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1999&pages=298-309&author=J.+B.+Domachowskeauthor=H.+F.+Rosenberg&title=Respiratory+syncytial+virus+infection%3A+Immune+response%2C+immunopathogenesis%2C+and+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment</span></div><div class="casAuthors">Domachowske J B; Rosenberg H F</div><div class="citationInfo"><span class="NLM_cas:title">Clinical microbiology reviews</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">298-309</span>
        ISSN:<span class="NLM_cas:issn">0893-8512</span>.
    </div><div class="casAbstract">Respiratory syncytial virus (RSV) is the single most important cause of lower respiratory tract infection during infancy and early childhood.  Once RSV infection is established, the host immune response includes the production of virus-neutralizing antibodies and T-cell-specific immunity.  The humoral immune response normally results in the development of anti-RSV neutralizing-antibody titers, but these are often suboptimal during an infant's initial infection.  Even when the production of RSV neutralizing antibody following RSV infection is robust, humoral immunity wanes over time.  Reinfection during subsequent seasons is common.  The cellular immune response to RSV infection is also important for the clearance of virus.  This immune response, vital for host defense against RSV, is also implicated in the immunopathogenesis of severe lower respiratory tract RSV bronchiolitis.  Many details of the immunology and immunopathologic mechanisms of RSV disease known at present have been learned from rodent models of RSV disease and are discussed in some detail.  In addition, the roles of immunoglobulin E, histamine, and eosinophils in the immunopathogenesis of RSV disease are considered.  Although the treatment of RSV bronchiolitis is primarily supportive, the role of ribavirin is briefly discussed.  Novel approaches to the development of new antiviral drugs with promising anti-RSV activity in vitro are also described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLMwn5Ypa32mGmni0r9GoKfW6udTcc2ebDfELQ5z5T8Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M3ht1Smsg%253D%253D&md5=b646bfa9c2bdbef4f4b54e2d40318fe2</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1128%2FCMR.12.2.298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.12.2.298%26sid%3Dliteratum%253Aachs%26aulast%3DDomachowske%26aufirst%3DJ.%2BB.%26aulast%3DRosenberg%26aufirst%3DH.%2BF.%26atitle%3DRespiratory%2520syncytial%2520virus%2520infection%253A%2520Immune%2520response%252C%2520immunopathogenesis%252C%2520and%2520treatment%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D1999%26volume%3D12%26spage%3D298%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">DeVincenzo, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaishnaw, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cehelsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nochur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meeking, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moane, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oxford, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pareek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Studholme, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambkin-Williams, R.</span><span> </span><span class="NLM_article-title">Viral load drives disease in humans experimentally infected with respiratory syncytial virus</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">182</span><span class="NLM_x">, </span> <span class="NLM_fpage">1305</span><span class="NLM_x">–</span> <span class="NLM_lpage">1314</span><span class="refDoi"> DOI: 10.1164/rccm.201002-0221OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1164%2Frccm.201002-0221OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=20622030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1equg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2010&pages=1305-1314&author=J.+P.+DeVincenzoauthor=T.+Wilkinsonauthor=A.+Vaishnawauthor=J.+Cehelskyauthor=R.+Meyersauthor=S.+Nochurauthor=L.+Harrisonauthor=P.+Meekingauthor=A.+Mannauthor=E.+Moaneauthor=J.+Oxfordauthor=R.+Pareekauthor=R.+Mooreauthor=E.+Walshauthor=R.+Studholmeauthor=P.+Dorsettauthor=R.+Alvarezauthor=R.+Lambkin-Williams&title=Viral+load+drives+disease+in+humans+experimentally+infected+with+respiratory+syncytial+virus&doi=10.1164%2Frccm.201002-0221OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Viral load drives disease in humans experimentally infected with respiratory syncytial virus</span></div><div class="casAuthors">DeVincenzo, John P.; Wilkinson, Tom; Vaishnaw, Akshay; Cehelsky, Jeff; Meyers, Rachel; Nochur, Saraswathy; Harrison, Lisa; Meeking, Patricia; Mann, Alex; Moane, Elizabeth; Oxford, John; Pareek, Rajat; Moore, Ryves; Walsh, Ed; Studholme, Robert; Dorsett, Preston; Alvarez, Rene; Lambkin-Williams, Robert</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1305-1314</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Respiratory syncytial virus (RSV) is the leading cause of childhood lower respiratory infection, yet viable therapies are lacking.  Two major challenges have stalled antiviral development: ethical difficulties in performing pediatric proof-of-concept studies and the prevailing concept that the disease is immune-mediated rather than being driven by viral load.  The development of a human exptl. wild-type RSV infection model to address these challenges.  Healthy volunteers (n = 35), in five cohorts, received increasing quantities (3.0-5.4 log plaque-forming units/person) of wild-type RSV-A intranasally.  Overall, 77% of volunteers consistently shed virus.  Infection rate, viral loads, disease severity, and safety were similar between cohorts and were unrelated to quantity of RSV received.  Symptoms began near the time of initial viral detection, peaked in severity near when viral load peaked, and subsided as viral loads (measured by real-time polymerase chain reaction) slowly declined.  Viral loads correlated significantly with intranasal proinflammatory cytokine concns. (IL-6 and IL-8).  Increased viral load correlated consistently with increases in multiple different disease measurements (symptoms, phys. examn., and amt. of nasal mucus).  Viral load appears to drive disease manifestations in humans with RSV infection.  The obsd. parallel viral and disease kinetics support a potential clin. benefit of RSV antivirals.  This reproducible model facilitates the development of future RSV therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-DVpVkrytZ7Vg90H21EOLACvtfcHk0lhWn-bN0eYY0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1equg%253D%253D&md5=baadbf1735812bf00a63b9499a2fe3bd</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1164%2Frccm.201002-0221OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.201002-0221OC%26sid%3Dliteratum%253Aachs%26aulast%3DDeVincenzo%26aufirst%3DJ.%2BP.%26aulast%3DWilkinson%26aufirst%3DT.%26aulast%3DVaishnaw%26aufirst%3DA.%26aulast%3DCehelsky%26aufirst%3DJ.%26aulast%3DMeyers%26aufirst%3DR.%26aulast%3DNochur%26aufirst%3DS.%26aulast%3DHarrison%26aufirst%3DL.%26aulast%3DMeeking%26aufirst%3DP.%26aulast%3DMann%26aufirst%3DA.%26aulast%3DMoane%26aufirst%3DE.%26aulast%3DOxford%26aufirst%3DJ.%26aulast%3DPareek%26aufirst%3DR.%26aulast%3DMoore%26aufirst%3DR.%26aulast%3DWalsh%26aufirst%3DE.%26aulast%3DStudholme%26aufirst%3DR.%26aulast%3DDorsett%26aufirst%3DP.%26aulast%3DAlvarez%26aufirst%3DR.%26aulast%3DLambkin-Williams%26aufirst%3DR.%26atitle%3DViral%2520load%2520drives%2520disease%2520in%2520humans%2520experimentally%2520infected%2520with%2520respiratory%2520syncytial%2520virus%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2010%26volume%3D182%26spage%3D1305%26epage%3D1314%26doi%3D10.1164%2Frccm.201002-0221OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">El Saleeby, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aitken, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devincenzo, J. P.</span><span> </span><span class="NLM_article-title">Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children</span> <span class="citation_source-journal">J. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">204</span><span class="NLM_x">, </span> <span class="NLM_fpage">996</span><span class="NLM_x">–</span> <span class="NLM_lpage">1002</span><span class="refDoi"> DOI: 10.1093/infdis/jir494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1093%2Finfdis%2Fjir494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=21881113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A280%3ADC%252BC3Mfgt1GnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=204&publication_year=2011&pages=996-1002&author=C.+M.+El+Saleebyauthor=A.+J.+Bushauthor=L.+M.+Harrisonauthor=J.+A.+Aitkenauthor=J.+P.+Devincenzo&title=Respiratory+syncytial+virus+load%2C+viral+dynamics%2C+and+disease+severity+in+previously+healthy+naturally+infected+children&doi=10.1093%2Finfdis%2Fjir494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children</span></div><div class="casAuthors">El Saleeby Chadi M; Bush Andy J; Harrison Lisa M; Aitken Jody A; Devincenzo John P</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of infectious diseases</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">204</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">996-1002</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Respiratory syncytial virus (RSV) disease severity was thought to be a result of host immunopathology but alternatively may be driven by high-level viral replication.  The relationships between RSV load, viral clearance dynamics, and disease severity have not been carefully evaluated.  METHODS:  Previously healthy RSV-infected children <2 years old were recruited.  RSV load was measured in respiratory secretions by fresh quantitative culture over 3 hospital days.  Measures of disease severity were hospital admission, duration of hospitalization, requirement for intensive care, and respiratory failure.  RESULTS:  Multivariate logistic regression models revealed independent predictors of increased duration of hospitalization: male sex, lower weight, and higher viral load on any day.  Viral loads at day 3 were more significantly associated with requirement for intensive care and respiratory failure than were viral loads at earlier time points.  Faster RSV clearance was independently associated with shorter hospitalization.  DISCUSSION:  These observations challenge the immunopathology-based pathogenesis paradigm.  They also have major therapeutic implications, suggesting that application of antiviral agents early in the disease course, even at a time when viral replication is at its highest, might improve subsequent morbidity by significantly lowering viral load and direct viral cytopathic effects, and aborting the potential downstream immunopathology.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTmIt942YeXHUPI-fCgwosgfW6udTcc2eYrDGqR9GU-F7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mfgt1GnsQ%253D%253D&md5=df2aee4217ba4325199646ac70599049</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2Fjir494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252Fjir494%26sid%3Dliteratum%253Aachs%26aulast%3DEl%2BSaleeby%26aufirst%3DC.%2BM.%26aulast%3DBush%26aufirst%3DA.%2BJ.%26aulast%3DHarrison%26aufirst%3DL.%2BM.%26aulast%3DAitken%26aufirst%3DJ.%2BA.%26aulast%3DDevincenzo%26aufirst%3DJ.%2BP.%26atitle%3DRespiratory%2520syncytial%2520virus%2520load%252C%2520viral%2520dynamics%252C%2520and%2520disease%2520severity%2520in%2520previously%2520healthy%2520naturally%2520infected%2520children%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2011%26volume%3D204%26spage%3D996%26epage%3D1002%26doi%3D10.1093%2Finfdis%2Fjir494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Anderson, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strikas, R. L.</span><span> </span><span class="NLM_article-title">Association between respiratory syncytial virus outbreaks and lower respiratory tract deaths of infants and young children</span> <span class="citation_source-journal">J. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">640</span><span class="NLM_x">–</span> <span class="NLM_lpage">646</span><span class="refDoi"> DOI: 10.1093/infdis/161.4.640</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1093%2Finfdis%2F161.4.640" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=2319164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A280%3ADyaK3c3gtlOjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=1990&pages=640-646&author=L.+J.+Andersonauthor=R.+A.+Parkerauthor=R.+L.+Strikas&title=Association+between+respiratory+syncytial+virus+outbreaks+and+lower+respiratory+tract+deaths+of+infants+and+young+children&doi=10.1093%2Finfdis%2F161.4.640"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Association between respiratory syncytial virus outbreaks and lower respiratory tract deaths of infants and young children</span></div><div class="casAuthors">Anderson L J; Parker R A; Strikas R L</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of infectious diseases</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">640-6</span>
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    </div><div class="casAbstract">The temporal patterns of respiratory virus isolations from 10 laboratories in the USA were compared with that of deaths of children less than 5 years old from July 1975 through June 1984.  Isolations of respiratory syncytial virus (RSV) occurred as yearly winter outbreaks; parainfluenza virus 1 and 2 isolations occurred as well-defined outbreaks every other year in the autumn; parainfluenza virus 3 isolations occurred throughout the year with periodic, increased isolations suggestive of outbreaks; and influenza virus isolations (A, B, or A plus B) occurred as yearly winter outbreaks.  After data were controlled for seasonal patterns, RSV isolations were strongly correlated with the winter peaks in lower respiratory tract illness (LRI) deaths of infants 1-11 months old; influenza virus isolations were correlated with the winter peak in LRI deaths of children 24-59 months old.  The parainfluenza viruses were not correlated with respiratory deaths.  This study supports the idea that RSV is a major contributor to winter peaks in LRI deaths of children 1-11 months old.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTK-a4aSxLr6K2q3xNe7a7QfW6udTcc2ebHrsvbt2gizbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3c3gtlOjtA%253D%253D&md5=80b2d878b06ae2bbc1c451de44fa7b71</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2F161.4.640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252F161.4.640%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DL.%2BJ.%26aulast%3DParker%26aufirst%3DR.%2BA.%26aulast%3DStrikas%26aufirst%3DR.%2BL.%26atitle%3DAssociation%2520between%2520respiratory%2520syncytial%2520virus%2520outbreaks%2520and%2520lower%2520respiratory%2520tract%2520deaths%2520of%2520infants%2520and%2520young%2520children%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D1990%26volume%3D161%26spage%3D640%26epage%3D646%26doi%3D10.1093%2Finfdis%2F161.4.640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Groothuis, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodin, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBride, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McWilliams, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauer, B. A.</span><span> </span><span class="NLM_article-title">Early ribavirin treatment of respiratory syncytial viral infection in high-risk children</span> <span class="citation_source-journal">J. Pediatr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">792</span><span class="NLM_x">–</span> <span class="NLM_lpage">798</span><span class="refDoi"> DOI: 10.1016/S0022-3476(05)83347-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1016%2FS0022-3476%2805%2983347-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=2231215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A280%3ADyaK3M%252FjvVKguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=1990&pages=792-798&author=J.+R.+Groothuisauthor=K.+A.+Woodinauthor=R.+Katzauthor=A.+D.+Robertsonauthor=J.+T.+McBrideauthor=C.+B.+Hallauthor=B.+C.+McWilliamsauthor=B.+A.+Lauer&title=Early+ribavirin+treatment+of+respiratory+syncytial+viral+infection+in+high-risk+children&doi=10.1016%2FS0022-3476%2805%2983347-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Early ribavirin treatment of respiratory syncytial viral infection in high-risk children</span></div><div class="casAuthors">Groothuis J R; Woodin K A; Katz R; Robertson A D; McBride J T; Hall C B; McWilliams B C; Lauer B A</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pediatrics</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">792-8</span>
        ISSN:<span class="NLM_cas:issn">0022-3476</span>.
    </div><div class="casAbstract">A 3-year prospective, blinded, multicenter study was done to assess the efficacy of early ribavirin intervention in mild respiratory syncytial virus illness in children with bronchopulmonary dysplasia or with congenital heart disease.  A cohort of 178 children younger than 36 months of age with bronchopulmonary dysplasia or congenital heart disease were followed.  Forty-seven infants whose respiratory syncytial virus infection resulted in mild symptoms of less than or equal to 72 hours' duration received ribavirin (n = 20) or water placebo aerosol (n = 27) either in a hospital or at home.  Outcome measures included respiratory and analog score, room air oxygen, saturation, and oxygen flow needed to maintain saturation at greater than or equal to 91%.  No difference in age, gender, family size, passive smoking, baseline oxygen saturations in room air, or duration of symptoms before treatment was found between groups.  After 3 days of therapy, ribavirin produced a greater rate of improvement of analog scores (p = less than or equal to 0.001), lower oxygen requirements (p = 0.01), and higher oxygen saturation (p = 0.01).  Respiratory scores and total hospital days did not differ significantly between the groups.  Treatment failure occurred in 2 of 20 children (10%) in the ribavirin group versus 5 of 27 children (18%) in the placebo group, a nonsignificant difference.  No child required assisted ventilation or had an adverse reaction.  We conclude that early ribavirin therapy may help to reduce morbidity from respiratory syncytial virus infection in high-risk young children.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQqYQckRvVdy0PI-fCgwosgfW6udTcc2ebHrsvbt2gizbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M%252FjvVKguw%253D%253D&md5=ec7c749052d6df250afc3d08534fd3ff</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0022-3476%2805%2983347-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-3476%252805%252983347-5%26sid%3Dliteratum%253Aachs%26aulast%3DGroothuis%26aufirst%3DJ.%2BR.%26aulast%3DWoodin%26aufirst%3DK.%2BA.%26aulast%3DKatz%26aufirst%3DR.%26aulast%3DRobertson%26aufirst%3DA.%2BD.%26aulast%3DMcBride%26aufirst%3DJ.%2BT.%26aulast%3DHall%26aufirst%3DC.%2BB.%26aulast%3DMcWilliams%26aufirst%3DB.%2BC.%26aulast%3DLauer%26aufirst%3DB.%2BA.%26atitle%3DEarly%2520ribavirin%2520treatment%2520of%2520respiratory%2520syncytial%2520viral%2520infection%2520in%2520high-risk%2520children%26jtitle%3DJ.%2520Pediatr.%26date%3D1990%26volume%3D117%26spage%3D792%26epage%3D798%26doi%3D10.1016%2FS0022-3476%2805%2983347-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Cox, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plemper, R. K.</span><span> </span><span class="NLM_article-title">Structure-guided design of small-molecule therapeutics against RSV disease</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">543</span><span class="NLM_x">–</span> <span class="NLM_lpage">556</span><span class="refDoi"> DOI: 10.1517/17460441.2016.1174212</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1517%2F17460441.2016.1174212" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=543-556&author=R.+Coxauthor=R.+K.+Plemper&title=Structure-guided+design+of+small-molecule+therapeutics+against+RSV+disease&doi=10.1517%2F17460441.2016.1174212"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1517%2F17460441.2016.1174212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2016.1174212%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DR.%26aulast%3DPlemper%26aufirst%3DR.%2BK.%26atitle%3DStructure-guided%2520design%2520of%2520small-molecule%2520therapeutics%2520against%2520RSV%2520disease%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2016%26volume%3D11%26spage%3D543%26epage%3D556%26doi%3D10.1517%2F17460441.2016.1174212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deval, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyatkina, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prhavc, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fung, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serebryany, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chanda, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blatt, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beigelman, L.</span><span> </span><span class="NLM_article-title">Discovery of 4′-chloromethyl-2′-deoxy-3′,5′-di-o-isobutyryl-2′-fluorocytidine (ALS-8176), a first-in-class RSV polymerase inhibitor for treatment of human respiratory syncytial virus infection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1862</span><span class="NLM_x">–</span> <span class="NLM_lpage">1878</span><span class="refDoi"> DOI: 10.1021/jm5017279</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5017279" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisF2jsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1862-1878&author=G.+Wangauthor=J.+Devalauthor=J.+Hongauthor=N.+Dyatkinaauthor=M.+Prhavcauthor=J.+Taylorauthor=A.+Fungauthor=Z.+Jinauthor=S.+K.+Stevensauthor=V.+Serebryanyauthor=J.+Liuauthor=Q.+Zhangauthor=Y.+Tamauthor=S.+M.+Chandaauthor=D.+B.+Smithauthor=J.+A.+Symonsauthor=L.+M.+Blattauthor=L.+Beigelman&title=Discovery+of+4%E2%80%B2-chloromethyl-2%E2%80%B2-deoxy-3%E2%80%B2%2C5%E2%80%B2-di-o-isobutyryl-2%E2%80%B2-fluorocytidine+%28ALS-8176%29%2C+a+first-in-class+RSV+polymerase+inhibitor+for+treatment+of+human+respiratory+syncytial+virus+infection&doi=10.1021%2Fjm5017279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 4'-Chloromethyl-2'-deoxy-3',5'-di-O-isobutyryl-2'-fluorocytidine (ALS-8176), A First-in-Class RSV Polymerase Inhibitor for Treatment of Human Respiratory Syncytial Virus Infection</span></div><div class="casAuthors">Wang, Guangyi; Deval, Jerome; Hong, Jin; Dyatkina, Natalia; Prhavc, Marija; Taylor, Joshua; Fung, Amy; Jin, Zhinan; Stevens, Sarah K.; Serebryany, Vladimir; Liu, Jyanwei; Zhang, Qingling; Tam, Yuen; Chanda, Sushmita M.; Smith, David B.; Symons, Julian A.; Blatt, Lawrence M.; Beigelman, Leo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1862-1878</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Respiratory syncytial virus (RSV) is a leading pathogen of childhood and is assocd. with significant morbidity and mortality.  To date, ribavirin is the only approved small mol. drug, which has limited use.  The only other RSV drug is palivizumab, a monoclonal antibody, which is used for RSV prophylaxis.  Clearly, there is an urgent need for small mol. RSV drugs.  This article reports the design, synthesis, anti-RSV activity, metab., and pharmacokinetics of a series of 4'-substituted cytidine nucleosides.  Among tested compds. 4'-chloromethyl-2'-deoxy-2'-fluorocytidine I exhibited the most promising activity in the RSV replicon assay with an EC50 of 0.15 μM.  The 5'-triphosphate of I (I-TP)inhibited RSV polymerase with an IC50 of 0.02 μM without appreciable inhibition of human DNA and RNA polymerases at 100 μM.  ALS-8176 II, the 3',5'-di-O-isobutyryl prodrug of I, demonstrated good oral bioavailability and a high level of I-TP in vivo.  Compd. II is a first-in-class nucleoside RSV polymerase inhibitor that demonstrated excellent anti-RSV efficacy and safety in a phase 2 clin. RSV challenge study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaKHh4AhV9drVg90H21EOLACvtfcHk0lj5O4gJbKAWVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisF2jsL4%253D&md5=da9e883eb67f20ca259dec06a6a05367</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm5017279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5017279%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DG.%26aulast%3DDeval%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DDyatkina%26aufirst%3DN.%26aulast%3DPrhavc%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DJ.%26aulast%3DFung%26aufirst%3DA.%26aulast%3DJin%26aufirst%3DZ.%26aulast%3DStevens%26aufirst%3DS.%2BK.%26aulast%3DSerebryany%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTam%26aufirst%3DY.%26aulast%3DChanda%26aufirst%3DS.%2BM.%26aulast%3DSmith%26aufirst%3DD.%2BB.%26aulast%3DSymons%26aufirst%3DJ.%2BA.%26aulast%3DBlatt%26aufirst%3DL.%2BM.%26aulast%3DBeigelman%26aufirst%3DL.%26atitle%3DDiscovery%2520of%25204%25E2%2580%25B2-chloromethyl-2%25E2%2580%25B2-deoxy-3%25E2%2580%25B2%252C5%25E2%2580%25B2-di-o-isobutyryl-2%25E2%2580%25B2-fluorocytidine%2520%2528ALS-8176%2529%252C%2520a%2520first-in-class%2520RSV%2520polymerase%2520inhibitor%2520for%2520treatment%2520of%2520human%2520respiratory%2520syncytial%2520virus%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1862%26epage%3D1878%26doi%3D10.1021%2Fjm5017279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">DeVincenzo, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitley, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scaglioni-Weinlich, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBride, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambkin-Williams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramanathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Riordan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toback, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, J. W.</span><span> </span><span class="NLM_article-title">Oral GS-5806 activity in a respiratory syncytial virus challenge study</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">722</span><span class="refDoi"> DOI: 10.1056/NEJMoa1401184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1056%2FNEJMoa1401184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=25140957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Cjsb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2014&pages=711-722&author=J.+P.+DeVincenzoauthor=R.+J.+Whitleyauthor=R.+L.+Mackmanauthor=C.+Scaglioni-Weinlichauthor=L.+Harrisonauthor=E.+Farrellauthor=S.+McBrideauthor=R.+Lambkin-Williamsauthor=R.+Jordanauthor=Y.+Xinauthor=S.+Ramanathanauthor=T.+O%E2%80%99Riordanauthor=S.+A.+Lewisauthor=X.+Liauthor=S.+L.+Tobackauthor=S.+L.+Linauthor=J.+W.+Chien&title=Oral+GS-5806+activity+in+a+respiratory+syncytial+virus+challenge+study&doi=10.1056%2FNEJMoa1401184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Oral GS-5806 activity in a respiratory syncytial virus challenge study</span></div><div class="casAuthors">DeVincenzo, John P.; Whitley, Richard J.; Mackman, Richard L.; Scaglioni-Weinlich, Cecilia; Harrison, Lisa; Farrell, Eric; McBride, Stephen; Lambkin-Williams, Robert; Jordan, Robert; Xin, Yan; Ramanathan, Srini; O'Riordan, Thomas; Lewis, Sandra A.; Li, Xiaoming; Toback, Seth L.; Lin, Shao-Lee; Chien, Jason W.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">711-722, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Respiratory syncytial virus (RSV) is a common cause of infant hospitalizations and is increasingly recognized as a cause of considerable morbidity and mortality.  No accepted antiviral treatment exists.  Methods: We conducted a double-blind, placebo-controlled study of GS-5806, an oral RSV-entry inhibitor, in healthy adults who received a clin. challenge strain of RSV intranasally.  Participants were monitored for 12 days.  At the time of a pos. test for RSV infection or 5 days after inoculation, whichever occurred first, participants were randomly assigned to receive GS-5806 or placebo in one of seven sequential cohorts.  Cohorts 1 to 4 received a first dose of 50 mg of GS-5806 and then 25 mg daily for the next 4 days, cohort 5 received a first dose of 50 mg and then 25 mg daily for the next 2 days, cohort 6 received one 100-mg dose, and cohort 7 received a first dose of 10 mg and then 5 mg daily for the next 4 days.  Dose selection for cohorts 5, 6, and 7 occurred after an interim anal. of data for cohorts 1 to 4.  The primary end point was the area under the curve (AUC) for the viral load, which was assessed after administration of the first dose through the 12th day after inoculation.  Secondary end points were mucus wt. and symptom scores.  Results: Among the 54 participants in cohorts 1 to 4 who were infected with RSV, active treatment was assocd. with a lower viral load (adjusted mean, 250.7 vs. 757.7 log10 plaque-forming-unit equiv. [PFUe] × hours per mL; P<0.001), lower total mucus wt. (mean, 6.9 g vs. 15.1 g; P = 0.03), and a lower AUC for the change from baseline in symptom scores (adjusted mean, -20.2 vs. 204.9 × hours; P = 0.005).  The results were similar in cohorts 5, 6, and 7.  Adverse events, including low neutrophil counts and increased levels of alanine aminotransferase, were more common among participants receiving GS-5806.  Conclusions: Treatment with GS-5806 reduced the viral load and the severity of clin. disease in a challenge study of healthy adults.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqxDrIVO5aQLVg90H21EOLACvtfcHk0lhyAri0KCIJww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Cjsb7O&md5=72276739a80d55a732269359e338fb95</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1401184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1401184%26sid%3Dliteratum%253Aachs%26aulast%3DDeVincenzo%26aufirst%3DJ.%2BP.%26aulast%3DWhitley%26aufirst%3DR.%2BJ.%26aulast%3DMackman%26aufirst%3DR.%2BL.%26aulast%3DScaglioni-Weinlich%26aufirst%3DC.%26aulast%3DHarrison%26aufirst%3DL.%26aulast%3DFarrell%26aufirst%3DE.%26aulast%3DMcBride%26aufirst%3DS.%26aulast%3DLambkin-Williams%26aufirst%3DR.%26aulast%3DJordan%26aufirst%3DR.%26aulast%3DXin%26aufirst%3DY.%26aulast%3DRamanathan%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Riordan%26aufirst%3DT.%26aulast%3DLewis%26aufirst%3DS.%2BA.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DToback%26aufirst%3DS.%2BL.%26aulast%3DLin%26aufirst%3DS.%2BL.%26aulast%3DChien%26aufirst%3DJ.%2BW.%26atitle%3DOral%2520GS-5806%2520activity%2520in%2520a%2520respiratory%2520syncytial%2520virus%2520challenge%2520study%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D371%26spage%3D711%26epage%3D722%26doi%3D10.1056%2FNEJMoa1401184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Yan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thakkar, V. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plemper, R. K.</span><span> </span><span class="NLM_article-title">Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">E3441</span><span class="NLM_x">–</span> <span class="NLM_lpage">3449</span><span class="refDoi"> DOI: 10.1073/pnas.1405198111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1073%2Fpnas.1405198111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=25092342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1GqtLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=E3441-3449&author=D.+Yanauthor=S.+Leeauthor=V.+D.+Thakkarauthor=M.+Luoauthor=M.+L.+Mooreauthor=R.+K.+Plemper&title=Cross-resistance+mechanism+of+respiratory+syncytial+virus+against+structurally+diverse+entry+inhibitors&doi=10.1073%2Fpnas.1405198111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors</span></div><div class="casAuthors">Yan, Dan; Lee, Sujin; Thakkar, Vidhi D.; Luo, Ming; Moore, Martin L.; Plemper, Richard Karl</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">E3441-E3449</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Respiratory syncytial virus (RSV) is a leading pediatric pathogen that is responsible for a majority of infant hospitalizations due to viral disease.  Despite its clin. importance, no vaccine prophylaxis against RSV disease or effective antiviral therapeutic is available.  In this study, the authors established a robust high-throughput drug screening protocol by using a recombinant RSV reporter virus to expand the pool of RSV inhibitor candidates.  Mechanistic characterization revealed that a potent newly identified inhibitor class blocks viral entry through specific targeting of the RSV fusion (F) protein.  Resistance against this class was induced and revealed overlapping hotspots with diverse, previously identified RSV entry blockers at different stages of preclin. and clin. development.  A structural and biochem. assessment of the mechanism of unique, broad RSV cross-resistance against structurally distinct entry inhibitors demonstrated that individual escape hotspots are located in immediate phys. proximity in the metastable conformation of RSV F and that the resistance mutations lower the barrier for prefusion F triggering, resulting in an accelerated RSV entry kinetics.  One resistant RSV recombinant remained fully pathogenic in a mouse model of RSV infection.  By identifying mol. determinants governing the RSV entry machinery, this study spotlights a mol. mechanism of broad RSV resistance against entry inhibition that may affect the impact of diverse viral entry inhibitors presently considered for clin. use and outlines a proactive design for future RSV drug discovery campaigns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrba8S35uwID7Vg90H21EOLACvtfcHk0lhyAri0KCIJww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1GqtLvL&md5=2f1b48d57c718ca871edd99c5d539cf4</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1405198111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1405198111%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DThakkar%26aufirst%3DV.%2BD.%26aulast%3DLuo%26aufirst%3DM.%26aulast%3DMoore%26aufirst%3DM.%2BL.%26aulast%3DPlemper%26aufirst%3DR.%2BK.%26atitle%3DCross-resistance%2520mechanism%2520of%2520respiratory%2520syncytial%2520virus%2520against%2520structurally%2520diverse%2520entry%2520inhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3DE3441%26epage%3D3449%26doi%3D10.1073%2Fpnas.1405198111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Bright, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Oronoz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallis, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Povinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klimov, A. I.</span><span> </span><span class="NLM_article-title">Incidence of adamantane resistance among influenza a (H3N2) viruses isolated worldwide from 1994 to 2005: A cause for concern</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">366</span><span class="NLM_x">, </span> <span class="NLM_fpage">1175</span><span class="NLM_x">–</span> <span class="NLM_lpage">1181</span><span class="refDoi"> DOI: 10.1016/S0140-6736(05)67338-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1016%2FS0140-6736%2805%2967338-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=16198766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVGrsrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2005&pages=1175-1181&author=R.+A.+Brightauthor=M.+J.+Medinaauthor=X.+Xuauthor=G.+Perez-Oronozauthor=T.+R.+Wallisauthor=X.+M.+Davisauthor=L.+Povinelliauthor=N.+J.+Coxauthor=A.+I.+Klimov&title=Incidence+of+adamantane+resistance+among+influenza+a+%28H3N2%29+viruses+isolated+worldwide+from+1994+to+2005%3A+A+cause+for+concern&doi=10.1016%2FS0140-6736%2805%2967338-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern</span></div><div class="casAuthors">Bright, Rick A.; Medina, Marie-jo; Xu, Xiyan; Perez-Oronoz, Gilda; Wallis, Teresa R.; Davis, Xiaohong M.; Povinelli, Laura; Cox, Nancy J.; Klimov, Alexander I.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">9492</span>),
    <span class="NLM_cas:pages">1175-1181</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Background: Adamantanes have been used to treat influenza A virus infections for many years.  Studies have shown a low incidence of resistance to these drugs among circulating influenza viruses; however, their use is rising worldwide and drug resistance has been reported among influenza A (H5N1) viruses isolated from poultry and human beings in Asia.  We sought to assess adamantane resistance among influenza A viruses isolated during the past decade from countries participating in WHO's global influenza surveillance network.  Methods: We analyzed data for influenza field isolates that were obtained worldwide and submitted to the WHO Collaborating Center for Influenza at the US Centers for Disease Control and Prevention between Oct 1, 1994, and Mar 31, 2005.  We used pyrosequencing, confirmatory sequence anal., and phenotypic testing to detect drug resistance among circulating influenza A H3N2 (n = 6524), H1N1 (n = 589), and H1N2 (n = 83) viruses.  Findings: More than 7000 influenza A field isolates were screened for specific aminoacid substitutions in the M2 gene known to confer drug resistance.  During the decade of surveillance a significant increase in drug resistance was noted, from 0·4% in 1994-1995 to 12·3% in 2003-2004.  This increase in the proportion of resistant viruses was weighted heavily by those obtained from Asia with 61% of resistant viruses isolated since 2003 being from people in Asia.  Interpretation: Our data raise concerns about the appropriate use of adamantanes and draw attention to the importance of tracking the emergence and spread of drug-resistant influenza A viruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplKUP7OtnoPbVg90H21EOLACvtfcHk0li6S8R1VxauIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVGrsrbK&md5=aff530ef884feb8e71dd8f0041039f49</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2805%2967338-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252805%252967338-2%26sid%3Dliteratum%253Aachs%26aulast%3DBright%26aufirst%3DR.%2BA.%26aulast%3DMedina%26aufirst%3DM.%2BJ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DPerez-Oronoz%26aufirst%3DG.%26aulast%3DWallis%26aufirst%3DT.%2BR.%26aulast%3DDavis%26aufirst%3DX.%2BM.%26aulast%3DPovinelli%26aufirst%3DL.%26aulast%3DCox%26aufirst%3DN.%2BJ.%26aulast%3DKlimov%26aufirst%3DA.%2BI.%26atitle%3DIncidence%2520of%2520adamantane%2520resistance%2520among%2520influenza%2520a%2520%2528H3N2%2529%2520viruses%2520isolated%2520worldwide%2520from%25201994%2520to%25202005%253A%2520A%2520cause%2520for%2520concern%26jtitle%3DLancet%26date%3D2005%26volume%3D366%26spage%3D1175%26epage%3D1181%26doi%3D10.1016%2FS0140-6736%2805%2967338-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Bright, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bresee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klimov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortiz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ctr, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">CDC</span><span> </span><span class="NLM_article-title">High levels of adamantane resistance among influenza a (H3N2) viruses and interim guidelines for use of antiviral agents - United States, 2005–06 influenza season</span> <span class="citation_source-journal">J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">295</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">882</span><span class="refDoi"> DOI: 10.1001/jama.295.8.881</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1001%2Fjama.295.8.881" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhs12msrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2006&pages=881-882&author=R.+A.+Brightauthor=D.+Shayauthor=J.+Breseeauthor=A.+Klimovauthor=N.+Coxauthor=J.+Ortizauthor=W.+C.+Ctrauthor=CDC&title=High+levels+of+adamantane+resistance+among+influenza+a+%28H3N2%29+viruses+and+interim+guidelines+for+use+of+antiviral+agents+-+United+States%2C+2005%E2%80%9306+influenza+season&doi=10.1001%2Fjama.295.8.881"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents - United States, 2005-06 influenza season</span></div><div class="casAuthors">Bright, R. A.; Shay, D.; Bresee, J.; Klimov, A.; Cox, N.; Ortiz, J.</div><div class="citationInfo"><span class="NLM_cas:title">JAMA, the Journal of the American Medical Association</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">881-882</span>CODEN:
                <span class="NLM_cas:coden">JAMAAP</span>;
        ISSN:<span class="NLM_cas:issn">0098-7484</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPLf3NZUVTxLVg90H21EOLACvtfcHk0li6S8R1VxauIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhs12msrY%253D&md5=5624049460ede754d2fa844aff7ffb6c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1001%2Fjama.295.8.881&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.295.8.881%26sid%3Dliteratum%253Aachs%26aulast%3DBright%26aufirst%3DR.%2BA.%26aulast%3DShay%26aufirst%3DD.%26aulast%3DBresee%26aufirst%3DJ.%26aulast%3DKlimov%26aufirst%3DA.%26aulast%3DCox%26aufirst%3DN.%26aulast%3DOrtiz%26aufirst%3DJ.%26aulast%3DCtr%26aufirst%3DW.%2BC.%26aulast%3D%26atitle%3DHigh%2520levels%2520of%2520adamantane%2520resistance%2520among%2520influenza%2520a%2520%2528H3N2%2529%2520viruses%2520and%2520interim%2520guidelines%2520for%2520use%2520of%2520antiviral%2520agents%2520-%2520United%2520States%252C%25202005%25E2%2580%259306%2520influenza%2520season%26jtitle%3DJ.%2520Am.%2520Med.%2520Assoc.%26date%3D2006%26volume%3D295%26spage%3D881%26epage%3D882%26doi%3D10.1001%2Fjama.295.8.881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Yan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisshaar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plemper, R. K.</span><span> </span><span class="NLM_article-title">Replication-competent influenza virus and respiratory syncytial virus luciferase reporter strains engineered for co-infections identify antiviral compounds in combination screens</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5589</span><span class="NLM_x">–</span> <span class="NLM_lpage">5604</span><span class="refDoi"> DOI: 10.1021/acs.biochem.5b00623</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.5b00623" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtl2hsr7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=5589-5604&author=D.+Yanauthor=M.+Weisshaarauthor=K.+Lambauthor=H.+K.+Chungauthor=M.+Z.+Linauthor=R.+K.+Plemper&title=Replication-competent+influenza+virus+and+respiratory+syncytial+virus+luciferase+reporter+strains+engineered+for+co-infections+identify+antiviral+compounds+in+combination+screens&doi=10.1021%2Facs.biochem.5b00623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Replication-Competent Influenza Virus and Respiratory Syncytial Virus Luciferase Reporter Strains Engineered for Co-Infections Identify Antiviral Compounds in Combination Screens</span></div><div class="casAuthors">Yan, Dan; Weisshaar, Marco; Lamb, Kristen; Chung, Hokyung K.; Lin, Michael Z.; Plemper, Richard K.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">5589-5604</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Myxoviruses such as influenza A virus (IAV) and respiratory syncytial virus (RSV) are major human pathogens, mandating the development of novel therapeutics.  To establish a high-throughput screening protocol for the simultaneous identification of pathogen- and host-targeted hit candidates against either pathogen or both, we have attempted co-infection of cells with IAV and RSV.  However, viral replication kinetics were incompatible, RSV signal window was low, and an IAV-driven minireplicon reporter assay used in initial screens narrowed the host cell range and restricted the assay to single-cycle infections.  To overcome these limitations, we developed an RSV strain carrying firefly luciferase fused to an innovative universal small-mol. assisted shut-off domain, which boosted assay signal window, and a hyperactive fusion protein that synchronized IAV and RSV reporter expression kinetics and suppressed the identification of RSV entry inhibitors sensitive to a recently reported RSV pan-resistance mechanism.  Combined with a replication-competent recombinant IAV strain harboring nanoluciferase, the assay performed well on a human respiratory cell line and supports multicycle infections.  Miniaturized to 384-well format, the protocol was validated through screening of a set of the National Institutes of Health Clin. Collection (NCC) in quadruplicate.  These test screens demonstrated favorable assay parameters and reproducibility.  Application to a LOPAC library of bioactive compds. in a proof-of-concept campaign detected licensed antimyxovirus therapeutics, ribavirin and the neuraminidase inhibitor zanamivir, and identified two unexpected RSV-specific hit candidates, Fenretinide and the opioid receptor antagonist BNTX-7.  Hits were evaluated in direct and orthogonal dose-response counterscreens using a std. recRSV reporter strain expressing Renilla luciferase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo520BUJWoYY7Vg90H21EOLACvtfcHk0ljy2U7cEiNJ1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtl2hsr7M&md5=3ae74894a743f5fac329ca835003340b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.5b00623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.5b00623%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DD.%26aulast%3DWeisshaar%26aufirst%3DM.%26aulast%3DLamb%26aufirst%3DK.%26aulast%3DChung%26aufirst%3DH.%2BK.%26aulast%3DLin%26aufirst%3DM.%2BZ.%26aulast%3DPlemper%26aufirst%3DR.%2BK.%26atitle%3DReplication-competent%2520influenza%2520virus%2520and%2520respiratory%2520syncytial%2520virus%2520luciferase%2520reporter%2520strains%2520engineered%2520for%2520co-infections%2520identify%2520antiviral%2520compounds%2520in%2520combination%2520screens%26jtitle%3DBiochemistry%26date%3D2015%26volume%3D54%26spage%3D5589%26epage%3D5604%26doi%3D10.1021%2Facs.biochem.5b00623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Moore, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luongo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukacs, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polosukhin, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huckabee, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, U. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowe, J. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goleniewska, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peebles, R. S.,  Jr.</span><span> </span><span class="NLM_article-title">A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">4185</span><span class="NLM_x">–</span> <span class="NLM_lpage">4194</span><span class="refDoi"> DOI: 10.1128/JVI.01853-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1128%2FJVI.01853-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=19211758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Kqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2009&pages=4185-4194&author=M.+L.+Mooreauthor=M.+H.+Chiauthor=C.+Luongoauthor=N.+W.+Lukacsauthor=V.+V.+Polosukhinauthor=M.+M.+Huckabeeauthor=D.+C.+Newcombauthor=U.+J.+Buchholzauthor=J.+E.+Croweauthor=K.+Goleniewskaauthor=J.+V.+Williamsauthor=P.+L.+Collinsauthor=R.+S.+Peebles&title=A+chimeric+A2+strain+of+respiratory+syncytial+virus+%28RSV%29+with+the+fusion+protein+of+RSV+strain+line+19+exhibits+enhanced+viral+load%2C+mucus%2C+and+airway+dysfunction&doi=10.1128%2FJVI.01853-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction</span></div><div class="casAuthors">Moore, Martin L.; Chi, Michael H.; Luongo, Cindy; Lukacs, Nicholas W.; Polosukhin, Vasiliy V.; Huckabee, Matthew M.; Newcomb, Dawn C.; Buchholz, Ursula J.; Crowe, James E., Jr.; Goleniewska, Kasia; Williams, John V.; Collins, Peter L.; Peebles, R. Stokes, Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4185-4194</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Respiratory syncytial virus (RSV) is the leading cause of respiratory failure and viral death in infants.  Abundant airway mucus contributes to airway obstruction in RSV disease.  Interleukin-13 (IL-13) is a mediator of pulmonary mucus secretion.  It has been shown that infection of BALB/c mice with the RSV line 19 strain but not with the RSV A2 lab. strain results in lung IL-13 and mucus expression.  Here, the authors sequenced the RSV line 19 genome and compared it to the commonly used A2 and Long strains.  There were six amino acid differences between the line 19 strain and both the A2 and Long RSV strains, five of which are in the fusion (F) protein.  The Long strain, like the A2 strain, did not induce lung IL-13 and mucus expression in BALB/c mice.  The authors hypothesized that the F protein of RSV line 19 is more mucogenic than the F proteins of A2 and Long.  The authors generated recombinant, F-chimeric RSVs by replacing the F gene of A2 with the F gene of either line 19 or Long.  Infection of BALB/c mice with RSV rA2 line 19F resulted in lower alpha interferon lung levels 24 h postinfection, higher lung viral load, higher lung IL-13 levels, greater airway mucin expression levels, and greater airway hyperresponsiveness than infection with rA2-A2F or rA2-LongF.  The authors identified the F protein of RSV line 19 as a factor that plays a role in pulmonary mucin expression in the setting of RSV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBi2sd77JXo7Vg90H21EOLACvtfcHk0ljy2U7cEiNJ1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Kqtbs%253D&md5=7ba4b8ff522f58440df584f5acc814e0</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2FJVI.01853-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01853-08%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DM.%2BL.%26aulast%3DChi%26aufirst%3DM.%2BH.%26aulast%3DLuongo%26aufirst%3DC.%26aulast%3DLukacs%26aufirst%3DN.%2BW.%26aulast%3DPolosukhin%26aufirst%3DV.%2BV.%26aulast%3DHuckabee%26aufirst%3DM.%2BM.%26aulast%3DNewcomb%26aufirst%3DD.%2BC.%26aulast%3DBuchholz%26aufirst%3DU.%2BJ.%26aulast%3DCrowe%26aufirst%3DJ.%2BE.%26aulast%3DGoleniewska%26aufirst%3DK.%26aulast%3DWilliams%26aufirst%3DJ.%2BV.%26aulast%3DCollins%26aufirst%3DP.%2BL.%26aulast%3DPeebles%26aufirst%3DR.%2BS.%26atitle%3DA%2520chimeric%2520A2%2520strain%2520of%2520respiratory%2520syncytial%2520virus%2520%2528RSV%2529%2520with%2520the%2520fusion%2520protein%2520of%2520RSV%2520strain%2520line%252019%2520exhibits%2520enhanced%2520viral%2520load%252C%2520mucus%252C%2520and%2520airway%2520dysfunction%26jtitle%3DJ.%2520Virol.%26date%3D2009%26volume%3D83%26spage%3D4185%26epage%3D4194%26doi%3D10.1128%2FJVI.01853-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Chung, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krumm, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plemper, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsien, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M. Z.</span><span> </span><span class="NLM_article-title">Tunable and reversible drug control of protein production via a self-excising degron</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">713</span><span class="NLM_x">–</span> <span class="NLM_lpage">720</span><span class="refDoi"> DOI: 10.1038/nchembio.1869</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1038%2Fnchembio.1869" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=26214256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1WltLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=713-720&author=H.+K.+Chungauthor=C.+L.+Jacobsauthor=Y.+Huoauthor=J.+Yangauthor=S.+A.+Krummauthor=R.+K.+Plemperauthor=R.+Y.+Tsienauthor=M.+Z.+Lin&title=Tunable+and+reversible+drug+control+of+protein+production+via+a+self-excising+degron&doi=10.1038%2Fnchembio.1869"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Tunable and reversible drug control of protein production via a self-excising degron</span></div><div class="casAuthors">Chung, Hokyung K.; Jacobs, Conor L.; Huo, Yunwen; Yang, Jin; Krumm, Stefanie A.; Plemper, Richard K.; Tsien, Roger Y.; Lin, Michael Z.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">713-720</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">An effective method for direct chem. control over the prodn. of specific proteins would be widely useful.  We describe small mol.-assisted shutoff (SMASh), a technique in which proteins are fused to a degron that removes itself in the absence of drug, resulting in the prodn. of an untagged protein.  Clin. tested HCV protease inhibitors can then block degron removal, inducing rapid degrdn. of subsequently synthesized copies of the protein.  SMASh allows reversible and dose-dependent shutoff of various proteins in multiple mammalian cell types and in yeast.  We also used SMASh to confer drug responsiveness onto an RNA virus for which no licensed inhibitors exist.  As SMASh does not require the permanent fusion of a large domain, it should be useful when control over protein prodn. with minimal structural modification is desired.  Furthermore, as SMASh involves only a single genetic modification and does not rely on modulating protein-protein interactions, it should be easy to generalize to multiple biol. contexts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnkBL1_a_xkbVg90H21EOLACvtfcHk0ljy2U7cEiNJ1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1WltLfN&md5=5a9d3cfb4eece76ba563cde246b8839d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1869%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DH.%2BK.%26aulast%3DJacobs%26aufirst%3DC.%2BL.%26aulast%3DHuo%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DKrumm%26aufirst%3DS.%2BA.%26aulast%3DPlemper%26aufirst%3DR.%2BK.%26aulast%3DTsien%26aufirst%3DR.%2BY.%26aulast%3DLin%26aufirst%3DM.%2BZ.%26atitle%3DTunable%2520and%2520reversible%2520drug%2520control%2520of%2520protein%2520production%2520via%2520a%2520self-excising%2520degron%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D713%26epage%3D720%26doi%3D10.1038%2Fnchembio.1869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Jacob, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirchhoff, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubig, R. R.</span><span> </span><span class="NLM_article-title">Mscreen: An integrated compound management and high-throughput screening data storage and analysis system</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1080</span><span class="NLM_x">–</span> <span class="NLM_lpage">1087</span><span class="refDoi"> DOI: 10.1177/1087057112450186</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1177%2F1087057112450186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=22706349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A280%3ADC%252BC38jisVOktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=1080-1087&author=R.+T.+Jacobauthor=M.+J.+Larsenauthor=S.+D.+Larsenauthor=P.+D.+Kirchhoffauthor=D.+H.+Shermanauthor=R.+R.+Neubig&title=Mscreen%3A+An+integrated+compound+management+and+high-throughput+screening+data+storage+and+analysis+system&doi=10.1177%2F1087057112450186"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">MScreen: an integrated compound management and high-throughput screening data storage and analysis system</span></div><div class="casAuthors">Jacob Renju T; Larsen Martha J; Larsen Scott D; Kirchhoff Paul D; Sherman David H; Neubig Richard R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1080-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">High-throughput screening (HTS) has historically been used by the pharmaceutical industry to rapidly test hundreds of thousands of compounds to identify potential drug candidates.  More recently, academic groups have used HTS to identify new chemical probes or small interfering RNA (siRNA) that can serve as experimental tools to examine the biology or physiology of novel proteins, processes, or interactions.  HTS presents a significant challenge with the vast and complex nature of data generated.  This report describes MScreen, a Web-based, open-source cheminformatics application for chemical library and siRNA plate management, primary HTS and dose-response data handling, structure search, and administrative functions.  Each project in MScreen can be secured with passwords or shared in an open-information environment that enables collaborators to easily compare data from many screens, providing a useful means to identify compounds with desired selectivity.  Unique features include compound, substance, mixture, and siRNA plate creation and formatting; automated dose-response fitting and quality control (QC); and user, target, and assay method administration.  MScreen provides an effective means to facilitate HTS information handling and analysis in the academic setting so that users can efficiently view their screening data and evaluate results for follow-up.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTZQz2O5zthF0wlCcfExbvbfW6udTcc2eaSwAf7HdLU1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38jisVOktg%253D%253D&md5=ba268e90cee118d543a05e45da933ed3</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1177%2F1087057112450186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057112450186%26sid%3Dliteratum%253Aachs%26aulast%3DJacob%26aufirst%3DR.%2BT.%26aulast%3DLarsen%26aufirst%3DM.%2BJ.%26aulast%3DLarsen%26aufirst%3DS.%2BD.%26aulast%3DKirchhoff%26aufirst%3DP.%2BD.%26aulast%3DSherman%26aufirst%3DD.%2BH.%26aulast%3DNeubig%26aufirst%3DR.%2BR.%26atitle%3DMscreen%253A%2520An%2520integrated%2520compound%2520management%2520and%2520high-throughput%2520screening%2520data%2520storage%2520and%2520analysis%2520system%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2012%26volume%3D17%26spage%3D1080%26epage%3D1087%26doi%3D10.1177%2F1087057112450186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Brideau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunter, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pikounis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liaw, A.</span><span> </span><span class="NLM_article-title">Improved statistical methods for hit selection in high-throughput screening</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">634</span><span class="NLM_x">–</span> <span class="NLM_lpage">647</span><span class="refDoi"> DOI: 10.1177/1087057103258285</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1177%2F1087057103258285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=14711389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A280%3ADC%252BD2c%252FhsVyjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=634-647&author=C.+Brideauauthor=B.+Gunterauthor=B.+Pikounisauthor=A.+Liaw&title=Improved+statistical+methods+for+hit+selection+in+high-throughput+screening&doi=10.1177%2F1087057103258285"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Improved statistical methods for hit selection in high-throughput screening</span></div><div class="casAuthors">Brideau Christine; Gunter Bert; Pikounis Bill; Liaw Andy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">634-47</span>
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    </div><div class="casAbstract">High-throughput screening (HTS) plays a central role in modern drug discovery, allowing the rapid screening of large compound collections against a variety of putative drug targets.  HTS is an industrial-scale process, relying on sophisticated automation, control, and state-of-the art detection technologies to organize, test, and measure hundreds of thousands to millions of compounds in nano- to microliter volumes.  Despite this high technology, hit selection for HTS is still typically done using simple data analysis and basic statistical methods.  The authors discuss in this article some shortcomings of these methods and present alternatives based on modern methods of statistical data analysis.  Most important, they describe and show numerous real examples from the biologist-friendly Stat Server HTS application (SHS), a custom-developed software tool built on the commercially available S-PLUS and StatServer statistical analysis and server software.  This system remotely processes HTS data using powerful and sophisticated statistical methodology but insulates users from the technical details by outputting results in a variety of readily interpretable graphs and tables.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTC1RVHw8Iwb-RS7coPn-RtfW6udTcc2eaSwAf7HdLU1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c%252FhsVyjtA%253D%253D&md5=ddc5921a0776f3372c664d6e91446ba3</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1177%2F1087057103258285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057103258285%26sid%3Dliteratum%253Aachs%26aulast%3DBrideau%26aufirst%3DC.%26aulast%3DGunter%26aufirst%3DB.%26aulast%3DPikounis%26aufirst%3DB.%26aulast%3DLiaw%26aufirst%3DA.%26atitle%3DImproved%2520statistical%2520methods%2520for%2520hit%2520selection%2520in%2520high-throughput%2520screening%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2003%26volume%3D8%26spage%3D634%26epage%3D647%26doi%3D10.1177%2F1087057103258285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Hotard, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Currier, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowe, J. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peebles, R. S.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plemper, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, M. L.</span><span> </span><span class="NLM_article-title">Identification of residues in the human respiratory syncytial virus fusion protein that modulate fusion activity and pathogenesis</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">512</span><span class="NLM_x">–</span> <span class="NLM_lpage">522</span><span class="refDoi"> DOI: 10.1128/JVI.02472-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1128%2FJVI.02472-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=25339762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVSju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2015&pages=512-522&author=A.+L.+Hotardauthor=S.+Leeauthor=M.+G.+Currierauthor=J.+E.+Croweauthor=K.+Sakamotoauthor=D.+C.+Newcombauthor=R.+S.+Peeblesauthor=R.+K.+Plemperauthor=M.+L.+Moore&title=Identification+of+residues+in+the+human+respiratory+syncytial+virus+fusion+protein+that+modulate+fusion+activity+and+pathogenesis&doi=10.1128%2FJVI.02472-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of residues in the human respiratory syncytial virus fusion protein that modulate fusion activity and pathogenesis</span></div><div class="casAuthors">Hotard, Anne L.; Lee, Sujin; Currier, Michael G.; Crowe, James E., Jr.; Sakamoto, Kaori; Newcomb, Dawn C.; Peebles, R. Stokes, Jr.; Plemper, Richard K.; Moore, Martin L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">512-522, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">1098-5514</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Human respiratory syncytial virus (RSV) lower respiratory tract infection can result in inflammation and mucus plugging of airways.  RSV strain A2-line19F induces relatively high viral load and mucus in mice.  The line 19 fusion (F) protein harbors 5 unique residues compared to the non-mucus-inducing strains A2 and Long, at positions 79, 191, 357, 371, and 557.  We hypothesized that differential fusion activity is a determinant of pathogenesis.  In a cell-cell fusion assay, line 19 F was more fusogenic than Long F.  We changed the residues unique to line 19 F to the corresponding residues in Long F and identified residues 79 and 191 together as responsible for high fusion activity.  Surprisingly, mutation of residues 357 or 357 with 371 resulted in gain of fusion activity.  Thus, we generated RSV F mutants with a range of defined fusion activity and engineered these into recombinant viruses.  We found a clear, pos. correlation between fusion activity and early viral load in mice; however, we did not detect a correlation between viral loads and levels of airway mucin expression.  The F mutant with the highest fusion activity, A2-line19F-K357T/Y371N, induced high viral loads, severe lung histopathol., and wt. loss but did not induce high levels of airway mucin expression.  We defined residues 79/191 as crit. for line 19 F fusion activity and 357/371 as playing a role in A2-line19F mucus induction.  Defining the mol. basis of the role of RSV F in pathogenesis may aid vaccine and therapeutic strategies aimed at this protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD1kx9R91Zl7Vg90H21EOLACvtfcHk0lgF8XD-4sjqYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVSju7Y%253D&md5=b605a2bc197d50647d9f90376cfe91ce</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1128%2FJVI.02472-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.02472-14%26sid%3Dliteratum%253Aachs%26aulast%3DHotard%26aufirst%3DA.%2BL.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DCurrier%26aufirst%3DM.%2BG.%26aulast%3DCrowe%26aufirst%3DJ.%2BE.%26aulast%3DSakamoto%26aufirst%3DK.%26aulast%3DNewcomb%26aufirst%3DD.%2BC.%26aulast%3DPeebles%26aufirst%3DR.%2BS.%26aulast%3DPlemper%26aufirst%3DR.%2BK.%26aulast%3DMoore%26aufirst%3DM.%2BL.%26atitle%3DIdentification%2520of%2520residues%2520in%2520the%2520human%2520respiratory%2520syncytial%2520virus%2520fusion%2520protein%2520that%2520modulate%2520fusion%2520activity%2520and%2520pathogenesis%26jtitle%3DJ.%2520Virol.%26date%3D2015%26volume%3D89%26spage%3D512%26epage%3D522%26doi%3D10.1128%2FJVI.02472-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Hawkins, E.; Butler, B.; Beck, M.; O’Grady, M.; Orr, L.; Wood, K.</span><span> </span><span class="NLM_article-title">Dual-glo Luciferase Assay System: Convenient Dual-Reporter Measurements in 96- and 384-Well Plates</span>.  <span class="citation_source-book">Promega Notes</span>; <span class="NLM_publisher-name">Promega Corporation</span>: <span class="NLM_publisher-loc">Madison, WI</span>,<span class="NLM_x"> </span><span class="NLM_year">2002</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">81</span>, pp  <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=22-26&author=E.+Hawkins&author=B.+Butler&author=M.+Beck&author=M.+O%E2%80%99Grady&author=L.+Orr&author=K.+Wood&title=Promega+Notes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHawkins%26aufirst%3DE.%26atitle%3DDual-glo%2520Luciferase%2520Assay%2520System%253A%2520Convenient%2520Dual-Reporter%2520Measurements%2520in%252096-%2520and%2520384-Well%2520Plates%26btitle%3DPromega%2520Notes%26pub%3DPromega%2520Corporation%26date%3D2002%26volume%3D81%26spage%3D22%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span>Scifinder; <span class="NLM_publisher-name">Chemical Abstracts Service</span>: <span class="NLM_publisher-loc">Columbus, OH</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Scifinder%3B+Chemical+Abstracts+Service%3A+Columbus%2C+OH%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DScifinder%26pub%3DChemical%2520Abstracts%2520Service%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Blackburn, C.; Chin, J.; Gigstad, K. M.; Xu, H.</span><span> </span><span class="NLM_article-title">Substituted Hydroxamic Acids and Uses Thereof</span>. U.S. Patent No. 8,946,223, Feb 3,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=C.+Blackburn&author=J.+Chin&author=K.+M.+Gigstad&author=H.+Xu&title=Substituted+Hydroxamic+Acids+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBlackburn%26aufirst%3DC.%26atitle%3DSubstituted%2520Hydroxamic%2520Acids%2520and%2520Uses%2520Thereof%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Moussa, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banister, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doddareddy, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacH, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassiou, M.</span><span> </span><span class="NLM_article-title">Exploration of ring size in a series of cyclic vicinal diamines with sigma1 receptor affinity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5493</span><span class="NLM_x">–</span> <span class="NLM_lpage">5497</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.07.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1016%2Fj.bmcl.2012.07.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5493-5497&author=I.+A.+Moussaauthor=S.+D.+Banisterauthor=M.+Manoliauthor=M.+R.+Doddareddyauthor=J.+Cuiauthor=R.+H.+MacHauthor=M.+Kassiou&title=Exploration+of+ring+size+in+a+series+of+cyclic+vicinal+diamines+with+sigma1+receptor+affinity&doi=10.1016%2Fj.bmcl.2012.07.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.07.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.07.026%26sid%3Dliteratum%253Aachs%26aulast%3DMoussa%26aufirst%3DI.%2BA.%26aulast%3DBanister%26aufirst%3DS.%2BD.%26aulast%3DManoli%26aufirst%3DM.%26aulast%3DDoddareddy%26aufirst%3DM.%2BR.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DMacH%26aufirst%3DR.%2BH.%26aulast%3DKassiou%26aufirst%3DM.%26atitle%3DExploration%2520of%2520ring%2520size%2520in%2520a%2520series%2520of%2520cyclic%2520vicinal%2520diamines%2520with%2520sigma1%2520receptor%2520affinity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5493%26epage%3D5497%26doi%3D10.1016%2Fj.bmcl.2012.07.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Lane, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. M.</span><span> </span><span class="NLM_article-title">Asymmetric total syntheses of (−)-jorumycin, (−)-renieramycin g, 3-epi-jorumycin, and 3-epi-renieramycin g</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">12684</span><span class="NLM_x">–</span> <span class="NLM_lpage">12690</span><span class="refDoi"> DOI: 10.1021/ja0535918</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0535918" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADC%252BD2MXot1Wjtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=12684-12690&author=J.+W.+Laneauthor=Y.+Chenauthor=R.+M.+Williams&title=Asymmetric+total+syntheses+of+%28%E2%88%92%29-jorumycin%2C+%28%E2%88%92%29-renieramycin+g%2C+3-epi-jorumycin%2C+and+3-epi-renieramycin+g&doi=10.1021%2Fja0535918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric Total Syntheses of (-)-Jorumycin, (-)-Renieramycin G, 3-epi-Jorumycin, and 3-epi-Renieramycin G</span></div><div class="casAuthors">Lane, Jonathan W.; Chen, Yuyin; Williams, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">12684-12690</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The total synthesis of (-)-jorumycin (I) and (-)-renieramycin G (II) has been accomplished in 25 and 23 steps, resp., from 5-benzyloxy-2,4-dimethoxy-3-methyl-benzyl alc.  The synthesis features a substrate-tunable stereoselective intramol. Pictet-Spengler-type reaction for the construction of the key pentacyclic core of both targets, bearing either the natural configuration or the epimeric configuration at C-3.  With access to a C-3 epi-pentacyclic framework, 3-epi-jorumycin and 3-epi-renieramycin G were also successfully synthesized.  Furthermore, preliminary biol. evaluation of 3-epi-jorumycin, in addn. to relevant synthetic intermediates, revealed that significant cytotoxicity had been retained in these compds.  Therefore, these early studies constitute the basis for a new structure activity relationship (SAR) investigation for this class of antitumor antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGCPDWZ4uT1LVg90H21EOLACvtfcHk0lgF8XD-4sjqYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXot1Wjtr0%253D&md5=dbd0989c14d944f7847a400926eedeac</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fja0535918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0535918%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DJ.%2BW.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWilliams%26aufirst%3DR.%2BM.%26atitle%3DAsymmetric%2520total%2520syntheses%2520of%2520%2528%25E2%2588%2592%2529-jorumycin%252C%2520%2528%25E2%2588%2592%2529-renieramycin%2520g%252C%25203-epi-jorumycin%252C%2520and%25203-epi-renieramycin%2520g%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D12684%26epage%3D12690%26doi%3D10.1021%2Fja0535918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Tomita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oomori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aramaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsushita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okabe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awazu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isono, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skene, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosfield, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, A.</span><span> </span><span class="NLM_article-title">Structure-based discovery of cellular-active allosteric inhibitors of FAK</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1779</span><span class="NLM_x">–</span> <span class="NLM_lpage">1785</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.01.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1016%2Fj.bmcl.2013.01.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=23414845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1Wrtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1779-1785&author=N.+Tomitaauthor=Y.+Hayashiauthor=S.+Suzukiauthor=Y.+Oomoriauthor=Y.+Aramakiauthor=Y.+Matsushitaauthor=M.+Iwataniauthor=H.+Iwataauthor=A.+Okabeauthor=Y.+Awazuauthor=O.+Isonoauthor=R.+J.+Skeneauthor=D.+J.+Hosfieldauthor=H.+Mikiauthor=T.+Kawamotoauthor=A.+Horiauthor=A.+Baba&title=Structure-based+discovery+of+cellular-active+allosteric+inhibitors+of+FAK&doi=10.1016%2Fj.bmcl.2013.01.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based discovery of cellular-active allosteric inhibitors of FAK</span></div><div class="casAuthors">Tomita, Naoki; Hayashi, Yoko; Suzuki, Shinkichi; Oomori, Yoshimasa; Aramaki, Yoshio; Matsushita, Yoshihiro; Iwatani, Misa; Iwata, Hidehisa; Okabe, Atsutoshi; Awazu, Yoshiko; Isono, Osamu; Skene, Robert J.; Hosfield, David J.; Miki, Hiroshi; Kawamoto, Tomohiro; Hori, Akira; Baba, Atsuo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1779-1785</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In order to develop potent and selective focal adhesion kinase (FAK) inhibitors, synthetic studies on pyrazolo[4,3-c][2,1]benzothiazines targeted for the FAK allosteric site were carried out.  Based on the X-ray structural anal. of the co-crystal of the lead compd., 8-(4-ethylphenyl)-5-methyl-1,5-dihydropyrazolo[4,3-c][2,1]benzothiazine 4,4-dioxide 1 with FAK, we designed and prepd. 1,5-dimethyl-1,5-dihydropyrazolo[4,3-c][2,1]benzothiazin derivs. which selectively inhibited kinase activity of FAK without affecting seven other kinases.  The optimized compd., N-(4-tert-butylbenzyl)-1,5-dimethyl-1,5-dihydropyrazolo[4,3-c][2,1]benzothiazin-8-amine 4,4-dioxide 30 possessed significant FAK kinase inhibitory activities both in cell-free (IC50 = 0.64 μM) and in cellular assays (IC50 = 7.1 μM).  These results clearly demonstrated a potential of FAK allosteric inhibitors as antitumor agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr-Jxocxt917Vg90H21EOLACvtfcHk0lhNWYJo2MhRQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1Wrtrk%253D&md5=309362a2ca95be142bb6d8e29520f367</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.01.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.01.047%26sid%3Dliteratum%253Aachs%26aulast%3DTomita%26aufirst%3DN.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DOomori%26aufirst%3DY.%26aulast%3DAramaki%26aufirst%3DY.%26aulast%3DMatsushita%26aufirst%3DY.%26aulast%3DIwatani%26aufirst%3DM.%26aulast%3DIwata%26aufirst%3DH.%26aulast%3DOkabe%26aufirst%3DA.%26aulast%3DAwazu%26aufirst%3DY.%26aulast%3DIsono%26aufirst%3DO.%26aulast%3DSkene%26aufirst%3DR.%2BJ.%26aulast%3DHosfield%26aufirst%3DD.%2BJ.%26aulast%3DMiki%26aufirst%3DH.%26aulast%3DKawamoto%26aufirst%3DT.%26aulast%3DHori%26aufirst%3DA.%26aulast%3DBaba%26aufirst%3DA.%26atitle%3DStructure-based%2520discovery%2520of%2520cellular-active%2520allosteric%2520inhibitors%2520of%2520FAK%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1779%26epage%3D1785%26doi%3D10.1016%2Fj.bmcl.2013.01.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Peng, H.; Xin, Z.; Zhang, L.; Sun, L.; Kumaravel, G.; Taveras, A.; Wang, D.</span> S1P and/or ATX Modulating Agents. US. Patent Application No. 14/772481, Feb 11,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Peng%2C+H.%3B+Xin%2C+Z.%3B+Zhang%2C+L.%3B+Sun%2C+L.%3B+Kumaravel%2C+G.%3B+Taveras%2C+A.%3B+Wang%2C+D.+S1P+and%2For+ATX+Modulating+Agents.+US.+Patent+Application+No.+14%2F772481%2C+Feb+11%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DH.%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Hoffman, R. V.</span><span> </span><span class="NLM_article-title">″Meta-trifluoromethylbenzenesulfonyl chloride</span> <span class="citation_source-journal">Org. Synth.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span><span class="refDoi"> DOI: 10.15227/orgsyn.060.0121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.15227%2Forgsyn.060.0121" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1981&pages=121-126&author=R.+V.+Hoffman&title=%E2%80%B3Meta-trifluoromethylbenzenesulfonyl+chloride&doi=10.15227%2Forgsyn.060.0121"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.15227%2Forgsyn.060.0121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15227%252Forgsyn.060.0121%26sid%3Dliteratum%253Aachs%26aulast%3DHoffman%26aufirst%3DR.%2BV.%26atitle%3D%25E2%2580%25B3Meta-trifluoromethylbenzenesulfonyl%2520chloride%26jtitle%3DOrg.%2520Synth.%26date%3D1981%26volume%3D60%26spage%3D121%26epage%3D126%26doi%3D10.15227%2Forgsyn.060.0121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Blackburn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">England, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gigstad, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ringeling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitors derived from 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine and related heterocycles selective for the HDAC6 isoform</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">5450</span><span class="NLM_x">–</span> <span class="NLM_lpage">5454</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.10.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1016%2Fj.bmcl.2014.10.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=5450-5454&author=C.+Blackburnauthor=C.+Barrettauthor=M.+Brunsonauthor=J.+Chinauthor=D.+Englandauthor=K.+Garciaauthor=K.+Gigstadauthor=A.+Gouldauthor=J.+Gutierrezauthor=K.+Hoarauthor=R.+S.+Rowlandauthor=C.+Tsuauthor=J.+Ringelingauthor=K.+Wagerauthor=H.+Xu&title=Histone+deacetylase+inhibitors+derived+from+1%2C2%2C3%2C4-tetrahydropyrrolo%5B1%2C2-a%5Dpyrazine+and+related+heterocycles+selective+for+the+HDAC6+isoform&doi=10.1016%2Fj.bmcl.2014.10.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.10.022%26sid%3Dliteratum%253Aachs%26aulast%3DBlackburn%26aufirst%3DC.%26aulast%3DBarrett%26aufirst%3DC.%26aulast%3DBrunson%26aufirst%3DM.%26aulast%3DChin%26aufirst%3DJ.%26aulast%3DEngland%26aufirst%3DD.%26aulast%3DGarcia%26aufirst%3DK.%26aulast%3DGigstad%26aufirst%3DK.%26aulast%3DGould%26aufirst%3DA.%26aulast%3DGutierrez%26aufirst%3DJ.%26aulast%3DHoar%26aufirst%3DK.%26aulast%3DRowland%26aufirst%3DR.%2BS.%26aulast%3DTsu%26aufirst%3DC.%26aulast%3DRingeling%26aufirst%3DJ.%26aulast%3DWager%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DH.%26atitle%3DHistone%2520deacetylase%2520inhibitors%2520derived%2520from%25201%252C2%252C3%252C4-tetrahydropyrrolo%255B1%252C2-a%255Dpyrazine%2520and%2520related%2520heterocycles%2520selective%2520for%2520the%2520HDAC6%2520isoform%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D5450%26epage%3D5454%26doi%3D10.1016%2Fj.bmcl.2014.10.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Andaloussi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Meer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sijm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulie, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Esch, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smits, R. A.</span><span> </span><span class="NLM_article-title">A novel series of histamine h4 receptor antagonists based on the pyrido[3,2-d]pyrimidine scaffold: Comparison of hERG binding and target residence time with PF-3893787</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2663</span><span class="NLM_x">–</span> <span class="NLM_lpage">2670</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.02.091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1016%2Fj.bmcl.2013.02.091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=23558237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1ejt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=2663-2670&author=M.+Andaloussiauthor=H.+D.+Limauthor=T.+van+der+Meerauthor=M.+Sijmauthor=C.+B.+Poulieauthor=I.+J.+de+Eschauthor=R.+Leursauthor=R.+A.+Smits&title=A+novel+series+of+histamine+h4+receptor+antagonists+based+on+the+pyrido%5B3%2C2-d%5Dpyrimidine+scaffold%3A+Comparison+of+hERG+binding+and+target+residence+time+with+PF-3893787&doi=10.1016%2Fj.bmcl.2013.02.091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A novel series of histamine H4 receptor antagonists based on the pyrido[3,2-d]pyrimidine scaffold: Comparison of hERG binding and target residence time with PF-3893787</span></div><div class="casAuthors">Andaloussi, Mounir; Lim, Herman D.; van der Meer, Tiffany; Sijm, Maarten; Poulie, Chris B. M.; de Esch, Iwan J. P.; Leurs, Rob; Smits, Rogier A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2663-2670</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In this work we describe the optimization of a lead compd. based on the quinazoline template to give a new series of potent pyrido[3,2-d]pyrimidines as histamine H4 receptor antagonists.  The pyrido[3,2-d]pyrimidine ligands have significantly reduced hERG binding compared to clin. stage compd. PF-3893787 while showing good affinities at the human and rodent histamine receptors.  The receptor residence time of several of these new compds. was detd. for the human H4R and compared with JNJ7777120 and PF-3893787.  The pyrido[3,2-d]pyrimidines showed residence times lower than JNJ7777120 but comparable to the residence time of PF-3893787.  Overall, the pyrido[3,2-d]pyrimidines show an excellent in vitro profile that warrants their further investigation in relevant models of human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5XgYab9jbM7Vg90H21EOLACvtfcHk0lhNWYJo2MhRQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1ejt7g%253D&md5=0c91102c3dab92c3f012c12c1a715380</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.02.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.02.091%26sid%3Dliteratum%253Aachs%26aulast%3DAndaloussi%26aufirst%3DM.%26aulast%3DLim%26aufirst%3DH.%2BD.%26aulast%3Dvan%2Bder%2BMeer%26aufirst%3DT.%26aulast%3DSijm%26aufirst%3DM.%26aulast%3DPoulie%26aufirst%3DC.%2BB.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DSmits%26aufirst%3DR.%2BA.%26atitle%3DA%2520novel%2520series%2520of%2520histamine%2520h4%2520receptor%2520antagonists%2520based%2520on%2520the%2520pyrido%255B3%252C2-d%255Dpyrimidine%2520scaffold%253A%2520Comparison%2520of%2520hERG%2520binding%2520and%2520target%2520residence%2520time%2520with%2520PF-3893787%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D2663%26epage%3D2670%26doi%3D10.1016%2Fj.bmcl.2013.02.091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Asakawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirayama, N.</span><span> </span><span class="NLM_article-title">Autogpa: An automated 3D-QSAR method based on pharmacophore alignment and grid potential analysis</span> <span class="citation_source-journal">Int. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span><span class="refDoi"> DOI: 10.1155/2012/498931</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1155%2F2012%2F498931" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=1-9&author=N.+Asakawaauthor=S.+Kobayashiauthor=J.+Gotoauthor=N.+Hirayama&title=Autogpa%3A+An+automated+3D-QSAR+method+based+on+pharmacophore+alignment+and+grid+potential+analysis&doi=10.1155%2F2012%2F498931"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1155%2F2012%2F498931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F498931%26sid%3Dliteratum%253Aachs%26aulast%3DAsakawa%26aufirst%3DN.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DGoto%26aufirst%3DJ.%26aulast%3DHirayama%26aufirst%3DN.%26atitle%3DAutogpa%253A%2520An%2520automated%25203D-QSAR%2520method%2520based%2520on%2520pharmacophore%2520alignment%2520and%2520grid%2520potential%2520analysis%26jtitle%3DInt.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D2012%26spage%3D1%26epage%3D9%26doi%3D10.1155%2F2012%2F498931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span>Molecular Operating Environment (MOE), 2013.08; <span class="NLM_publisher-name">Chemical Computing Group Inc.</span>: <span class="NLM_publisher-loc">Montreal, Canada</span>,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">; </span>H3a 2r7.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Molecular+Operating+Environment+%28MOE%29%2C+2013.08%3B+Chemical+Computing+Group+Inc.%3A+Montreal%2C+Canada%2C+2017%3B+H3a+2r7."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Operating%2520Environment%2520%2528MOE%2529%252C%25202013.08%26pub%3DChemical%2520Computing%2520Group%2520Inc%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Battles, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langedijk, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furmanova-Hollenstein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaiwatpongsakorn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costello, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwanten, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vranckx, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vink, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaensch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonckers, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koul, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnoult, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peeples, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roymans, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLellan, J. S.</span><span> </span><span class="NLM_article-title">Molecular mechanism of respiratory syncytial virus fusion inhibitors</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span><span class="refDoi"> DOI: 10.1038/nchembio.1982</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1038%2Fnchembio.1982" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=26641933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFemsbrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=87-93&author=M.+B.+Battlesauthor=J.+P.+Langedijkauthor=P.+Furmanova-Hollensteinauthor=S.+Chaiwatpongsakornauthor=H.+M.+Costelloauthor=L.+Kwantenauthor=L.+Vranckxauthor=P.+Vinkauthor=S.+Jaenschauthor=T.+H.+Jonckersauthor=A.+Koulauthor=E.+Arnoultauthor=M.+E.+Peeplesauthor=D.+Roymansauthor=J.+S.+McLellan&title=Molecular+mechanism+of+respiratory+syncytial+virus+fusion+inhibitors&doi=10.1038%2Fnchembio.1982"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanism of respiratory syncytial virus fusion inhibitors</span></div><div class="casAuthors">Battles, Michael B.; Langedijk, Johannes P.; Furmanova-Hollenstein, Polina; Chaiwatpongsakorn, Supranee; Costello, Heather M.; Kwanten, Leen; Vranckx, Luc; Vink, Paul; Jaensch, Steffen; Jonckers, Tim H. M.; Koul, Anil; Arnoult, Eric; Peeples, Mark E.; Roymans, Dirk; McLellan, Jason S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">87-93</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Respiratory syncytial virus (RSV) is a leading cause of pneumonia and bronchiolitis in young children and the elderly.  Therapeutic small mols. have been developed that bind the RSV F glycoprotein and inhibit membrane fusion, yet their binding sites and mol. mechanisms of action remain largely unknown.  Here we show that these inhibitors bind to a three-fold-sym. pocket within the central cavity of the metastable prefusion conformation of RSV F.  Inhibitor binding stabilizes this conformation by tethering two regions that must undergo a structural rearrangement to facilitate membrane fusion.  Inhibitor-escape mutations occur in residues that directly contact the inhibitors or are involved in the conformational rearrangements required to accommodate inhibitor binding.  Resistant viruses do not propagate as well as wild-type RSV in vitro, indicating a fitness cost for inhibitor escape.  Collectively, these findings provide new insight into class I viral fusion proteins and should facilitate development of optimal RSV fusion inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowEnQ0xJnoFLVg90H21EOLACvtfcHk0li1lZdZJswhgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFemsbrK&md5=c126990069d3f23d95d06693fe90a061</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1982%26sid%3Dliteratum%253Aachs%26aulast%3DBattles%26aufirst%3DM.%2BB.%26aulast%3DLangedijk%26aufirst%3DJ.%2BP.%26aulast%3DFurmanova-Hollenstein%26aufirst%3DP.%26aulast%3DChaiwatpongsakorn%26aufirst%3DS.%26aulast%3DCostello%26aufirst%3DH.%2BM.%26aulast%3DKwanten%26aufirst%3DL.%26aulast%3DVranckx%26aufirst%3DL.%26aulast%3DVink%26aufirst%3DP.%26aulast%3DJaensch%26aufirst%3DS.%26aulast%3DJonckers%26aufirst%3DT.%2BH.%26aulast%3DKoul%26aufirst%3DA.%26aulast%3DArnoult%26aufirst%3DE.%26aulast%3DPeeples%26aufirst%3DM.%2BE.%26aulast%3DRoymans%26aufirst%3DD.%26aulast%3DMcLellan%26aufirst%3DJ.%2BS.%26atitle%3DMolecular%2520mechanism%2520of%2520respiratory%2520syncytial%2520virus%2520fusion%2520inhibitors%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D87%26epage%3D93%26doi%3D10.1038%2Fnchembio.1982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Hotard, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaikh, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teng, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plemper, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowe, J. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, M. L.</span><span> </span><span class="NLM_article-title">A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis</span> <span class="citation_source-journal">Virology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">434</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span><span class="refDoi"> DOI: 10.1016/j.virol.2012.09.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1016%2Fj.virol.2012.09.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2012&pages=129-136&author=A.+L.+Hotardauthor=F.+Y.+Shaikhauthor=S.+Leeauthor=D.+Yanauthor=M.+N.+Tengauthor=R.+K.+Plemperauthor=J.+E.+Croweauthor=M.+L.+Moore&title=A+stabilized+respiratory+syncytial+virus+reverse+genetics+system+amenable+to+recombination-mediated+mutagenesis&doi=10.1016%2Fj.virol.2012.09.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.virol.2012.09.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virol.2012.09.022%26sid%3Dliteratum%253Aachs%26aulast%3DHotard%26aufirst%3DA.%2BL.%26aulast%3DShaikh%26aufirst%3DF.%2BY.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DYan%26aufirst%3DD.%26aulast%3DTeng%26aufirst%3DM.%2BN.%26aulast%3DPlemper%26aufirst%3DR.%2BK.%26aulast%3DCrowe%26aufirst%3DJ.%2BE.%26aulast%3DMoore%26aufirst%3DM.%2BL.%26atitle%3DA%2520stabilized%2520respiratory%2520syncytial%2520virus%2520reverse%2520genetics%2520system%2520amenable%2520to%2520recombination-mediated%2520mutagenesis%26jtitle%3DVirology%26date%3D2012%26volume%3D434%26spage%3D129%26epage%3D136%26doi%3D10.1016%2Fj.virol.2012.09.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Cramer, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunce, J. D.</span><span> </span><span class="NLM_article-title">Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">5959</span><span class="NLM_x">–</span> <span class="NLM_lpage">5967</span><span class="refDoi"> DOI: 10.1021/ja00226a005</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00226a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADyaL1cXltVCqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=1988&pages=5959-5967&author=R.+D.+Cramerauthor=D.+E.+Pattersonauthor=J.+D.+Bunce&title=Comparative+molecular+field+analysis+%28CoMFA%29.+1.+Effect+of+shape+on+binding+of+steroids+to+carrier+proteins&doi=10.1021%2Fja00226a005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative molecular field analysis (CoMFA).  1.  Effect of shape on binding of steroids to carrier proteins</span></div><div class="casAuthors">Cramer, Richard D., III; Patterson, David E.; Bunce, Jeffrey D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5959-67</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Comparative mol. field anal. (CoMFA) which represents ligand mols. by their steric and electrostatic fields was used to analyze the affinity of 21 steroids to corticosteroid- and testosterone-binding globulins and then to predict the binding consts. of 10 more, structurally diverse, steroids.  QSAR obtained with CoMFA parameters had greater predictive, and also correlative, power then QSAR obtained by other parameters combinations.  The predicted affinities of the addnl. 10 steroids were highly correlated with the actual binding data with the poorest predictions being for steroids that were most dissimilar from the original 21 steroids analyzed.  The CoMFA methodol is characterized by inherent generality, ease of use, superior anal. power, and predictive utility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkkJZS5v2zRrVg90H21EOLACvtfcHk0li1lZdZJswhgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXltVCqsbs%253D&md5=8829e9efd71a65faa7c9397c9eb13cc7</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fja00226a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00226a005%26sid%3Dliteratum%253Aachs%26aulast%3DCramer%26aufirst%3DR.%2BD.%26aulast%3DPatterson%26aufirst%3DD.%2BE.%26aulast%3DBunce%26aufirst%3DJ.%2BD.%26atitle%3DComparative%2520molecular%2520field%2520analysis%2520%2528CoMFA%2529.%25201.%2520Effect%2520of%2520shape%2520on%2520binding%2520of%2520steroids%2520to%2520carrier%2520proteins%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1988%26volume%3D110%26spage%3D5959%26epage%3D5967%26doi%3D10.1021%2Fja00226a005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 8 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">G. Stuart Cockerill, James A. D. Good, <span class="NLM_string-name hlFld-ContribAuthor">Neil Mathews</span>. </span><span class="cited-content_cbyCitation_article-title">State of the Art in Respiratory Syncytial Virus Drug Discovery and Development. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (7)
                                     , 3206-3227. <a href="https://doi.org/10.1021/acs.jmedchem.8b01361" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01361</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01361%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DState%252Bof%252Bthe%252BArt%252Bin%252BRespiratory%252BSyncytial%252BVirus%252BDrug%252BDiscovery%252Band%252BDevelopment%26aulast%3DCockerill%26aufirst%3DG.%2BStuart%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D31082018%26date%3D21112018%26date%3D09112018%26volume%3D62%26issue%3D7%26spage%3D3206%26epage%3D3227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yan He, Zhi Zheng, Qimeng Liu, Guixian Song, Nan Sun, <span class="NLM_string-name hlFld-ContribAuthor">Xinyuan Chai</span>. </span><span class="cited-content_cbyCitation_article-title">Tunable Synthesis of 2-Ene-1,4-diones, 4-Hydroxycyclopent-2-en-1-ones, and 2-(Furan-3-yl)acetamides via Palladium-Catalyzed Cascade Reactions of Allenols. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (20)
                                     , 12514-12526. <a href="https://doi.org/10.1021/acs.joc.8b01753" title="DOI URL">https://doi.org/10.1021/acs.joc.8b01753</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b01753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b01753%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DTunable%252BSynthesis%252Bof%252B2-Ene-1%25252C4-diones%25252C%252B4-Hydroxycyclopent-2-en-1-ones%25252C%252Band%252B2-%252528Furan-3-yl%252529acetamides%252Bvia%252BPalladium-Catalyzed%252BCascade%252BReactions%252Bof%252BAllenols%26aulast%3DHe%26aufirst%3DYan%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D11072018%26date%3D04102018%26date%3D21092018%26volume%3D83%26issue%3D20%26spage%3D12514%26epage%3D12526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lin-bo Luan, Zi-jie Song, Zhi-ming Li, Quan-rui Wang, <span class="NLM_string-name hlFld-ContribAuthor">Jing-mei Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Triazolodiazepinium Salts: Sequential [3++2] Cycloaddition/Rearrangement Reaction of 1-Aza-2-azoniaallenium Cation Intermediates Generated from Piperidin-4-ones. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (7)
                                     , 3441-3452. <a href="https://doi.org/10.1021/acs.joc.7b02742" title="DOI URL">https://doi.org/10.1021/acs.joc.7b02742</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b02742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b02742%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BTriazolodiazepinium%252BSalts%25253A%252BSequential%252B%25255B3%25252B%25252B2%25255D%252BCycloaddition%25252FRearrangement%252BReaction%252Bof%252B1-Aza-2-azoniaallenium%252BCation%252BIntermediates%252BGenerated%252Bfrom%252BPiperidin-4-ones%26aulast%3DLuan%26aufirst%3DLin-bo%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D30102017%26date%3D22032018%26date%3D02032018%26volume%3D83%26issue%3D7%26spage%3D3441%26epage%3D3452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jimin  Xu</span>, <span class="hlFld-ContribAuthor ">Wenzhe  Wu</span>, <span class="hlFld-ContribAuthor ">Haiying  Chen</span>, <span class="hlFld-ContribAuthor ">Yu  Xue</span>, <span class="hlFld-ContribAuthor ">Xiaoyong  Bao</span>, <span class="hlFld-ContribAuthor ">Jia  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Substituted N-(4-amino-2-chlorophenyl)-5-chloro-2-hydroxybenzamide analogues potently inhibit respiratory syncytial virus (RSV) replication and RSV infection-associated inflammatory responses. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>39 </em>, 116157. <a href="https://doi.org/10.1016/j.bmc.2021.116157" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116157</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116157%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSubstituted%252BN-%2525284-amino-2-chlorophenyl%252529-5-chloro-2-hydroxybenzamide%252Banalogues%252Bpotently%252Binhibit%252Brespiratory%252Bsyncytial%252Bvirus%252B%252528RSV%252529%252Breplication%252Band%252BRSV%252Binfection-associated%252Binflammatory%252Bresponses%26aulast%3DXu%26aufirst%3DJimin%26date%3D2021%26volume%3D39%26spage%3D116157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Namdeo  Bhujbal</span>, <span class="hlFld-ContribAuthor ">Dattatray  Gaikwad</span>, <span class="hlFld-ContribAuthor ">Yuvraj  Jagdale</span>, <span class="hlFld-ContribAuthor ">Chandrakant  Pawar</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, antimicrobial and anti‐tubercular activity study of N‐(substituted‐benzyl)‐4‐(trifluoromethyl)thiazole‐2‐sulfonamide and 2‐(N‐(substituted‐benzyl)sulfamoyl)thiazole‐4‐carboxylic acid. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Chinese Chemical Society</span><span> <strong>2021,</strong> <em>430 </em><a href="https://doi.org/10.1002/jccs.202000421" title="DOI URL">https://doi.org/10.1002/jccs.202000421</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jccs.202000421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjccs.202000421%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Chinese%2520Chemical%2520Society%26atitle%3DSynthesis%25252C%252Bantimicrobial%252Band%252Banti%2525E2%252580%252590tubercular%252Bactivity%252Bstudy%252Bof%252BN%2525E2%252580%252590%252528substituted%2525E2%252580%252590benzyl%252529%2525E2%252580%2525904%2525E2%252580%252590%252528trifluoromethyl%252529thiazole%2525E2%252580%2525902%2525E2%252580%252590sulfonamide%252Band%252B2%2525E2%252580%252590%252528N%2525E2%252580%252590%252528substituted%2525E2%252580%252590benzyl%252529sulfamoyl%252529thiazole%2525E2%252580%2525904%2525E2%252580%252590carboxylic%252Bacid%26aulast%3DBhujbal%26aufirst%3DNamdeo%26date%3D2021%26date%3D2021%26volume%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert M.  Cox</span>, <span class="hlFld-ContribAuthor ">Mart  Toots</span>, <span class="hlFld-ContribAuthor ">Jeong-Joong  Yoon</span>, <span class="hlFld-ContribAuthor ">Julien  Sourimant</span>, <span class="hlFld-ContribAuthor ">Barbara  Ludeke</span>, <span class="hlFld-ContribAuthor ">Rachel  Fearns</span>, <span class="hlFld-ContribAuthor ">Elyse  Bourque</span>, <span class="hlFld-ContribAuthor ">Joseph  Patti</span>, <span class="hlFld-ContribAuthor ">Edward  Lee</span>, <span class="hlFld-ContribAuthor ">John  Vernachio</span>, <span class="hlFld-ContribAuthor ">Richard K.  Plemper</span>. </span><span class="cited-content_cbyCitation_article-title">Development of an allosteric inhibitor class blocking RNA elongation by the respiratory syncytial virus polymerase complex. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2018,</strong> <em>293 </em>
                                    (43)
                                     , 16761-16777. <a href="https://doi.org/10.1074/jbc.RA118.004862" title="DOI URL">https://doi.org/10.1074/jbc.RA118.004862</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.RA118.004862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.RA118.004862%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DDevelopment%252Bof%252Ban%252Ballosteric%252Binhibitor%252Bclass%252Bblocking%252BRNA%252Belongation%252Bby%252Bthe%252Brespiratory%252Bsyncytial%252Bvirus%252Bpolymerase%252Bcomplex%26aulast%3DCox%26aufirst%3DRobert%2BM.%26date%3D2018%26volume%3D293%26issue%3D43%26spage%3D16761%26epage%3D16777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeong-Joong  Yoon</span>, <span class="hlFld-ContribAuthor ">Mart  Toots</span>, <span class="hlFld-ContribAuthor ">Sujin  Lee</span>, <span class="hlFld-ContribAuthor ">Myung-Eun  Lee</span>, <span class="hlFld-ContribAuthor ">Barbara  Ludeke</span>, <span class="hlFld-ContribAuthor ">Jasmina M.  Luczo</span>, <span class="hlFld-ContribAuthor ">Ketaki  Ganti</span>, <span class="hlFld-ContribAuthor ">Robert M.  Cox</span>, <span class="hlFld-ContribAuthor ">Zachary M.  Sticher</span>, <span class="hlFld-ContribAuthor ">Vindya  Edpuganti</span>, <span class="hlFld-ContribAuthor ">Deborah G.  Mitchell</span>, <span class="hlFld-ContribAuthor ">Mark A.  Lockwood</span>, <span class="hlFld-ContribAuthor ">Alexander A.  Kolykhalov</span>, <span class="hlFld-ContribAuthor ">Alexander L.  Greninger</span>, <span class="hlFld-ContribAuthor ">Martin L.  Moore</span>, <span class="hlFld-ContribAuthor ">George R.  Painter</span>, <span class="hlFld-ContribAuthor ">Anice C.  Lowen</span>, <span class="hlFld-ContribAuthor ">Stephen M.  Tompkins</span>, <span class="hlFld-ContribAuthor ">Rachel  Fearns</span>, <span class="hlFld-ContribAuthor ">Michael G.  Natchus</span>, <span class="hlFld-ContribAuthor ">Richard K.  Plemper</span>. </span><span class="cited-content_cbyCitation_article-title">Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2018,</strong> <em>62 </em>
                                    (8)
                                     <a href="https://doi.org/10.1128/AAC.00766-18" title="DOI URL">https://doi.org/10.1128/AAC.00766-18</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.00766-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.00766-18%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DOrally%252BEfficacious%252BBroad-Spectrum%252BRibonucleoside%252BAnalog%252BInhibitor%252Bof%252BInfluenza%252Band%252BRespiratory%252BSyncytial%252BViruses%26aulast%3DYoon%26aufirst%3DJeong-Joong%26date%3D2018%26volume%3D62%26issue%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander A.  Fadeev</span>, <span class="hlFld-ContribAuthor ">Maxim G.  Uchuskin</span>, <span class="hlFld-ContribAuthor ">Igor V.  Trushkov</span>, <span class="hlFld-ContribAuthor ">Anton S.  Makarov</span>. </span><span class="cited-content_cbyCitation_article-title">Copper(II) bromide-catalyzed conjugate addition of furans to α,β-unsaturated carbonyl compounds. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2017,</strong> <em>53 </em>
                                    (12)
                                     , 1286-1293. <a href="https://doi.org/10.1007/s10593-018-2206-1" title="DOI URL">https://doi.org/10.1007/s10593-018-2206-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-018-2206-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-018-2206-1%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DCopper%252528II%252529%252Bbromide-catalyzed%252Bconjugate%252Baddition%252Bof%252Bfurans%252Bto%252B%2525CE%2525B1%25252C%2525CE%2525B2-unsaturated%252Bcarbonyl%252Bcompounds%26aulast%3DFadeev%26aufirst%3DAlexander%2BA.%26date%3D2017%26date%3D2018%26volume%3D53%26issue%3D12%26spage%3D1286%26epage%3D1293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0001.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. RSV inhibitors currently in phase II clinical trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0002.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Primary HTS and counterscreening for hit discovery. (A) Primary hit identification. Assay plates were analyzed using both control-dependent (% inhibition by plate) and independent (robust z-score) statistical approaches. Dashed lines represent hit cutoffs (75% inhibition and a z-score of >4.5, respectively), and red symbols denote hit candidates (180 total) selected for counterscreening. (B) Direct counter and cytotoxicity screens of the selected hit candidates against recRSV-A2-L19F<sub>D489E</sub>-fireSMASh. Confirmation plates were screened twice, and error bars depict the range. (C) Orthogonal dose–response counterscreens of 26 hit candidates selected (B) against recRSV-A2-L19F<sub>D489E</sub>-fireSMASh and recRSV-A2-L19F-renilla. EC<sub>50</sub> concentrations were determined through regression modeling. The solid line marks the parity of active concentrations against either target virus; the dashed line specifies the cutoff for further consideration (15-fold less potency against recRSV-A2-L19F-renilla than recRSV-A2-L19F<sub>D489E</sub>-fireSMASh). (D) RSV minigenome dose–response assay of the 14 confirmed compounds from C; red symbols. Regression curves are shown for each candidate, and symbols represent averages of relative minireplicon activities ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0003.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of confirmed hits.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0004.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Progeny virus yield-based dose–response assay of five selected candidates from the subpanel shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>C (red symbols) against recRSV-A2-L19F. Virus titers were determined through TCID<sub>50</sub> titration. Symbols represent averages of two repeats ± range, regression curves and calculated EC<sub>50</sub> values are shown. Compounds tested were <b>1a</b>, <b>4</b>, <b>5</b>, <b>6</b>, and <b>7</b>. (B) Dose–response reporter assays against the recRSV-A2-L19F<sub>D489E</sub>-fireSMASh screening strain to compare the potency of resynthesized <b>1a</b> and the sourced material. Only resynthesized <b>1a</b> was tested against two distinct RNA viruses, vesicular stomatitis virus (VSV) and influenza A virus A/WSN/1933 (H1N1) (IAV). Symbols represent averages of three repeats ± SEM, and nonlinear (RSV) and linear (VSV, IAV) regression curves, each with 95% confidence intervals, and EC<sub>50</sub> values are shown. N/A, not applicable. (C) RT-qPCR assay to determine relative RSV N mRNA levels. Cells were infected with recRSV-A2-L19F (MOI 3.0) and incubated in the presence of a range of <b>1a</b> concentrations as specified, previously reported <b>2</b> (30 μM), or volume-equivalent of vehicle (DMSO) for 20 h. Values represent averages of three experiments, determined in duplicate each ± SD. Statistical variation was assessed through one-way ANOVA with Sidak’s multiple comparison post test (***, <i>P</i> < 0.001; **, <i>P</i> < 0.01; NS, not significant).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of Compounds <b>1a</b>–<b>1s</b> and Syntheses of Compounds <b>1t</b> and <b>1u</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) EDCI, HOBt, aniline, DMF, RT, 65%. (b) PhSH, Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, RT, 50%. (c) EDCI, HOBt, R<sup>1</sup>COOH, DMF, RT, 22–87%. (d) 3-methyl-2-furaldehyde, NaBH(OAc)<sub>3</sub>, AcOH, DMA, 60 °C, 13%. (e) furan-2-sulfonyl chloride, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to RT, 58%.</p></p></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0005.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. SAR strategy of hit compound <b>1a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Synthesis of Compounds <b>8a</b>–<b>8o</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) PhSH, Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, RT, 66%. (b) EDCI, HOBt, 3-methylfuran-2-carboxylic acid, DMF, RT, 90%. (c) 3 N NaOH, MeOH/THF, then aq. HCl, RT, 95%. (d) EDCI, HOBt, R<sup>3</sup>R<sup>4</sup>NH, DMF, or HATU, DIPEA, DMF, RT, 12–74%.</p></p></figure><figure data-id="sch3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0010.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Syntheses of Compounds <b>8p</b> and <b>8q</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeNH(OMe)·HCl, EDCI, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 41%. (b) BnMgCl, THF, 0 °C to RT, 25%. (c) IBCF, NMM, THF, 0 °C, then aq. NaBH<sub>4</sub>, 0 °C, 41%. (d) MsCl, Et<sub>3</sub>N, THF, 0 °C. (e) aniline, Et<sub>3</sub>N, THF, 20% (2 steps).</p></p></figure><figure data-id="sch4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0011.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compound <b>8r</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DPPA, Et<sub>3</sub>N, <i>t-</i>BuOH/toluene/1,2-dichloroethane 1.5:1.5:1, RT to reflux, 32%. (b) HCl/dioxane, then NaHCO<sub>3</sub>, RT, 99%. (c) NaNO<sub>2</sub>/aq. HCl, then CuSO<sub>4</sub>, SO<sub>2</sub>, AcOH/water, −10 °C to RT, 36%. (d) PhNH<sub>2</sub>, Et<sub>3</sub>N, THF, RT, 84%. (e) PhSH, Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, RT, 79%. (f) EDCI, HOBt, 3-methylfuran-2-carboxylic acid, DMF, RT, 76%.</p></p></figure><figure data-id="sch5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0012.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Syntheses of Compounds <b>8s</b> and <b>8t</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BzCl, DIPEA, THF, 0 °C to RT, 90%. (b) PhSO<sub>2</sub>Cl, DIPEA, THF, 0 °C to RT, quant. (c) PhSH, Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, RT, 75%–quant. (d) EDCI, HOBt, 3-methylfuran-2-carboxylic acid, DMF, RT, 29–68%.</p></p></figure><figure data-id="sch6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0013.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Compound <b>9a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) EDCI, HOBt, 3-methylfuran-2-carboxylic acid, DMF, RT, 65%. (b) NaOH, H<sub>2</sub>O/MeOH/THF, then aq. HCl, RT. (c) EDCI, HOBt, aniline, DMF, RT, 54% (2 steps).</p></p></figure><figure data-id="sch7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0014.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Compound <b>9b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HATU, Et<sub>3</sub>N, 3-methylfuran-2-carboxylic acid, CH<sub>2</sub>Cl<sub>2</sub>, RT, 22%. (b) LiOH, H<sub>2</sub>O/MeOH/THF, then aq. HCl, RT. (c) HATU, DIPEA, aniline, DMF, RT, 15% (2 steps).</p></p></figure><figure data-id="sch8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0015.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Compound <b>9c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) EDCI, HOBt, <i>o-</i>fluoroaniline, DMF, RT, 65%. (b) PhSH, Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, RT, 55%. (c) EDCI, HOBt, furan-2-carboxylic acid, DMF, RT, 59%.</p></p></figure><figure data-id="fig6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0006.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Amide bonds in compound <b>1a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/medium/jm-2016-01568k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0007.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Pharmacophore modeling. (A) AutoGPA-based 3D-QSAR model, shown from two rotational angels. Orange and green spheres represent aromatic and hydrophobic centers, respectively. The allowable space model is shown in gray, and electrostatically active portions are in red and blue. Areas of steric constrain (yellow) and freedom (solid green) are marked. (B) Correlation between the predicted and observed pIC50 values for the training (19 compounds) and test (6 compounds) sets. Model statistics are shown in the graph.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01568/20170317/images/large/jm-2016-01568k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01568&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i102">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57174" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57174" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 38 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Afonso, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amarasinghe, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banyai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basler, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bavari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bejerman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blasdell, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briand, F. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briese, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukreyev, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calisher, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clawson, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietzgen, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolnik, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domier, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durrwald, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dye, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easton, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebihara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farkas, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freitas-Astua, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Formenty, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fouchier, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghedin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodin, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyndman, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitajima, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobinger, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurath, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenardon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroy, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longdon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maisner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muhlberger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Netesov, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowotny, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paweska, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randall, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rima, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rota, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubbenstroth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwemmle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smither, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenglein, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terregino, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tesh, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomonaga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tordo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Towner, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasilakis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbeek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volchkov, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl-Jensen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetzel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitfield, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuen, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, J. H.</span><span> </span><span class="NLM_article-title">Taxonomy of the order mononegavirales: Update 2016</span> <span class="citation_source-journal">Arch. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">2351</span><span class="NLM_x">–</span> <span class="NLM_lpage">2360</span><span class="refDoi"> DOI: 10.1007/s00705-016-2880-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1007%2Fs00705-016-2880-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=27216929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADC%252BC28XosVSqu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2016&pages=2351-2360&author=C.+L.+Afonsoauthor=G.+K.+Amarasingheauthor=K.+Banyaiauthor=Y.+Baoauthor=C.+F.+Baslerauthor=S.+Bavariauthor=N.+Bejermanauthor=K.+R.+Blasdellauthor=F.+X.+Briandauthor=T.+Brieseauthor=A.+Bukreyevauthor=C.+H.+Calisherauthor=K.+Chandranauthor=J.+Chengauthor=A.+N.+Clawsonauthor=P.+L.+Collinsauthor=R.+G.+Dietzgenauthor=O.+Dolnikauthor=L.+L.+Domierauthor=R.+Durrwaldauthor=J.+M.+Dyeauthor=A.+J.+Eastonauthor=H.+Ebiharaauthor=S.+L.+Farkasauthor=J.+Freitas-Astuaauthor=P.+Formentyauthor=R.+A.+Fouchierauthor=Y.+Fuauthor=E.+Ghedinauthor=M.+M.+Goodinauthor=R.+Hewsonauthor=M.+Horieauthor=T.+H.+Hyndmanauthor=D.+Jiangauthor=E.+W.+Kitajimaauthor=G.+P.+Kobingerauthor=H.+Kondoauthor=G.+Kurathauthor=R.+A.+Lambauthor=S.+Lenardonauthor=E.+M.+Leroyauthor=C.+X.+Liauthor=X.+D.+Linauthor=L.+Liuauthor=B.+Longdonauthor=S.+Martonauthor=A.+Maisnerauthor=E.+Muhlbergerauthor=S.+V.+Netesovauthor=N.+Nowotnyauthor=J.+L.+Pattersonauthor=S.+L.+Payneauthor=J.+T.+Paweskaauthor=R.+E.+Randallauthor=B.+K.+Rimaauthor=P.+Rotaauthor=D.+Rubbenstrothauthor=M.+Schwemmleauthor=M.+Shiauthor=S.+J.+Smitherauthor=M.+D.+Stengleinauthor=D.+M.+Stoneauthor=A.+Takadaauthor=C.+Terreginoauthor=R.+B.+Teshauthor=J.+H.+Tianauthor=K.+Tomonagaauthor=N.+Tordoauthor=J.+S.+Townerauthor=N.+Vasilakisauthor=M.+Verbeekauthor=V.+E.+Volchkovauthor=V.+Wahl-Jensenauthor=J.+A.+Walshauthor=P.+J.+Walkerauthor=D.+Wangauthor=L.+F.+Wangauthor=T.+Wetzelauthor=A.+E.+Whitfieldauthor=J.+T.+Xieauthor=K.+Y.+Yuenauthor=Y.+Z.+Zhangauthor=J.+H.+Kuhn&title=Taxonomy+of+the+order+mononegavirales%3A+Update+2016&doi=10.1007%2Fs00705-016-2880-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Taxonomy of the order Mononegavirales: update 2016</span></div><div class="casAuthors">Afonso, Claudio L.; Amarasinghe, Gaya K.; Banyai, Krisztian; Bao, Yiming; Basler, Christopher F.; Bavari, Sina; Bejerman, Nicolas; Blasdell, Kim R.; Briand, Francois-Xavier; Briese, Thomas; Bukreyev, Alexander; Calisher, Charles H.; Chandran, Kartik; Cheng, Jiasen; Clawson, Anna N.; Collins, Peter L.; Dietzgen, Ralf G.; Dolnik, Olga; Domier, Leslie L.; Durrwald, Ralf; Dye, John M.; Easton, Andrew J.; Ebihara, Hideki; Farkas, Szilvia L.; Freitas-Astua, Juliana; Formenty, Pierre; Fouchier, Ron A. M.; Fu, Yanping; Ghedin, Elodie; Goodin, Michael M.; Hewson, Roger; Horie, Masayuki; Hyndman, Timothy H.; Jiang, Daohong; Kitajima, Elliot W.; Kobinger, Gary P.; Kondo, Hideki; Kurath, Gael; Lamb, Robert A.; Lenardon, Sergio; Leroy, Eric M.; Li, Ci-Xiu; Lin, Xian-Dan; Liu, Lijiang; Longdon, Ben; Marton, Szilvia; Maisner, Andrea; Muhlberger, Elke; Netesov, Sergey V.; Nowotny, Norbert; Patterson, Jean L.; Payne, Susan L.; Paweska, Janusz T.; Randall, Rick E.; Rima, Bertus K.; Rota, Paul; Rubbenstroth, Dennis; Schwemmle, Martin; Shi, Mang; Smither, Sophie J.; Stenglein, Mark D.; Stone, David M.; Takada, Ayato; Terregino, Calogero; Tesh, Robert B.; Tian, Jun-Hua; Tomonaga, Keizo; Tordo, Noel; Towner, Jonathan S.; Vasilakis, Nikos; Verbeek, Martin; Volchkov, Viktor E.; Wahl-Jensen, Victoria; Walsh, John A.; Walker, Peter J.; Wang, David; Wang, Lin-Fa; Wetzel, Thierry; Whitfield, Anna E.; Xie, Jiatao; Yuen, Kwok-Yung; Zhang, Yong-Zhen; Kuhn, Jens H.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Virology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2351-2360</span>CODEN:
                <span class="NLM_cas:coden">ARVIDF</span>;
        ISSN:<span class="NLM_cas:issn">0304-8608</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag GmbH</span>)
        </div><div class="casAbstract">In 2016, the order Mononegavirales was emended through the addn. of two new families (Mymonaviridae and Sunviridae), the elevation of the paramyxoviral subfamily Pneumovirinae to family status (Pneumoviridae), the addn. of five free-floating genera (Anphevirus, Arlivirus, Chengtivirus, Crustavirus, and Wastrivirus), and several other changes at the genus and species levels.  This article presents the updated taxonomy of the order Mononegavirales as now accepted by the International Committee on Taxonomy of Viruses (ICTV).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJf1Zbq5k5fbVg90H21EOLACvtfcHk0lh9997qSdArhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosVSqu7Y%253D&md5=42c7698d6765f50874b7c6dc90d4f30a</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs00705-016-2880-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00705-016-2880-1%26sid%3Dliteratum%253Aachs%26aulast%3DAfonso%26aufirst%3DC.%2BL.%26aulast%3DAmarasinghe%26aufirst%3DG.%2BK.%26aulast%3DBanyai%26aufirst%3DK.%26aulast%3DBao%26aufirst%3DY.%26aulast%3DBasler%26aufirst%3DC.%2BF.%26aulast%3DBavari%26aufirst%3DS.%26aulast%3DBejerman%26aufirst%3DN.%26aulast%3DBlasdell%26aufirst%3DK.%2BR.%26aulast%3DBriand%26aufirst%3DF.%2BX.%26aulast%3DBriese%26aufirst%3DT.%26aulast%3DBukreyev%26aufirst%3DA.%26aulast%3DCalisher%26aufirst%3DC.%2BH.%26aulast%3DChandran%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DClawson%26aufirst%3DA.%2BN.%26aulast%3DCollins%26aufirst%3DP.%2BL.%26aulast%3DDietzgen%26aufirst%3DR.%2BG.%26aulast%3DDolnik%26aufirst%3DO.%26aulast%3DDomier%26aufirst%3DL.%2BL.%26aulast%3DDurrwald%26aufirst%3DR.%26aulast%3DDye%26aufirst%3DJ.%2BM.%26aulast%3DEaston%26aufirst%3DA.%2BJ.%26aulast%3DEbihara%26aufirst%3DH.%26aulast%3DFarkas%26aufirst%3DS.%2BL.%26aulast%3DFreitas-Astua%26aufirst%3DJ.%26aulast%3DFormenty%26aufirst%3DP.%26aulast%3DFouchier%26aufirst%3DR.%2BA.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DGhedin%26aufirst%3DE.%26aulast%3DGoodin%26aufirst%3DM.%2BM.%26aulast%3DHewson%26aufirst%3DR.%26aulast%3DHorie%26aufirst%3DM.%26aulast%3DHyndman%26aufirst%3DT.%2BH.%26aulast%3DJiang%26aufirst%3DD.%26aulast%3DKitajima%26aufirst%3DE.%2BW.%26aulast%3DKobinger%26aufirst%3DG.%2BP.%26aulast%3DKondo%26aufirst%3DH.%26aulast%3DKurath%26aufirst%3DG.%26aulast%3DLamb%26aufirst%3DR.%2BA.%26aulast%3DLenardon%26aufirst%3DS.%26aulast%3DLeroy%26aufirst%3DE.%2BM.%26aulast%3DLi%26aufirst%3DC.%2BX.%26aulast%3DLin%26aufirst%3DX.%2BD.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLongdon%26aufirst%3DB.%26aulast%3DMarton%26aufirst%3DS.%26aulast%3DMaisner%26aufirst%3DA.%26aulast%3DMuhlberger%26aufirst%3DE.%26aulast%3DNetesov%26aufirst%3DS.%2BV.%26aulast%3DNowotny%26aufirst%3DN.%26aulast%3DPatterson%26aufirst%3DJ.%2BL.%26aulast%3DPayne%26aufirst%3DS.%2BL.%26aulast%3DPaweska%26aufirst%3DJ.%2BT.%26aulast%3DRandall%26aufirst%3DR.%2BE.%26aulast%3DRima%26aufirst%3DB.%2BK.%26aulast%3DRota%26aufirst%3DP.%26aulast%3DRubbenstroth%26aufirst%3DD.%26aulast%3DSchwemmle%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DM.%26aulast%3DSmither%26aufirst%3DS.%2BJ.%26aulast%3DStenglein%26aufirst%3DM.%2BD.%26aulast%3DStone%26aufirst%3DD.%2BM.%26aulast%3DTakada%26aufirst%3DA.%26aulast%3DTerregino%26aufirst%3DC.%26aulast%3DTesh%26aufirst%3DR.%2BB.%26aulast%3DTian%26aufirst%3DJ.%2BH.%26aulast%3DTomonaga%26aufirst%3DK.%26aulast%3DTordo%26aufirst%3DN.%26aulast%3DTowner%26aufirst%3DJ.%2BS.%26aulast%3DVasilakis%26aufirst%3DN.%26aulast%3DVerbeek%26aufirst%3DM.%26aulast%3DVolchkov%26aufirst%3DV.%2BE.%26aulast%3DWahl-Jensen%26aufirst%3DV.%26aulast%3DWalsh%26aufirst%3DJ.%2BA.%26aulast%3DWalker%26aufirst%3DP.%2BJ.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.%2BF.%26aulast%3DWetzel%26aufirst%3DT.%26aulast%3DWhitfield%26aufirst%3DA.%2BE.%26aulast%3DXie%26aufirst%3DJ.%2BT.%26aulast%3DYuen%26aufirst%3DK.%2BY.%26aulast%3DZhang%26aufirst%3DY.%2BZ.%26aulast%3DKuhn%26aufirst%3DJ.%2BH.%26atitle%3DTaxonomy%2520of%2520the%2520order%2520mononegavirales%253A%2520Update%25202016%26jtitle%3DArch.%2520Virol.%26date%3D2016%26volume%3D161%26spage%3D2351%26epage%3D2360%26doi%3D10.1007%2Fs00705-016-2880-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Thompson, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shay, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weintraub, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brammer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuda, K.</span><span> </span><span class="NLM_article-title">Mortality associated with influenza and respiratory syncytial virus in the United States</span> <span class="citation_source-journal">J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span><span class="refDoi"> DOI: 10.1001/jama.289.2.179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1001%2Fjama.289.2.179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=12517228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A280%3ADC%252BD3s%252FhtFOntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2003&pages=179-186&author=W.+W.+Thompsonauthor=D.+K.+Shayauthor=E.+Weintraubauthor=L.+Brammerauthor=N.+Coxauthor=L.+J.+Andersonauthor=K.+Fukuda&title=Mortality+associated+with+influenza+and+respiratory+syncytial+virus+in+the+United+States&doi=10.1001%2Fjama.289.2.179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mortality associated with influenza and respiratory syncytial virus in the United States</span></div><div class="casAuthors">Thompson William W; Shay David K; Weintraub Eric; Brammer Lynnette; Cox Nancy; Anderson Larry J; Fukuda Keiji</div><div class="citationInfo"><span class="NLM_cas:title">JAMA</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">179-86</span>
        ISSN:<span class="NLM_cas:issn">0098-7484</span>.
    </div><div class="casAbstract">CONTEXT:  Influenza and respiratory syncytial virus (RSV) cause substantial morbidity and mortality.  Statistical methods used to estimate deaths in the United States attributable to influenza have not accounted for RSV circulation.  OBJECTIVE:  To develop a statistical model using national mortality and viral surveillance data to estimate annual influenza- and RSV-associated deaths in the United States, by age group, virus, and influenza type and subtype.  DESIGN, SETTING, AND POPULATION:  Age-specific Poisson regression models using national viral surveillance data for the 1976-1977 through 1998-1999 seasons were used to estimate influenza-associated deaths.  Influenza- and RSV-associated deaths were simultaneously estimated for the 1990-1991 through 1998-1999 seasons.  MAIN OUTCOME MEASURES:  Attributable deaths for 3 categories: underlying pneumonia and influenza, underlying respiratory and circulatory, and all causes.  RESULTS:  Annual estimates of influenza-associated deaths increased significantly between the 1976-1977 and 1998-1999 seasons for all 3 death categories (P<.001 for each category).  For the 1990-1991 through 1998-1999 seasons, the greatest mean numbers of deaths were associated with influenza A(H3N2) viruses, followed by RSV, influenza B, and influenza A(H1N1).  Influenza viruses and RSV, respectively, were associated with annual means (SD) of 8097 (3084) and 2707 (196) underlying pneumonia and influenza deaths, 36 155 (11 055) and 11 321 (668) underlying respiratory and circulatory deaths, and 51 203 (15 081) and 17 358 (1086) all-cause deaths.  For underlying respiratory and circulatory deaths, 90% of influenza- and 78% of RSV-associated deaths occurred among persons aged 65 years or older.  Influenza was associated with more deaths than RSV in all age groups except for children younger than 1 year.  On average, influenza was associated with 3 times as many deaths as RSV.  CONCLUSIONS:  Mortality associated with both influenza and RSV circulation disproportionately affects elderly persons.  Influenza deaths have increased substantially in the last 2 decades, in part because of aging of the population, underscoring the need for better prevention measures, including more effective vaccines and vaccination programs for elderly persons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4QBM7LTwlvHqj_yg7twvpfW6udTcc2eYKSQaPn5Nijbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s%252FhtFOntA%253D%253D&md5=76dba2ff0597ae7dafd32c90820fa1f7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1001%2Fjama.289.2.179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.289.2.179%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DW.%2BW.%26aulast%3DShay%26aufirst%3DD.%2BK.%26aulast%3DWeintraub%26aufirst%3DE.%26aulast%3DBrammer%26aufirst%3DL.%26aulast%3DCox%26aufirst%3DN.%26aulast%3DAnderson%26aufirst%3DL.%2BJ.%26aulast%3DFukuda%26aufirst%3DK.%26atitle%3DMortality%2520associated%2520with%2520influenza%2520and%2520respiratory%2520syncytial%2520virus%2520in%2520the%2520United%2520States%26jtitle%3DJ.%2520Am.%2520Med.%2520Assoc.%26date%3D2003%26volume%3D289%26spage%3D179%26epage%3D186%26doi%3D10.1001%2Fjama.289.2.179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Collins, P. L.; Crowe, J. E.,  Jr.</span><span> </span><span class="NLM_article-title">Respiratory Syncytial Virus and Metapneumoviruses</span>. In  <span class="citation_source-book">Fields Virology</span>, <span class="NLM_edition">5</span>th ed.; <span class="NLM_contrib-group">Knipe, D. M.; Howley, P. M.</span>, Eds.; <span class="NLM_publisher-name">Lippincott, Williams, & Wilkins</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">2</span>, pp  <span class="NLM_fpage">1601</span><span class="NLM_x">–</span> <span class="NLM_lpage">1645</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=1601-1645&author=P.+L.+Collins&author=J.+E.+Croweauthor=D.+M.+Knipe&author=P.+M.+Howley&title=Fields+Virology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DP.%2BL.%26atitle%3DRespiratory%2520Syncytial%2520Virus%2520and%2520Metapneumoviruses%26btitle%3DFields%2520Virology%26aulast%3DKnipe%26aufirst%3DD.%2BM.%26pub%3DLippincott%252C%2520Williams%252C%2520%2526%2520Wilkins%26date%3D2007%26volume%3D2%26spage%3D1601%26epage%3D1645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Elliot, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, D. M.</span><span> </span><span class="NLM_article-title">Influenza and respiratory syncytial virus in the elderly</span> <span class="citation_source-journal">Expert Rev. Vaccines</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span><span class="refDoi"> DOI: 10.1586/14760584.7.2.249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1586%2F14760584.7.2.249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=18324893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A280%3ADC%252BD1c7mvFaguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=249-258&author=A.+J.+Elliotauthor=D.+M.+Fleming&title=Influenza+and+respiratory+syncytial+virus+in+the+elderly&doi=10.1586%2F14760584.7.2.249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Influenza and respiratory syncytial virus in the elderly</span></div><div class="casAuthors">Elliot Alex J; Fleming Douglas M</div><div class="citationInfo"><span class="NLM_cas:title">Expert review of vaccines</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">249-58</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Respiratory infections are one of the leading causes of morbidity and mortality worldwide: influenza and respiratory syncytial virus (RSV) are the predominant pathogens responsible.  Annual vaccination and the use of antiviral drugs provides both protection and treatment against influenza, particularly protecting those patients most at risk, including the elderly and individuals with chronic comorbidities.  Currently, there are extremely limited options in the protection against RSV infection, making those at-risk patients vulnerable to serious disease, complications and death.  This review focuses on recent trends in respiratory illness in the elderly, particularly focusing on the burden of influenza and RSV on hospitalizations and mortality.  We discuss the potential benefit of influenza vaccination on these outcomes, including the recent controversial debate over the effectiveness of influenza vaccination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRNyeSHlOW6MJPlX7E30qdzfW6udTcc2eYKSQaPn5Nijbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7mvFaguw%253D%253D&md5=ef4849de4ad796c341cbcc8ef0eed2c6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1586%2F14760584.7.2.249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14760584.7.2.249%26sid%3Dliteratum%253Aachs%26aulast%3DElliot%26aufirst%3DA.%2BJ.%26aulast%3DFleming%26aufirst%3DD.%2BM.%26atitle%3DInfluenza%2520and%2520respiratory%2520syncytial%2520virus%2520in%2520the%2520elderly%26jtitle%3DExpert%2520Rev.%2520Vaccines%26date%3D2008%26volume%3D7%26spage%3D249%26epage%3D258%26doi%3D10.1586%2F14760584.7.2.249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Aherne, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bird, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Court, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQuillin, J.</span><span> </span><span class="NLM_article-title">Pathological changes in virus infections of the lower respiratory tract in children</span> <span class="citation_source-journal">J. Clin. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span><span class="refDoi"> DOI: 10.1136/jcp.23.1.7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1136%2Fjcp.23.1.7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=4909103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A280%3ADyaE3c7mtFaitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1970&pages=7-18&author=W.+Aherneauthor=T.+Birdauthor=S.+D.+Courtauthor=P.+S.+Gardnerauthor=J.+McQuillin&title=Pathological+changes+in+virus+infections+of+the+lower+respiratory+tract+in+children&doi=10.1136%2Fjcp.23.1.7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Pathological changes in virus infections of the lower respiratory tract in children</span></div><div class="casAuthors">Aherne W; Bird T; Court S D; Gardner P S; McQuillin J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical pathology</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-18</span>
        ISSN:<span class="NLM_cas:issn">0021-9746</span>.
    </div><div class="casAbstract">The pathological changes are described in 22 children with proven or suspected virus infection of the lower respiratory tract.  Two main patterns of disease were found: acute bronchiolitis and interstitial pneumonia.  Particular viruses were not specifically associated with particular histological changes.  The prime importance of the respiratory syncytial virus (RSV) as a cause of disease and death in young infants is again shown.  Structural lesions and clinical dysfunction correlate fairly well; in acute bronchiolitis the main lesion is epithelial necrosis when a dense plug is formed in the bronchiolar lumen leading to trapping air and other mechanical interference with ventilation: in interstitial pneumonia there is widespread inflammation and necrosis of lung parenchyma, and severe lesions of the bronchial and bronchiolar mucosa as well.  The implications of these structural changes for clinical management are discussed.  The possibility of a hypersensitivity reaction in the cot death syndrome is raised, mediated by a serum antibody-antigen-complement reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS01jf-M8Pu0zjk2McQZ6XmfW6udTcc2eZFkt4g_oLVKbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE3c7mtFaitg%253D%253D&md5=58dda7fdb25a55f6903d3ab2bb8b2aab</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1136%2Fjcp.23.1.7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjcp.23.1.7%26sid%3Dliteratum%253Aachs%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DBird%26aufirst%3DT.%26aulast%3DCourt%26aufirst%3DS.%2BD.%26aulast%3DGardner%26aufirst%3DP.%2BS.%26aulast%3DMcQuillin%26aufirst%3DJ.%26atitle%3DPathological%2520changes%2520in%2520virus%2520infections%2520of%2520the%2520lower%2520respiratory%2520tract%2520in%2520children%26jtitle%3DJ.%2520Clin.%2520Pathol.%26date%3D1970%26volume%3D23%26spage%3D7%26epage%3D18%26doi%3D10.1136%2Fjcp.23.1.7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Lugo, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nahata, M. C.</span><span> </span><span class="NLM_article-title">Pathogenesis and treatment of bronchiolitis</span> <span class="citation_source-journal">Clin. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=8095871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A280%3ADyaK3s3gtFyrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1993&pages=95-116&author=R.+A.+Lugoauthor=M.+C.+Nahata&title=Pathogenesis+and+treatment+of+bronchiolitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogenesis and treatment of bronchiolitis</span></div><div class="casAuthors">Lugo R A; Nahata M C</div><div class="citationInfo"><span class="NLM_cas:title">Clinical pharmacy</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">95-116</span>
        ISSN:<span class="NLM_cas:issn">0278-2677</span>.
    </div><div class="casAbstract">The pathogenesis, epidemiology, clinical features, sequelae, and treatment of bronchiolitis are reviewed.  Acute bronchiolitis is the most common severe lower-respiratory-tract infection of infancy.  During epidemics, more than 80% of cases may be caused by respiratory syncytial virus (RSV).  Although signs and symptoms may become severe, most infections are self-limited and improvement occurs within several days.  Approximately 1-2% of infants less than one year of age require hospitalization.  Generally, patients who develop severe, life-threatening RSV bronchiolitis are those with underlying cardiopulmonary disease, immunosuppression, bronchopulmonary dysplasia, or a history of premature birth.  In severe bronchiolitis, necrosis of the respiratory epithelium, excessive mucus production, and lymphocytic infiltration result in edema, dense plugs of debris, and subsequent bronchiolar obstruction.  IgE-mediated reactions and release of inflammatory mediators may result in exacerbation of acute obstruction and may contribute to chronic obstructive pulmonary dysfunction, a common sequela of bronchiolitis.  Patients hospitalized with bronchiolitis usually require supportive therapy and may require mechanical ventilation.  Based on recent data, a trial of aerosolized beta 2 agonists is warranted in all patients.  Systemic corticosteroids have not proved efficacious and have a limited role in the treatment of acute bronchiolitis.  Inhaled corticosteroids may be useful in reducing the severity of chronic wheezing that may follow acute bronchiolitis.  Ribavirin may be considered in patients with severe illness or in those at high risk for severe RSV disease.  Intravenous immune globulin may have a role in the treatment of lower-respiratory-tract infections involving RSV; however, since few studies have been performed in humans, it is not possible to determine its place in the treatment of bronchiolitis.  A trial of aerosolized beta 2 agonists is warranted in patients with bronchiolitis.  Ribavirin may be considered in patients with severe disease or those at high risk for severe disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQtslZVRRlDLI3yKPtYViAGfW6udTcc2eZFkt4g_oLVKbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s3gtFyrsw%253D%253D&md5=8daaba023aadc470f9d448b335b94d20</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLugo%26aufirst%3DR.%2BA.%26aulast%3DNahata%26aufirst%3DM.%2BC.%26atitle%3DPathogenesis%2520and%2520treatment%2520of%2520bronchiolitis%26jtitle%3DClin.%2520Pharm.%26date%3D1993%26volume%3D12%26spage%3D95%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Domachowske, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, H. F.</span><span> </span><span class="NLM_article-title">Respiratory syncytial virus infection: Immune response, immunopathogenesis, and treatment</span> <span class="citation_source-journal">Clin. Microbiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">298</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1128%2FCMR.12.2.298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10194461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A280%3ADyaK1M3ht1Smsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1999&pages=298-309&author=J.+B.+Domachowskeauthor=H.+F.+Rosenberg&title=Respiratory+syncytial+virus+infection%3A+Immune+response%2C+immunopathogenesis%2C+and+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment</span></div><div class="casAuthors">Domachowske J B; Rosenberg H F</div><div class="citationInfo"><span class="NLM_cas:title">Clinical microbiology reviews</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">298-309</span>
        ISSN:<span class="NLM_cas:issn">0893-8512</span>.
    </div><div class="casAbstract">Respiratory syncytial virus (RSV) is the single most important cause of lower respiratory tract infection during infancy and early childhood.  Once RSV infection is established, the host immune response includes the production of virus-neutralizing antibodies and T-cell-specific immunity.  The humoral immune response normally results in the development of anti-RSV neutralizing-antibody titers, but these are often suboptimal during an infant's initial infection.  Even when the production of RSV neutralizing antibody following RSV infection is robust, humoral immunity wanes over time.  Reinfection during subsequent seasons is common.  The cellular immune response to RSV infection is also important for the clearance of virus.  This immune response, vital for host defense against RSV, is also implicated in the immunopathogenesis of severe lower respiratory tract RSV bronchiolitis.  Many details of the immunology and immunopathologic mechanisms of RSV disease known at present have been learned from rodent models of RSV disease and are discussed in some detail.  In addition, the roles of immunoglobulin E, histamine, and eosinophils in the immunopathogenesis of RSV disease are considered.  Although the treatment of RSV bronchiolitis is primarily supportive, the role of ribavirin is briefly discussed.  Novel approaches to the development of new antiviral drugs with promising anti-RSV activity in vitro are also described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLMwn5Ypa32mGmni0r9GoKfW6udTcc2eb1JrADiOuqlrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M3ht1Smsg%253D%253D&md5=b646bfa9c2bdbef4f4b54e2d40318fe2</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1128%2FCMR.12.2.298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.12.2.298%26sid%3Dliteratum%253Aachs%26aulast%3DDomachowske%26aufirst%3DJ.%2BB.%26aulast%3DRosenberg%26aufirst%3DH.%2BF.%26atitle%3DRespiratory%2520syncytial%2520virus%2520infection%253A%2520Immune%2520response%252C%2520immunopathogenesis%252C%2520and%2520treatment%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D1999%26volume%3D12%26spage%3D298%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">DeVincenzo, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaishnaw, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cehelsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nochur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meeking, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moane, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oxford, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pareek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Studholme, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambkin-Williams, R.</span><span> </span><span class="NLM_article-title">Viral load drives disease in humans experimentally infected with respiratory syncytial virus</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">182</span><span class="NLM_x">, </span> <span class="NLM_fpage">1305</span><span class="NLM_x">–</span> <span class="NLM_lpage">1314</span><span class="refDoi"> DOI: 10.1164/rccm.201002-0221OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1164%2Frccm.201002-0221OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=20622030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1equg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2010&pages=1305-1314&author=J.+P.+DeVincenzoauthor=T.+Wilkinsonauthor=A.+Vaishnawauthor=J.+Cehelskyauthor=R.+Meyersauthor=S.+Nochurauthor=L.+Harrisonauthor=P.+Meekingauthor=A.+Mannauthor=E.+Moaneauthor=J.+Oxfordauthor=R.+Pareekauthor=R.+Mooreauthor=E.+Walshauthor=R.+Studholmeauthor=P.+Dorsettauthor=R.+Alvarezauthor=R.+Lambkin-Williams&title=Viral+load+drives+disease+in+humans+experimentally+infected+with+respiratory+syncytial+virus&doi=10.1164%2Frccm.201002-0221OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Viral load drives disease in humans experimentally infected with respiratory syncytial virus</span></div><div class="casAuthors">DeVincenzo, John P.; Wilkinson, Tom; Vaishnaw, Akshay; Cehelsky, Jeff; Meyers, Rachel; Nochur, Saraswathy; Harrison, Lisa; Meeking, Patricia; Mann, Alex; Moane, Elizabeth; Oxford, John; Pareek, Rajat; Moore, Ryves; Walsh, Ed; Studholme, Robert; Dorsett, Preston; Alvarez, Rene; Lambkin-Williams, Robert</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1305-1314</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Respiratory syncytial virus (RSV) is the leading cause of childhood lower respiratory infection, yet viable therapies are lacking.  Two major challenges have stalled antiviral development: ethical difficulties in performing pediatric proof-of-concept studies and the prevailing concept that the disease is immune-mediated rather than being driven by viral load.  The development of a human exptl. wild-type RSV infection model to address these challenges.  Healthy volunteers (n = 35), in five cohorts, received increasing quantities (3.0-5.4 log plaque-forming units/person) of wild-type RSV-A intranasally.  Overall, 77% of volunteers consistently shed virus.  Infection rate, viral loads, disease severity, and safety were similar between cohorts and were unrelated to quantity of RSV received.  Symptoms began near the time of initial viral detection, peaked in severity near when viral load peaked, and subsided as viral loads (measured by real-time polymerase chain reaction) slowly declined.  Viral loads correlated significantly with intranasal proinflammatory cytokine concns. (IL-6 and IL-8).  Increased viral load correlated consistently with increases in multiple different disease measurements (symptoms, phys. examn., and amt. of nasal mucus).  Viral load appears to drive disease manifestations in humans with RSV infection.  The obsd. parallel viral and disease kinetics support a potential clin. benefit of RSV antivirals.  This reproducible model facilitates the development of future RSV therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-DVpVkrytZ7Vg90H21EOLACvtfcHk0lhkBQQE1FURvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1equg%253D%253D&md5=baadbf1735812bf00a63b9499a2fe3bd</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1164%2Frccm.201002-0221OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.201002-0221OC%26sid%3Dliteratum%253Aachs%26aulast%3DDeVincenzo%26aufirst%3DJ.%2BP.%26aulast%3DWilkinson%26aufirst%3DT.%26aulast%3DVaishnaw%26aufirst%3DA.%26aulast%3DCehelsky%26aufirst%3DJ.%26aulast%3DMeyers%26aufirst%3DR.%26aulast%3DNochur%26aufirst%3DS.%26aulast%3DHarrison%26aufirst%3DL.%26aulast%3DMeeking%26aufirst%3DP.%26aulast%3DMann%26aufirst%3DA.%26aulast%3DMoane%26aufirst%3DE.%26aulast%3DOxford%26aufirst%3DJ.%26aulast%3DPareek%26aufirst%3DR.%26aulast%3DMoore%26aufirst%3DR.%26aulast%3DWalsh%26aufirst%3DE.%26aulast%3DStudholme%26aufirst%3DR.%26aulast%3DDorsett%26aufirst%3DP.%26aulast%3DAlvarez%26aufirst%3DR.%26aulast%3DLambkin-Williams%26aufirst%3DR.%26atitle%3DViral%2520load%2520drives%2520disease%2520in%2520humans%2520experimentally%2520infected%2520with%2520respiratory%2520syncytial%2520virus%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2010%26volume%3D182%26spage%3D1305%26epage%3D1314%26doi%3D10.1164%2Frccm.201002-0221OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">El Saleeby, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aitken, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devincenzo, J. P.</span><span> </span><span class="NLM_article-title">Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children</span> <span class="citation_source-journal">J. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">204</span><span class="NLM_x">, </span> <span class="NLM_fpage">996</span><span class="NLM_x">–</span> <span class="NLM_lpage">1002</span><span class="refDoi"> DOI: 10.1093/infdis/jir494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1093%2Finfdis%2Fjir494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=21881113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A280%3ADC%252BC3Mfgt1GnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=204&publication_year=2011&pages=996-1002&author=C.+M.+El+Saleebyauthor=A.+J.+Bushauthor=L.+M.+Harrisonauthor=J.+A.+Aitkenauthor=J.+P.+Devincenzo&title=Respiratory+syncytial+virus+load%2C+viral+dynamics%2C+and+disease+severity+in+previously+healthy+naturally+infected+children&doi=10.1093%2Finfdis%2Fjir494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children</span></div><div class="casAuthors">El Saleeby Chadi M; Bush Andy J; Harrison Lisa M; Aitken Jody A; Devincenzo John P</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of infectious diseases</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">204</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">996-1002</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Respiratory syncytial virus (RSV) disease severity was thought to be a result of host immunopathology but alternatively may be driven by high-level viral replication.  The relationships between RSV load, viral clearance dynamics, and disease severity have not been carefully evaluated.  METHODS:  Previously healthy RSV-infected children <2 years old were recruited.  RSV load was measured in respiratory secretions by fresh quantitative culture over 3 hospital days.  Measures of disease severity were hospital admission, duration of hospitalization, requirement for intensive care, and respiratory failure.  RESULTS:  Multivariate logistic regression models revealed independent predictors of increased duration of hospitalization: male sex, lower weight, and higher viral load on any day.  Viral loads at day 3 were more significantly associated with requirement for intensive care and respiratory failure than were viral loads at earlier time points.  Faster RSV clearance was independently associated with shorter hospitalization.  DISCUSSION:  These observations challenge the immunopathology-based pathogenesis paradigm.  They also have major therapeutic implications, suggesting that application of antiviral agents early in the disease course, even at a time when viral replication is at its highest, might improve subsequent morbidity by significantly lowering viral load and direct viral cytopathic effects, and aborting the potential downstream immunopathology.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTmIt942YeXHUPI-fCgwosgfW6udTcc2eYp5zO63BMMG7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mfgt1GnsQ%253D%253D&md5=df2aee4217ba4325199646ac70599049</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2Fjir494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252Fjir494%26sid%3Dliteratum%253Aachs%26aulast%3DEl%2BSaleeby%26aufirst%3DC.%2BM.%26aulast%3DBush%26aufirst%3DA.%2BJ.%26aulast%3DHarrison%26aufirst%3DL.%2BM.%26aulast%3DAitken%26aufirst%3DJ.%2BA.%26aulast%3DDevincenzo%26aufirst%3DJ.%2BP.%26atitle%3DRespiratory%2520syncytial%2520virus%2520load%252C%2520viral%2520dynamics%252C%2520and%2520disease%2520severity%2520in%2520previously%2520healthy%2520naturally%2520infected%2520children%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2011%26volume%3D204%26spage%3D996%26epage%3D1002%26doi%3D10.1093%2Finfdis%2Fjir494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Anderson, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strikas, R. L.</span><span> </span><span class="NLM_article-title">Association between respiratory syncytial virus outbreaks and lower respiratory tract deaths of infants and young children</span> <span class="citation_source-journal">J. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">640</span><span class="NLM_x">–</span> <span class="NLM_lpage">646</span><span class="refDoi"> DOI: 10.1093/infdis/161.4.640</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1093%2Finfdis%2F161.4.640" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=2319164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A280%3ADyaK3c3gtlOjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=1990&pages=640-646&author=L.+J.+Andersonauthor=R.+A.+Parkerauthor=R.+L.+Strikas&title=Association+between+respiratory+syncytial+virus+outbreaks+and+lower+respiratory+tract+deaths+of+infants+and+young+children&doi=10.1093%2Finfdis%2F161.4.640"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Association between respiratory syncytial virus outbreaks and lower respiratory tract deaths of infants and young children</span></div><div class="casAuthors">Anderson L J; Parker R A; Strikas R L</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of infectious diseases</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">640-6</span>
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    </div><div class="casAbstract">The temporal patterns of respiratory virus isolations from 10 laboratories in the USA were compared with that of deaths of children less than 5 years old from July 1975 through June 1984.  Isolations of respiratory syncytial virus (RSV) occurred as yearly winter outbreaks; parainfluenza virus 1 and 2 isolations occurred as well-defined outbreaks every other year in the autumn; parainfluenza virus 3 isolations occurred throughout the year with periodic, increased isolations suggestive of outbreaks; and influenza virus isolations (A, B, or A plus B) occurred as yearly winter outbreaks.  After data were controlled for seasonal patterns, RSV isolations were strongly correlated with the winter peaks in lower respiratory tract illness (LRI) deaths of infants 1-11 months old; influenza virus isolations were correlated with the winter peak in LRI deaths of children 24-59 months old.  The parainfluenza viruses were not correlated with respiratory deaths.  This study supports the idea that RSV is a major contributor to winter peaks in LRI deaths of children 1-11 months old.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTK-a4aSxLr6K2q3xNe7a7QfW6udTcc2eYp5zO63BMMG7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3c3gtlOjtA%253D%253D&md5=80b2d878b06ae2bbc1c451de44fa7b71</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2F161.4.640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252F161.4.640%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DL.%2BJ.%26aulast%3DParker%26aufirst%3DR.%2BA.%26aulast%3DStrikas%26aufirst%3DR.%2BL.%26atitle%3DAssociation%2520between%2520respiratory%2520syncytial%2520virus%2520outbreaks%2520and%2520lower%2520respiratory%2520tract%2520deaths%2520of%2520infants%2520and%2520young%2520children%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D1990%26volume%3D161%26spage%3D640%26epage%3D646%26doi%3D10.1093%2Finfdis%2F161.4.640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Groothuis, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodin, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBride, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McWilliams, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauer, B. A.</span><span> </span><span class="NLM_article-title">Early ribavirin treatment of respiratory syncytial viral infection in high-risk children</span> <span class="citation_source-journal">J. Pediatr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">792</span><span class="NLM_x">–</span> <span class="NLM_lpage">798</span><span class="refDoi"> DOI: 10.1016/S0022-3476(05)83347-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1016%2FS0022-3476%2805%2983347-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=2231215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A280%3ADyaK3M%252FjvVKguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=1990&pages=792-798&author=J.+R.+Groothuisauthor=K.+A.+Woodinauthor=R.+Katzauthor=A.+D.+Robertsonauthor=J.+T.+McBrideauthor=C.+B.+Hallauthor=B.+C.+McWilliamsauthor=B.+A.+Lauer&title=Early+ribavirin+treatment+of+respiratory+syncytial+viral+infection+in+high-risk+children&doi=10.1016%2FS0022-3476%2805%2983347-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Early ribavirin treatment of respiratory syncytial viral infection in high-risk children</span></div><div class="casAuthors">Groothuis J R; Woodin K A; Katz R; Robertson A D; McBride J T; Hall C B; McWilliams B C; Lauer B A</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pediatrics</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">792-8</span>
        ISSN:<span class="NLM_cas:issn">0022-3476</span>.
    </div><div class="casAbstract">A 3-year prospective, blinded, multicenter study was done to assess the efficacy of early ribavirin intervention in mild respiratory syncytial virus illness in children with bronchopulmonary dysplasia or with congenital heart disease.  A cohort of 178 children younger than 36 months of age with bronchopulmonary dysplasia or congenital heart disease were followed.  Forty-seven infants whose respiratory syncytial virus infection resulted in mild symptoms of less than or equal to 72 hours' duration received ribavirin (n = 20) or water placebo aerosol (n = 27) either in a hospital or at home.  Outcome measures included respiratory and analog score, room air oxygen, saturation, and oxygen flow needed to maintain saturation at greater than or equal to 91%.  No difference in age, gender, family size, passive smoking, baseline oxygen saturations in room air, or duration of symptoms before treatment was found between groups.  After 3 days of therapy, ribavirin produced a greater rate of improvement of analog scores (p = less than or equal to 0.001), lower oxygen requirements (p = 0.01), and higher oxygen saturation (p = 0.01).  Respiratory scores and total hospital days did not differ significantly between the groups.  Treatment failure occurred in 2 of 20 children (10%) in the ribavirin group versus 5 of 27 children (18%) in the placebo group, a nonsignificant difference.  No child required assisted ventilation or had an adverse reaction.  We conclude that early ribavirin therapy may help to reduce morbidity from respiratory syncytial virus infection in high-risk young children.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQqYQckRvVdy0PI-fCgwosgfW6udTcc2eahuNmyMRKqT7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M%252FjvVKguw%253D%253D&md5=ec7c749052d6df250afc3d08534fd3ff</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0022-3476%2805%2983347-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-3476%252805%252983347-5%26sid%3Dliteratum%253Aachs%26aulast%3DGroothuis%26aufirst%3DJ.%2BR.%26aulast%3DWoodin%26aufirst%3DK.%2BA.%26aulast%3DKatz%26aufirst%3DR.%26aulast%3DRobertson%26aufirst%3DA.%2BD.%26aulast%3DMcBride%26aufirst%3DJ.%2BT.%26aulast%3DHall%26aufirst%3DC.%2BB.%26aulast%3DMcWilliams%26aufirst%3DB.%2BC.%26aulast%3DLauer%26aufirst%3DB.%2BA.%26atitle%3DEarly%2520ribavirin%2520treatment%2520of%2520respiratory%2520syncytial%2520viral%2520infection%2520in%2520high-risk%2520children%26jtitle%3DJ.%2520Pediatr.%26date%3D1990%26volume%3D117%26spage%3D792%26epage%3D798%26doi%3D10.1016%2FS0022-3476%2805%2983347-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Cox, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plemper, R. K.</span><span> </span><span class="NLM_article-title">Structure-guided design of small-molecule therapeutics against RSV disease</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">543</span><span class="NLM_x">–</span> <span class="NLM_lpage">556</span><span class="refDoi"> DOI: 10.1517/17460441.2016.1174212</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1517%2F17460441.2016.1174212" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=543-556&author=R.+Coxauthor=R.+K.+Plemper&title=Structure-guided+design+of+small-molecule+therapeutics+against+RSV+disease&doi=10.1517%2F17460441.2016.1174212"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1517%2F17460441.2016.1174212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2016.1174212%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DR.%26aulast%3DPlemper%26aufirst%3DR.%2BK.%26atitle%3DStructure-guided%2520design%2520of%2520small-molecule%2520therapeutics%2520against%2520RSV%2520disease%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2016%26volume%3D11%26spage%3D543%26epage%3D556%26doi%3D10.1517%2F17460441.2016.1174212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deval, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyatkina, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prhavc, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fung, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serebryany, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chanda, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blatt, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beigelman, L.</span><span> </span><span class="NLM_article-title">Discovery of 4′-chloromethyl-2′-deoxy-3′,5′-di-o-isobutyryl-2′-fluorocytidine (ALS-8176), a first-in-class RSV polymerase inhibitor for treatment of human respiratory syncytial virus infection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1862</span><span class="NLM_x">–</span> <span class="NLM_lpage">1878</span><span class="refDoi"> DOI: 10.1021/jm5017279</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5017279" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisF2jsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1862-1878&author=G.+Wangauthor=J.+Devalauthor=J.+Hongauthor=N.+Dyatkinaauthor=M.+Prhavcauthor=J.+Taylorauthor=A.+Fungauthor=Z.+Jinauthor=S.+K.+Stevensauthor=V.+Serebryanyauthor=J.+Liuauthor=Q.+Zhangauthor=Y.+Tamauthor=S.+M.+Chandaauthor=D.+B.+Smithauthor=J.+A.+Symonsauthor=L.+M.+Blattauthor=L.+Beigelman&title=Discovery+of+4%E2%80%B2-chloromethyl-2%E2%80%B2-deoxy-3%E2%80%B2%2C5%E2%80%B2-di-o-isobutyryl-2%E2%80%B2-fluorocytidine+%28ALS-8176%29%2C+a+first-in-class+RSV+polymerase+inhibitor+for+treatment+of+human+respiratory+syncytial+virus+infection&doi=10.1021%2Fjm5017279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 4'-Chloromethyl-2'-deoxy-3',5'-di-O-isobutyryl-2'-fluorocytidine (ALS-8176), A First-in-Class RSV Polymerase Inhibitor for Treatment of Human Respiratory Syncytial Virus Infection</span></div><div class="casAuthors">Wang, Guangyi; Deval, Jerome; Hong, Jin; Dyatkina, Natalia; Prhavc, Marija; Taylor, Joshua; Fung, Amy; Jin, Zhinan; Stevens, Sarah K.; Serebryany, Vladimir; Liu, Jyanwei; Zhang, Qingling; Tam, Yuen; Chanda, Sushmita M.; Smith, David B.; Symons, Julian A.; Blatt, Lawrence M.; Beigelman, Leo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1862-1878</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Respiratory syncytial virus (RSV) is a leading pathogen of childhood and is assocd. with significant morbidity and mortality.  To date, ribavirin is the only approved small mol. drug, which has limited use.  The only other RSV drug is palivizumab, a monoclonal antibody, which is used for RSV prophylaxis.  Clearly, there is an urgent need for small mol. RSV drugs.  This article reports the design, synthesis, anti-RSV activity, metab., and pharmacokinetics of a series of 4'-substituted cytidine nucleosides.  Among tested compds. 4'-chloromethyl-2'-deoxy-2'-fluorocytidine I exhibited the most promising activity in the RSV replicon assay with an EC50 of 0.15 μM.  The 5'-triphosphate of I (I-TP)inhibited RSV polymerase with an IC50 of 0.02 μM without appreciable inhibition of human DNA and RNA polymerases at 100 μM.  ALS-8176 II, the 3',5'-di-O-isobutyryl prodrug of I, demonstrated good oral bioavailability and a high level of I-TP in vivo.  Compd. II is a first-in-class nucleoside RSV polymerase inhibitor that demonstrated excellent anti-RSV efficacy and safety in a phase 2 clin. RSV challenge study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaKHh4AhV9drVg90H21EOLACvtfcHk0liQq5rAWf3lcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisF2jsL4%253D&md5=da9e883eb67f20ca259dec06a6a05367</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm5017279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5017279%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DG.%26aulast%3DDeval%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DDyatkina%26aufirst%3DN.%26aulast%3DPrhavc%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DJ.%26aulast%3DFung%26aufirst%3DA.%26aulast%3DJin%26aufirst%3DZ.%26aulast%3DStevens%26aufirst%3DS.%2BK.%26aulast%3DSerebryany%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTam%26aufirst%3DY.%26aulast%3DChanda%26aufirst%3DS.%2BM.%26aulast%3DSmith%26aufirst%3DD.%2BB.%26aulast%3DSymons%26aufirst%3DJ.%2BA.%26aulast%3DBlatt%26aufirst%3DL.%2BM.%26aulast%3DBeigelman%26aufirst%3DL.%26atitle%3DDiscovery%2520of%25204%25E2%2580%25B2-chloromethyl-2%25E2%2580%25B2-deoxy-3%25E2%2580%25B2%252C5%25E2%2580%25B2-di-o-isobutyryl-2%25E2%2580%25B2-fluorocytidine%2520%2528ALS-8176%2529%252C%2520a%2520first-in-class%2520RSV%2520polymerase%2520inhibitor%2520for%2520treatment%2520of%2520human%2520respiratory%2520syncytial%2520virus%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1862%26epage%3D1878%26doi%3D10.1021%2Fjm5017279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">DeVincenzo, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitley, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scaglioni-Weinlich, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBride, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambkin-Williams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramanathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Riordan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toback, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, J. W.</span><span> </span><span class="NLM_article-title">Oral GS-5806 activity in a respiratory syncytial virus challenge study</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">722</span><span class="refDoi"> DOI: 10.1056/NEJMoa1401184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1056%2FNEJMoa1401184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=25140957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Cjsb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2014&pages=711-722&author=J.+P.+DeVincenzoauthor=R.+J.+Whitleyauthor=R.+L.+Mackmanauthor=C.+Scaglioni-Weinlichauthor=L.+Harrisonauthor=E.+Farrellauthor=S.+McBrideauthor=R.+Lambkin-Williamsauthor=R.+Jordanauthor=Y.+Xinauthor=S.+Ramanathanauthor=T.+O%E2%80%99Riordanauthor=S.+A.+Lewisauthor=X.+Liauthor=S.+L.+Tobackauthor=S.+L.+Linauthor=J.+W.+Chien&title=Oral+GS-5806+activity+in+a+respiratory+syncytial+virus+challenge+study&doi=10.1056%2FNEJMoa1401184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Oral GS-5806 activity in a respiratory syncytial virus challenge study</span></div><div class="casAuthors">DeVincenzo, John P.; Whitley, Richard J.; Mackman, Richard L.; Scaglioni-Weinlich, Cecilia; Harrison, Lisa; Farrell, Eric; McBride, Stephen; Lambkin-Williams, Robert; Jordan, Robert; Xin, Yan; Ramanathan, Srini; O'Riordan, Thomas; Lewis, Sandra A.; Li, Xiaoming; Toback, Seth L.; Lin, Shao-Lee; Chien, Jason W.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">711-722, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Respiratory syncytial virus (RSV) is a common cause of infant hospitalizations and is increasingly recognized as a cause of considerable morbidity and mortality.  No accepted antiviral treatment exists.  Methods: We conducted a double-blind, placebo-controlled study of GS-5806, an oral RSV-entry inhibitor, in healthy adults who received a clin. challenge strain of RSV intranasally.  Participants were monitored for 12 days.  At the time of a pos. test for RSV infection or 5 days after inoculation, whichever occurred first, participants were randomly assigned to receive GS-5806 or placebo in one of seven sequential cohorts.  Cohorts 1 to 4 received a first dose of 50 mg of GS-5806 and then 25 mg daily for the next 4 days, cohort 5 received a first dose of 50 mg and then 25 mg daily for the next 2 days, cohort 6 received one 100-mg dose, and cohort 7 received a first dose of 10 mg and then 5 mg daily for the next 4 days.  Dose selection for cohorts 5, 6, and 7 occurred after an interim anal. of data for cohorts 1 to 4.  The primary end point was the area under the curve (AUC) for the viral load, which was assessed after administration of the first dose through the 12th day after inoculation.  Secondary end points were mucus wt. and symptom scores.  Results: Among the 54 participants in cohorts 1 to 4 who were infected with RSV, active treatment was assocd. with a lower viral load (adjusted mean, 250.7 vs. 757.7 log10 plaque-forming-unit equiv. [PFUe] × hours per mL; P<0.001), lower total mucus wt. (mean, 6.9 g vs. 15.1 g; P = 0.03), and a lower AUC for the change from baseline in symptom scores (adjusted mean, -20.2 vs. 204.9 × hours; P = 0.005).  The results were similar in cohorts 5, 6, and 7.  Adverse events, including low neutrophil counts and increased levels of alanine aminotransferase, were more common among participants receiving GS-5806.  Conclusions: Treatment with GS-5806 reduced the viral load and the severity of clin. disease in a challenge study of healthy adults.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqxDrIVO5aQLVg90H21EOLACvtfcHk0lg1qb7AKU-DBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Cjsb7O&md5=72276739a80d55a732269359e338fb95</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1401184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1401184%26sid%3Dliteratum%253Aachs%26aulast%3DDeVincenzo%26aufirst%3DJ.%2BP.%26aulast%3DWhitley%26aufirst%3DR.%2BJ.%26aulast%3DMackman%26aufirst%3DR.%2BL.%26aulast%3DScaglioni-Weinlich%26aufirst%3DC.%26aulast%3DHarrison%26aufirst%3DL.%26aulast%3DFarrell%26aufirst%3DE.%26aulast%3DMcBride%26aufirst%3DS.%26aulast%3DLambkin-Williams%26aufirst%3DR.%26aulast%3DJordan%26aufirst%3DR.%26aulast%3DXin%26aufirst%3DY.%26aulast%3DRamanathan%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Riordan%26aufirst%3DT.%26aulast%3DLewis%26aufirst%3DS.%2BA.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DToback%26aufirst%3DS.%2BL.%26aulast%3DLin%26aufirst%3DS.%2BL.%26aulast%3DChien%26aufirst%3DJ.%2BW.%26atitle%3DOral%2520GS-5806%2520activity%2520in%2520a%2520respiratory%2520syncytial%2520virus%2520challenge%2520study%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D371%26spage%3D711%26epage%3D722%26doi%3D10.1056%2FNEJMoa1401184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Yan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thakkar, V. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plemper, R. K.</span><span> </span><span class="NLM_article-title">Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">E3441</span><span class="NLM_x">–</span> <span class="NLM_lpage">3449</span><span class="refDoi"> DOI: 10.1073/pnas.1405198111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1073%2Fpnas.1405198111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=25092342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1GqtLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=E3441-3449&author=D.+Yanauthor=S.+Leeauthor=V.+D.+Thakkarauthor=M.+Luoauthor=M.+L.+Mooreauthor=R.+K.+Plemper&title=Cross-resistance+mechanism+of+respiratory+syncytial+virus+against+structurally+diverse+entry+inhibitors&doi=10.1073%2Fpnas.1405198111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors</span></div><div class="casAuthors">Yan, Dan; Lee, Sujin; Thakkar, Vidhi D.; Luo, Ming; Moore, Martin L.; Plemper, Richard Karl</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">E3441-E3449</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Respiratory syncytial virus (RSV) is a leading pediatric pathogen that is responsible for a majority of infant hospitalizations due to viral disease.  Despite its clin. importance, no vaccine prophylaxis against RSV disease or effective antiviral therapeutic is available.  In this study, the authors established a robust high-throughput drug screening protocol by using a recombinant RSV reporter virus to expand the pool of RSV inhibitor candidates.  Mechanistic characterization revealed that a potent newly identified inhibitor class blocks viral entry through specific targeting of the RSV fusion (F) protein.  Resistance against this class was induced and revealed overlapping hotspots with diverse, previously identified RSV entry blockers at different stages of preclin. and clin. development.  A structural and biochem. assessment of the mechanism of unique, broad RSV cross-resistance against structurally distinct entry inhibitors demonstrated that individual escape hotspots are located in immediate phys. proximity in the metastable conformation of RSV F and that the resistance mutations lower the barrier for prefusion F triggering, resulting in an accelerated RSV entry kinetics.  One resistant RSV recombinant remained fully pathogenic in a mouse model of RSV infection.  By identifying mol. determinants governing the RSV entry machinery, this study spotlights a mol. mechanism of broad RSV resistance against entry inhibition that may affect the impact of diverse viral entry inhibitors presently considered for clin. use and outlines a proactive design for future RSV drug discovery campaigns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrba8S35uwID7Vg90H21EOLACvtfcHk0lg1qb7AKU-DBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1GqtLvL&md5=2f1b48d57c718ca871edd99c5d539cf4</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1405198111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1405198111%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DThakkar%26aufirst%3DV.%2BD.%26aulast%3DLuo%26aufirst%3DM.%26aulast%3DMoore%26aufirst%3DM.%2BL.%26aulast%3DPlemper%26aufirst%3DR.%2BK.%26atitle%3DCross-resistance%2520mechanism%2520of%2520respiratory%2520syncytial%2520virus%2520against%2520structurally%2520diverse%2520entry%2520inhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3DE3441%26epage%3D3449%26doi%3D10.1073%2Fpnas.1405198111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Bright, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Oronoz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallis, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Povinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klimov, A. I.</span><span> </span><span class="NLM_article-title">Incidence of adamantane resistance among influenza a (H3N2) viruses isolated worldwide from 1994 to 2005: A cause for concern</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">366</span><span class="NLM_x">, </span> <span class="NLM_fpage">1175</span><span class="NLM_x">–</span> <span class="NLM_lpage">1181</span><span class="refDoi"> DOI: 10.1016/S0140-6736(05)67338-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1016%2FS0140-6736%2805%2967338-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=16198766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVGrsrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2005&pages=1175-1181&author=R.+A.+Brightauthor=M.+J.+Medinaauthor=X.+Xuauthor=G.+Perez-Oronozauthor=T.+R.+Wallisauthor=X.+M.+Davisauthor=L.+Povinelliauthor=N.+J.+Coxauthor=A.+I.+Klimov&title=Incidence+of+adamantane+resistance+among+influenza+a+%28H3N2%29+viruses+isolated+worldwide+from+1994+to+2005%3A+A+cause+for+concern&doi=10.1016%2FS0140-6736%2805%2967338-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern</span></div><div class="casAuthors">Bright, Rick A.; Medina, Marie-jo; Xu, Xiyan; Perez-Oronoz, Gilda; Wallis, Teresa R.; Davis, Xiaohong M.; Povinelli, Laura; Cox, Nancy J.; Klimov, Alexander I.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">9492</span>),
    <span class="NLM_cas:pages">1175-1181</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Background: Adamantanes have been used to treat influenza A virus infections for many years.  Studies have shown a low incidence of resistance to these drugs among circulating influenza viruses; however, their use is rising worldwide and drug resistance has been reported among influenza A (H5N1) viruses isolated from poultry and human beings in Asia.  We sought to assess adamantane resistance among influenza A viruses isolated during the past decade from countries participating in WHO's global influenza surveillance network.  Methods: We analyzed data for influenza field isolates that were obtained worldwide and submitted to the WHO Collaborating Center for Influenza at the US Centers for Disease Control and Prevention between Oct 1, 1994, and Mar 31, 2005.  We used pyrosequencing, confirmatory sequence anal., and phenotypic testing to detect drug resistance among circulating influenza A H3N2 (n = 6524), H1N1 (n = 589), and H1N2 (n = 83) viruses.  Findings: More than 7000 influenza A field isolates were screened for specific aminoacid substitutions in the M2 gene known to confer drug resistance.  During the decade of surveillance a significant increase in drug resistance was noted, from 0·4% in 1994-1995 to 12·3% in 2003-2004.  This increase in the proportion of resistant viruses was weighted heavily by those obtained from Asia with 61% of resistant viruses isolated since 2003 being from people in Asia.  Interpretation: Our data raise concerns about the appropriate use of adamantanes and draw attention to the importance of tracking the emergence and spread of drug-resistant influenza A viruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplKUP7OtnoPbVg90H21EOLACvtfcHk0lg1qb7AKU-DBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVGrsrbK&md5=aff530ef884feb8e71dd8f0041039f49</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2805%2967338-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252805%252967338-2%26sid%3Dliteratum%253Aachs%26aulast%3DBright%26aufirst%3DR.%2BA.%26aulast%3DMedina%26aufirst%3DM.%2BJ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DPerez-Oronoz%26aufirst%3DG.%26aulast%3DWallis%26aufirst%3DT.%2BR.%26aulast%3DDavis%26aufirst%3DX.%2BM.%26aulast%3DPovinelli%26aufirst%3DL.%26aulast%3DCox%26aufirst%3DN.%2BJ.%26aulast%3DKlimov%26aufirst%3DA.%2BI.%26atitle%3DIncidence%2520of%2520adamantane%2520resistance%2520among%2520influenza%2520a%2520%2528H3N2%2529%2520viruses%2520isolated%2520worldwide%2520from%25201994%2520to%25202005%253A%2520A%2520cause%2520for%2520concern%26jtitle%3DLancet%26date%3D2005%26volume%3D366%26spage%3D1175%26epage%3D1181%26doi%3D10.1016%2FS0140-6736%2805%2967338-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Bright, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bresee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klimov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortiz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ctr, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">CDC</span><span> </span><span class="NLM_article-title">High levels of adamantane resistance among influenza a (H3N2) viruses and interim guidelines for use of antiviral agents - United States, 2005–06 influenza season</span> <span class="citation_source-journal">J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">295</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">882</span><span class="refDoi"> DOI: 10.1001/jama.295.8.881</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1001%2Fjama.295.8.881" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhs12msrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2006&pages=881-882&author=R.+A.+Brightauthor=D.+Shayauthor=J.+Breseeauthor=A.+Klimovauthor=N.+Coxauthor=J.+Ortizauthor=W.+C.+Ctrauthor=CDC&title=High+levels+of+adamantane+resistance+among+influenza+a+%28H3N2%29+viruses+and+interim+guidelines+for+use+of+antiviral+agents+-+United+States%2C+2005%E2%80%9306+influenza+season&doi=10.1001%2Fjama.295.8.881"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents - United States, 2005-06 influenza season</span></div><div class="casAuthors">Bright, R. A.; Shay, D.; Bresee, J.; Klimov, A.; Cox, N.; Ortiz, J.</div><div class="citationInfo"><span class="NLM_cas:title">JAMA, the Journal of the American Medical Association</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">881-882</span>CODEN:
                <span class="NLM_cas:coden">JAMAAP</span>;
        ISSN:<span class="NLM_cas:issn">0098-7484</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPLf3NZUVTxLVg90H21EOLACvtfcHk0lifS5yWmggc1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhs12msrY%253D&md5=5624049460ede754d2fa844aff7ffb6c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1001%2Fjama.295.8.881&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.295.8.881%26sid%3Dliteratum%253Aachs%26aulast%3DBright%26aufirst%3DR.%2BA.%26aulast%3DShay%26aufirst%3DD.%26aulast%3DBresee%26aufirst%3DJ.%26aulast%3DKlimov%26aufirst%3DA.%26aulast%3DCox%26aufirst%3DN.%26aulast%3DOrtiz%26aufirst%3DJ.%26aulast%3DCtr%26aufirst%3DW.%2BC.%26aulast%3D%26atitle%3DHigh%2520levels%2520of%2520adamantane%2520resistance%2520among%2520influenza%2520a%2520%2528H3N2%2529%2520viruses%2520and%2520interim%2520guidelines%2520for%2520use%2520of%2520antiviral%2520agents%2520-%2520United%2520States%252C%25202005%25E2%2580%259306%2520influenza%2520season%26jtitle%3DJ.%2520Am.%2520Med.%2520Assoc.%26date%3D2006%26volume%3D295%26spage%3D881%26epage%3D882%26doi%3D10.1001%2Fjama.295.8.881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Yan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisshaar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plemper, R. K.</span><span> </span><span class="NLM_article-title">Replication-competent influenza virus and respiratory syncytial virus luciferase reporter strains engineered for co-infections identify antiviral compounds in combination screens</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5589</span><span class="NLM_x">–</span> <span class="NLM_lpage">5604</span><span class="refDoi"> DOI: 10.1021/acs.biochem.5b00623</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.5b00623" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtl2hsr7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=5589-5604&author=D.+Yanauthor=M.+Weisshaarauthor=K.+Lambauthor=H.+K.+Chungauthor=M.+Z.+Linauthor=R.+K.+Plemper&title=Replication-competent+influenza+virus+and+respiratory+syncytial+virus+luciferase+reporter+strains+engineered+for+co-infections+identify+antiviral+compounds+in+combination+screens&doi=10.1021%2Facs.biochem.5b00623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Replication-Competent Influenza Virus and Respiratory Syncytial Virus Luciferase Reporter Strains Engineered for Co-Infections Identify Antiviral Compounds in Combination Screens</span></div><div class="casAuthors">Yan, Dan; Weisshaar, Marco; Lamb, Kristen; Chung, Hokyung K.; Lin, Michael Z.; Plemper, Richard K.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">5589-5604</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Myxoviruses such as influenza A virus (IAV) and respiratory syncytial virus (RSV) are major human pathogens, mandating the development of novel therapeutics.  To establish a high-throughput screening protocol for the simultaneous identification of pathogen- and host-targeted hit candidates against either pathogen or both, we have attempted co-infection of cells with IAV and RSV.  However, viral replication kinetics were incompatible, RSV signal window was low, and an IAV-driven minireplicon reporter assay used in initial screens narrowed the host cell range and restricted the assay to single-cycle infections.  To overcome these limitations, we developed an RSV strain carrying firefly luciferase fused to an innovative universal small-mol. assisted shut-off domain, which boosted assay signal window, and a hyperactive fusion protein that synchronized IAV and RSV reporter expression kinetics and suppressed the identification of RSV entry inhibitors sensitive to a recently reported RSV pan-resistance mechanism.  Combined with a replication-competent recombinant IAV strain harboring nanoluciferase, the assay performed well on a human respiratory cell line and supports multicycle infections.  Miniaturized to 384-well format, the protocol was validated through screening of a set of the National Institutes of Health Clin. Collection (NCC) in quadruplicate.  These test screens demonstrated favorable assay parameters and reproducibility.  Application to a LOPAC library of bioactive compds. in a proof-of-concept campaign detected licensed antimyxovirus therapeutics, ribavirin and the neuraminidase inhibitor zanamivir, and identified two unexpected RSV-specific hit candidates, Fenretinide and the opioid receptor antagonist BNTX-7.  Hits were evaluated in direct and orthogonal dose-response counterscreens using a std. recRSV reporter strain expressing Renilla luciferase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo520BUJWoYY7Vg90H21EOLACvtfcHk0lg5mDK-apHQBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtl2hsr7M&md5=3ae74894a743f5fac329ca835003340b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.5b00623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.5b00623%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DD.%26aulast%3DWeisshaar%26aufirst%3DM.%26aulast%3DLamb%26aufirst%3DK.%26aulast%3DChung%26aufirst%3DH.%2BK.%26aulast%3DLin%26aufirst%3DM.%2BZ.%26aulast%3DPlemper%26aufirst%3DR.%2BK.%26atitle%3DReplication-competent%2520influenza%2520virus%2520and%2520respiratory%2520syncytial%2520virus%2520luciferase%2520reporter%2520strains%2520engineered%2520for%2520co-infections%2520identify%2520antiviral%2520compounds%2520in%2520combination%2520screens%26jtitle%3DBiochemistry%26date%3D2015%26volume%3D54%26spage%3D5589%26epage%3D5604%26doi%3D10.1021%2Facs.biochem.5b00623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Moore, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luongo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukacs, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polosukhin, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huckabee, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, U. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowe, J. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goleniewska, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peebles, R. S.,  Jr.</span><span> </span><span class="NLM_article-title">A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">4185</span><span class="NLM_x">–</span> <span class="NLM_lpage">4194</span><span class="refDoi"> DOI: 10.1128/JVI.01853-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1128%2FJVI.01853-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=19211758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Kqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2009&pages=4185-4194&author=M.+L.+Mooreauthor=M.+H.+Chiauthor=C.+Luongoauthor=N.+W.+Lukacsauthor=V.+V.+Polosukhinauthor=M.+M.+Huckabeeauthor=D.+C.+Newcombauthor=U.+J.+Buchholzauthor=J.+E.+Croweauthor=K.+Goleniewskaauthor=J.+V.+Williamsauthor=P.+L.+Collinsauthor=R.+S.+Peebles&title=A+chimeric+A2+strain+of+respiratory+syncytial+virus+%28RSV%29+with+the+fusion+protein+of+RSV+strain+line+19+exhibits+enhanced+viral+load%2C+mucus%2C+and+airway+dysfunction&doi=10.1128%2FJVI.01853-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction</span></div><div class="casAuthors">Moore, Martin L.; Chi, Michael H.; Luongo, Cindy; Lukacs, Nicholas W.; Polosukhin, Vasiliy V.; Huckabee, Matthew M.; Newcomb, Dawn C.; Buchholz, Ursula J.; Crowe, James E., Jr.; Goleniewska, Kasia; Williams, John V.; Collins, Peter L.; Peebles, R. Stokes, Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4185-4194</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Respiratory syncytial virus (RSV) is the leading cause of respiratory failure and viral death in infants.  Abundant airway mucus contributes to airway obstruction in RSV disease.  Interleukin-13 (IL-13) is a mediator of pulmonary mucus secretion.  It has been shown that infection of BALB/c mice with the RSV line 19 strain but not with the RSV A2 lab. strain results in lung IL-13 and mucus expression.  Here, the authors sequenced the RSV line 19 genome and compared it to the commonly used A2 and Long strains.  There were six amino acid differences between the line 19 strain and both the A2 and Long RSV strains, five of which are in the fusion (F) protein.  The Long strain, like the A2 strain, did not induce lung IL-13 and mucus expression in BALB/c mice.  The authors hypothesized that the F protein of RSV line 19 is more mucogenic than the F proteins of A2 and Long.  The authors generated recombinant, F-chimeric RSVs by replacing the F gene of A2 with the F gene of either line 19 or Long.  Infection of BALB/c mice with RSV rA2 line 19F resulted in lower alpha interferon lung levels 24 h postinfection, higher lung viral load, higher lung IL-13 levels, greater airway mucin expression levels, and greater airway hyperresponsiveness than infection with rA2-A2F or rA2-LongF.  The authors identified the F protein of RSV line 19 as a factor that plays a role in pulmonary mucin expression in the setting of RSV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBi2sd77JXo7Vg90H21EOLACvtfcHk0lg5mDK-apHQBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Kqtbs%253D&md5=7ba4b8ff522f58440df584f5acc814e0</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2FJVI.01853-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01853-08%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DM.%2BL.%26aulast%3DChi%26aufirst%3DM.%2BH.%26aulast%3DLuongo%26aufirst%3DC.%26aulast%3DLukacs%26aufirst%3DN.%2BW.%26aulast%3DPolosukhin%26aufirst%3DV.%2BV.%26aulast%3DHuckabee%26aufirst%3DM.%2BM.%26aulast%3DNewcomb%26aufirst%3DD.%2BC.%26aulast%3DBuchholz%26aufirst%3DU.%2BJ.%26aulast%3DCrowe%26aufirst%3DJ.%2BE.%26aulast%3DGoleniewska%26aufirst%3DK.%26aulast%3DWilliams%26aufirst%3DJ.%2BV.%26aulast%3DCollins%26aufirst%3DP.%2BL.%26aulast%3DPeebles%26aufirst%3DR.%2BS.%26atitle%3DA%2520chimeric%2520A2%2520strain%2520of%2520respiratory%2520syncytial%2520virus%2520%2528RSV%2529%2520with%2520the%2520fusion%2520protein%2520of%2520RSV%2520strain%2520line%252019%2520exhibits%2520enhanced%2520viral%2520load%252C%2520mucus%252C%2520and%2520airway%2520dysfunction%26jtitle%3DJ.%2520Virol.%26date%3D2009%26volume%3D83%26spage%3D4185%26epage%3D4194%26doi%3D10.1128%2FJVI.01853-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Chung, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krumm, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plemper, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsien, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M. Z.</span><span> </span><span class="NLM_article-title">Tunable and reversible drug control of protein production via a self-excising degron</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">713</span><span class="NLM_x">–</span> <span class="NLM_lpage">720</span><span class="refDoi"> DOI: 10.1038/nchembio.1869</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1038%2Fnchembio.1869" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=26214256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1WltLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=713-720&author=H.+K.+Chungauthor=C.+L.+Jacobsauthor=Y.+Huoauthor=J.+Yangauthor=S.+A.+Krummauthor=R.+K.+Plemperauthor=R.+Y.+Tsienauthor=M.+Z.+Lin&title=Tunable+and+reversible+drug+control+of+protein+production+via+a+self-excising+degron&doi=10.1038%2Fnchembio.1869"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Tunable and reversible drug control of protein production via a self-excising degron</span></div><div class="casAuthors">Chung, Hokyung K.; Jacobs, Conor L.; Huo, Yunwen; Yang, Jin; Krumm, Stefanie A.; Plemper, Richard K.; Tsien, Roger Y.; Lin, Michael Z.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">713-720</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">An effective method for direct chem. control over the prodn. of specific proteins would be widely useful.  We describe small mol.-assisted shutoff (SMASh), a technique in which proteins are fused to a degron that removes itself in the absence of drug, resulting in the prodn. of an untagged protein.  Clin. tested HCV protease inhibitors can then block degron removal, inducing rapid degrdn. of subsequently synthesized copies of the protein.  SMASh allows reversible and dose-dependent shutoff of various proteins in multiple mammalian cell types and in yeast.  We also used SMASh to confer drug responsiveness onto an RNA virus for which no licensed inhibitors exist.  As SMASh does not require the permanent fusion of a large domain, it should be useful when control over protein prodn. with minimal structural modification is desired.  Furthermore, as SMASh involves only a single genetic modification and does not rely on modulating protein-protein interactions, it should be easy to generalize to multiple biol. contexts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnkBL1_a_xkbVg90H21EOLACvtfcHk0lg5mDK-apHQBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1WltLfN&md5=5a9d3cfb4eece76ba563cde246b8839d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1869%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DH.%2BK.%26aulast%3DJacobs%26aufirst%3DC.%2BL.%26aulast%3DHuo%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DKrumm%26aufirst%3DS.%2BA.%26aulast%3DPlemper%26aufirst%3DR.%2BK.%26aulast%3DTsien%26aufirst%3DR.%2BY.%26aulast%3DLin%26aufirst%3DM.%2BZ.%26atitle%3DTunable%2520and%2520reversible%2520drug%2520control%2520of%2520protein%2520production%2520via%2520a%2520self-excising%2520degron%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D713%26epage%3D720%26doi%3D10.1038%2Fnchembio.1869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Jacob, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirchhoff, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubig, R. R.</span><span> </span><span class="NLM_article-title">Mscreen: An integrated compound management and high-throughput screening data storage and analysis system</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1080</span><span class="NLM_x">–</span> <span class="NLM_lpage">1087</span><span class="refDoi"> DOI: 10.1177/1087057112450186</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1177%2F1087057112450186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=22706349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A280%3ADC%252BC38jisVOktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=1080-1087&author=R.+T.+Jacobauthor=M.+J.+Larsenauthor=S.+D.+Larsenauthor=P.+D.+Kirchhoffauthor=D.+H.+Shermanauthor=R.+R.+Neubig&title=Mscreen%3A+An+integrated+compound+management+and+high-throughput+screening+data+storage+and+analysis+system&doi=10.1177%2F1087057112450186"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">MScreen: an integrated compound management and high-throughput screening data storage and analysis system</span></div><div class="casAuthors">Jacob Renju T; Larsen Martha J; Larsen Scott D; Kirchhoff Paul D; Sherman David H; Neubig Richard R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1080-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">High-throughput screening (HTS) has historically been used by the pharmaceutical industry to rapidly test hundreds of thousands of compounds to identify potential drug candidates.  More recently, academic groups have used HTS to identify new chemical probes or small interfering RNA (siRNA) that can serve as experimental tools to examine the biology or physiology of novel proteins, processes, or interactions.  HTS presents a significant challenge with the vast and complex nature of data generated.  This report describes MScreen, a Web-based, open-source cheminformatics application for chemical library and siRNA plate management, primary HTS and dose-response data handling, structure search, and administrative functions.  Each project in MScreen can be secured with passwords or shared in an open-information environment that enables collaborators to easily compare data from many screens, providing a useful means to identify compounds with desired selectivity.  Unique features include compound, substance, mixture, and siRNA plate creation and formatting; automated dose-response fitting and quality control (QC); and user, target, and assay method administration.  MScreen provides an effective means to facilitate HTS information handling and analysis in the academic setting so that users can efficiently view their screening data and evaluate results for follow-up.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTZQz2O5zthF0wlCcfExbvbfW6udTcc2eY0v8jznt1D4Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38jisVOktg%253D%253D&md5=ba268e90cee118d543a05e45da933ed3</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1177%2F1087057112450186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057112450186%26sid%3Dliteratum%253Aachs%26aulast%3DJacob%26aufirst%3DR.%2BT.%26aulast%3DLarsen%26aufirst%3DM.%2BJ.%26aulast%3DLarsen%26aufirst%3DS.%2BD.%26aulast%3DKirchhoff%26aufirst%3DP.%2BD.%26aulast%3DSherman%26aufirst%3DD.%2BH.%26aulast%3DNeubig%26aufirst%3DR.%2BR.%26atitle%3DMscreen%253A%2520An%2520integrated%2520compound%2520management%2520and%2520high-throughput%2520screening%2520data%2520storage%2520and%2520analysis%2520system%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2012%26volume%3D17%26spage%3D1080%26epage%3D1087%26doi%3D10.1177%2F1087057112450186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Brideau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunter, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pikounis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liaw, A.</span><span> </span><span class="NLM_article-title">Improved statistical methods for hit selection in high-throughput screening</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">634</span><span class="NLM_x">–</span> <span class="NLM_lpage">647</span><span class="refDoi"> DOI: 10.1177/1087057103258285</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1177%2F1087057103258285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=14711389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A280%3ADC%252BD2c%252FhsVyjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=634-647&author=C.+Brideauauthor=B.+Gunterauthor=B.+Pikounisauthor=A.+Liaw&title=Improved+statistical+methods+for+hit+selection+in+high-throughput+screening&doi=10.1177%2F1087057103258285"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Improved statistical methods for hit selection in high-throughput screening</span></div><div class="casAuthors">Brideau Christine; Gunter Bert; Pikounis Bill; Liaw Andy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">634-47</span>
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    </div><div class="casAbstract">High-throughput screening (HTS) plays a central role in modern drug discovery, allowing the rapid screening of large compound collections against a variety of putative drug targets.  HTS is an industrial-scale process, relying on sophisticated automation, control, and state-of-the art detection technologies to organize, test, and measure hundreds of thousands to millions of compounds in nano- to microliter volumes.  Despite this high technology, hit selection for HTS is still typically done using simple data analysis and basic statistical methods.  The authors discuss in this article some shortcomings of these methods and present alternatives based on modern methods of statistical data analysis.  Most important, they describe and show numerous real examples from the biologist-friendly Stat Server HTS application (SHS), a custom-developed software tool built on the commercially available S-PLUS and StatServer statistical analysis and server software.  This system remotely processes HTS data using powerful and sophisticated statistical methodology but insulates users from the technical details by outputting results in a variety of readily interpretable graphs and tables.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTC1RVHw8Iwb-RS7coPn-RtfW6udTcc2eY0v8jznt1D4Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c%252FhsVyjtA%253D%253D&md5=ddc5921a0776f3372c664d6e91446ba3</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1177%2F1087057103258285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057103258285%26sid%3Dliteratum%253Aachs%26aulast%3DBrideau%26aufirst%3DC.%26aulast%3DGunter%26aufirst%3DB.%26aulast%3DPikounis%26aufirst%3DB.%26aulast%3DLiaw%26aufirst%3DA.%26atitle%3DImproved%2520statistical%2520methods%2520for%2520hit%2520selection%2520in%2520high-throughput%2520screening%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2003%26volume%3D8%26spage%3D634%26epage%3D647%26doi%3D10.1177%2F1087057103258285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Hotard, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Currier, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowe, J. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peebles, R. S.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plemper, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, M. L.</span><span> </span><span class="NLM_article-title">Identification of residues in the human respiratory syncytial virus fusion protein that modulate fusion activity and pathogenesis</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">512</span><span class="NLM_x">–</span> <span class="NLM_lpage">522</span><span class="refDoi"> DOI: 10.1128/JVI.02472-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1128%2FJVI.02472-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=25339762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVSju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2015&pages=512-522&author=A.+L.+Hotardauthor=S.+Leeauthor=M.+G.+Currierauthor=J.+E.+Croweauthor=K.+Sakamotoauthor=D.+C.+Newcombauthor=R.+S.+Peeblesauthor=R.+K.+Plemperauthor=M.+L.+Moore&title=Identification+of+residues+in+the+human+respiratory+syncytial+virus+fusion+protein+that+modulate+fusion+activity+and+pathogenesis&doi=10.1128%2FJVI.02472-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of residues in the human respiratory syncytial virus fusion protein that modulate fusion activity and pathogenesis</span></div><div class="casAuthors">Hotard, Anne L.; Lee, Sujin; Currier, Michael G.; Crowe, James E., Jr.; Sakamoto, Kaori; Newcomb, Dawn C.; Peebles, R. Stokes, Jr.; Plemper, Richard K.; Moore, Martin L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">512-522, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">1098-5514</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Human respiratory syncytial virus (RSV) lower respiratory tract infection can result in inflammation and mucus plugging of airways.  RSV strain A2-line19F induces relatively high viral load and mucus in mice.  The line 19 fusion (F) protein harbors 5 unique residues compared to the non-mucus-inducing strains A2 and Long, at positions 79, 191, 357, 371, and 557.  We hypothesized that differential fusion activity is a determinant of pathogenesis.  In a cell-cell fusion assay, line 19 F was more fusogenic than Long F.  We changed the residues unique to line 19 F to the corresponding residues in Long F and identified residues 79 and 191 together as responsible for high fusion activity.  Surprisingly, mutation of residues 357 or 357 with 371 resulted in gain of fusion activity.  Thus, we generated RSV F mutants with a range of defined fusion activity and engineered these into recombinant viruses.  We found a clear, pos. correlation between fusion activity and early viral load in mice; however, we did not detect a correlation between viral loads and levels of airway mucin expression.  The F mutant with the highest fusion activity, A2-line19F-K357T/Y371N, induced high viral loads, severe lung histopathol., and wt. loss but did not induce high levels of airway mucin expression.  We defined residues 79/191 as crit. for line 19 F fusion activity and 357/371 as playing a role in A2-line19F mucus induction.  Defining the mol. basis of the role of RSV F in pathogenesis may aid vaccine and therapeutic strategies aimed at this protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD1kx9R91Zl7Vg90H21EOLACvtfcHk0lh5JyxDdsImRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVSju7Y%253D&md5=b605a2bc197d50647d9f90376cfe91ce</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1128%2FJVI.02472-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.02472-14%26sid%3Dliteratum%253Aachs%26aulast%3DHotard%26aufirst%3DA.%2BL.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DCurrier%26aufirst%3DM.%2BG.%26aulast%3DCrowe%26aufirst%3DJ.%2BE.%26aulast%3DSakamoto%26aufirst%3DK.%26aulast%3DNewcomb%26aufirst%3DD.%2BC.%26aulast%3DPeebles%26aufirst%3DR.%2BS.%26aulast%3DPlemper%26aufirst%3DR.%2BK.%26aulast%3DMoore%26aufirst%3DM.%2BL.%26atitle%3DIdentification%2520of%2520residues%2520in%2520the%2520human%2520respiratory%2520syncytial%2520virus%2520fusion%2520protein%2520that%2520modulate%2520fusion%2520activity%2520and%2520pathogenesis%26jtitle%3DJ.%2520Virol.%26date%3D2015%26volume%3D89%26spage%3D512%26epage%3D522%26doi%3D10.1128%2FJVI.02472-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Hawkins, E.; Butler, B.; Beck, M.; O’Grady, M.; Orr, L.; Wood, K.</span><span> </span><span class="NLM_article-title">Dual-glo Luciferase Assay System: Convenient Dual-Reporter Measurements in 96- and 384-Well Plates</span>.  <span class="citation_source-book">Promega Notes</span>; <span class="NLM_publisher-name">Promega Corporation</span>: <span class="NLM_publisher-loc">Madison, WI</span>,<span class="NLM_x"> </span><span class="NLM_year">2002</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">81</span>, pp  <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=22-26&author=E.+Hawkins&author=B.+Butler&author=M.+Beck&author=M.+O%E2%80%99Grady&author=L.+Orr&author=K.+Wood&title=Promega+Notes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHawkins%26aufirst%3DE.%26atitle%3DDual-glo%2520Luciferase%2520Assay%2520System%253A%2520Convenient%2520Dual-Reporter%2520Measurements%2520in%252096-%2520and%2520384-Well%2520Plates%26btitle%3DPromega%2520Notes%26pub%3DPromega%2520Corporation%26date%3D2002%26volume%3D81%26spage%3D22%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span>Scifinder; <span class="NLM_publisher-name">Chemical Abstracts Service</span>: <span class="NLM_publisher-loc">Columbus, OH</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Scifinder%3B+Chemical+Abstracts+Service%3A+Columbus%2C+OH%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DScifinder%26pub%3DChemical%2520Abstracts%2520Service%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Blackburn, C.; Chin, J.; Gigstad, K. M.; Xu, H.</span><span> </span><span class="NLM_article-title">Substituted Hydroxamic Acids and Uses Thereof</span>. U.S. Patent No. 8,946,223, Feb 3,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=C.+Blackburn&author=J.+Chin&author=K.+M.+Gigstad&author=H.+Xu&title=Substituted+Hydroxamic+Acids+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBlackburn%26aufirst%3DC.%26atitle%3DSubstituted%2520Hydroxamic%2520Acids%2520and%2520Uses%2520Thereof%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Moussa, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banister, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doddareddy, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacH, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassiou, M.</span><span> </span><span class="NLM_article-title">Exploration of ring size in a series of cyclic vicinal diamines with sigma1 receptor affinity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5493</span><span class="NLM_x">–</span> <span class="NLM_lpage">5497</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.07.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1016%2Fj.bmcl.2012.07.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5493-5497&author=I.+A.+Moussaauthor=S.+D.+Banisterauthor=M.+Manoliauthor=M.+R.+Doddareddyauthor=J.+Cuiauthor=R.+H.+MacHauthor=M.+Kassiou&title=Exploration+of+ring+size+in+a+series+of+cyclic+vicinal+diamines+with+sigma1+receptor+affinity&doi=10.1016%2Fj.bmcl.2012.07.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.07.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.07.026%26sid%3Dliteratum%253Aachs%26aulast%3DMoussa%26aufirst%3DI.%2BA.%26aulast%3DBanister%26aufirst%3DS.%2BD.%26aulast%3DManoli%26aufirst%3DM.%26aulast%3DDoddareddy%26aufirst%3DM.%2BR.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DMacH%26aufirst%3DR.%2BH.%26aulast%3DKassiou%26aufirst%3DM.%26atitle%3DExploration%2520of%2520ring%2520size%2520in%2520a%2520series%2520of%2520cyclic%2520vicinal%2520diamines%2520with%2520sigma1%2520receptor%2520affinity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5493%26epage%3D5497%26doi%3D10.1016%2Fj.bmcl.2012.07.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Lane, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. M.</span><span> </span><span class="NLM_article-title">Asymmetric total syntheses of (−)-jorumycin, (−)-renieramycin g, 3-epi-jorumycin, and 3-epi-renieramycin g</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">12684</span><span class="NLM_x">–</span> <span class="NLM_lpage">12690</span><span class="refDoi"> DOI: 10.1021/ja0535918</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0535918" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADC%252BD2MXot1Wjtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=12684-12690&author=J.+W.+Laneauthor=Y.+Chenauthor=R.+M.+Williams&title=Asymmetric+total+syntheses+of+%28%E2%88%92%29-jorumycin%2C+%28%E2%88%92%29-renieramycin+g%2C+3-epi-jorumycin%2C+and+3-epi-renieramycin+g&doi=10.1021%2Fja0535918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric Total Syntheses of (-)-Jorumycin, (-)-Renieramycin G, 3-epi-Jorumycin, and 3-epi-Renieramycin G</span></div><div class="casAuthors">Lane, Jonathan W.; Chen, Yuyin; Williams, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">12684-12690</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The total synthesis of (-)-jorumycin (I) and (-)-renieramycin G (II) has been accomplished in 25 and 23 steps, resp., from 5-benzyloxy-2,4-dimethoxy-3-methyl-benzyl alc.  The synthesis features a substrate-tunable stereoselective intramol. Pictet-Spengler-type reaction for the construction of the key pentacyclic core of both targets, bearing either the natural configuration or the epimeric configuration at C-3.  With access to a C-3 epi-pentacyclic framework, 3-epi-jorumycin and 3-epi-renieramycin G were also successfully synthesized.  Furthermore, preliminary biol. evaluation of 3-epi-jorumycin, in addn. to relevant synthetic intermediates, revealed that significant cytotoxicity had been retained in these compds.  Therefore, these early studies constitute the basis for a new structure activity relationship (SAR) investigation for this class of antitumor antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGCPDWZ4uT1LVg90H21EOLACvtfcHk0lggw8zlZ00Mcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXot1Wjtr0%253D&md5=dbd0989c14d944f7847a400926eedeac</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fja0535918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0535918%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DJ.%2BW.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWilliams%26aufirst%3DR.%2BM.%26atitle%3DAsymmetric%2520total%2520syntheses%2520of%2520%2528%25E2%2588%2592%2529-jorumycin%252C%2520%2528%25E2%2588%2592%2529-renieramycin%2520g%252C%25203-epi-jorumycin%252C%2520and%25203-epi-renieramycin%2520g%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D12684%26epage%3D12690%26doi%3D10.1021%2Fja0535918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Tomita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oomori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aramaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsushita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okabe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awazu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isono, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skene, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosfield, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, A.</span><span> </span><span class="NLM_article-title">Structure-based discovery of cellular-active allosteric inhibitors of FAK</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1779</span><span class="NLM_x">–</span> <span class="NLM_lpage">1785</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.01.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1016%2Fj.bmcl.2013.01.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=23414845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1Wrtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1779-1785&author=N.+Tomitaauthor=Y.+Hayashiauthor=S.+Suzukiauthor=Y.+Oomoriauthor=Y.+Aramakiauthor=Y.+Matsushitaauthor=M.+Iwataniauthor=H.+Iwataauthor=A.+Okabeauthor=Y.+Awazuauthor=O.+Isonoauthor=R.+J.+Skeneauthor=D.+J.+Hosfieldauthor=H.+Mikiauthor=T.+Kawamotoauthor=A.+Horiauthor=A.+Baba&title=Structure-based+discovery+of+cellular-active+allosteric+inhibitors+of+FAK&doi=10.1016%2Fj.bmcl.2013.01.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based discovery of cellular-active allosteric inhibitors of FAK</span></div><div class="casAuthors">Tomita, Naoki; Hayashi, Yoko; Suzuki, Shinkichi; Oomori, Yoshimasa; Aramaki, Yoshio; Matsushita, Yoshihiro; Iwatani, Misa; Iwata, Hidehisa; Okabe, Atsutoshi; Awazu, Yoshiko; Isono, Osamu; Skene, Robert J.; Hosfield, David J.; Miki, Hiroshi; Kawamoto, Tomohiro; Hori, Akira; Baba, Atsuo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1779-1785</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In order to develop potent and selective focal adhesion kinase (FAK) inhibitors, synthetic studies on pyrazolo[4,3-c][2,1]benzothiazines targeted for the FAK allosteric site were carried out.  Based on the X-ray structural anal. of the co-crystal of the lead compd., 8-(4-ethylphenyl)-5-methyl-1,5-dihydropyrazolo[4,3-c][2,1]benzothiazine 4,4-dioxide 1 with FAK, we designed and prepd. 1,5-dimethyl-1,5-dihydropyrazolo[4,3-c][2,1]benzothiazin derivs. which selectively inhibited kinase activity of FAK without affecting seven other kinases.  The optimized compd., N-(4-tert-butylbenzyl)-1,5-dimethyl-1,5-dihydropyrazolo[4,3-c][2,1]benzothiazin-8-amine 4,4-dioxide 30 possessed significant FAK kinase inhibitory activities both in cell-free (IC50 = 0.64 μM) and in cellular assays (IC50 = 7.1 μM).  These results clearly demonstrated a potential of FAK allosteric inhibitors as antitumor agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr-Jxocxt917Vg90H21EOLACvtfcHk0lggw8zlZ00Mcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1Wrtrk%253D&md5=309362a2ca95be142bb6d8e29520f367</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.01.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.01.047%26sid%3Dliteratum%253Aachs%26aulast%3DTomita%26aufirst%3DN.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DOomori%26aufirst%3DY.%26aulast%3DAramaki%26aufirst%3DY.%26aulast%3DMatsushita%26aufirst%3DY.%26aulast%3DIwatani%26aufirst%3DM.%26aulast%3DIwata%26aufirst%3DH.%26aulast%3DOkabe%26aufirst%3DA.%26aulast%3DAwazu%26aufirst%3DY.%26aulast%3DIsono%26aufirst%3DO.%26aulast%3DSkene%26aufirst%3DR.%2BJ.%26aulast%3DHosfield%26aufirst%3DD.%2BJ.%26aulast%3DMiki%26aufirst%3DH.%26aulast%3DKawamoto%26aufirst%3DT.%26aulast%3DHori%26aufirst%3DA.%26aulast%3DBaba%26aufirst%3DA.%26atitle%3DStructure-based%2520discovery%2520of%2520cellular-active%2520allosteric%2520inhibitors%2520of%2520FAK%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1779%26epage%3D1785%26doi%3D10.1016%2Fj.bmcl.2013.01.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Peng, H.; Xin, Z.; Zhang, L.; Sun, L.; Kumaravel, G.; Taveras, A.; Wang, D.</span> S1P and/or ATX Modulating Agents. US. Patent Application No. 14/772481, Feb 11,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Peng%2C+H.%3B+Xin%2C+Z.%3B+Zhang%2C+L.%3B+Sun%2C+L.%3B+Kumaravel%2C+G.%3B+Taveras%2C+A.%3B+Wang%2C+D.+S1P+and%2For+ATX+Modulating+Agents.+US.+Patent+Application+No.+14%2F772481%2C+Feb+11%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DH.%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Hoffman, R. V.</span><span> </span><span class="NLM_article-title">″Meta-trifluoromethylbenzenesulfonyl chloride</span> <span class="citation_source-journal">Org. Synth.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span><span class="refDoi"> DOI: 10.15227/orgsyn.060.0121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.15227%2Forgsyn.060.0121" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1981&pages=121-126&author=R.+V.+Hoffman&title=%E2%80%B3Meta-trifluoromethylbenzenesulfonyl+chloride&doi=10.15227%2Forgsyn.060.0121"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.15227%2Forgsyn.060.0121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15227%252Forgsyn.060.0121%26sid%3Dliteratum%253Aachs%26aulast%3DHoffman%26aufirst%3DR.%2BV.%26atitle%3D%25E2%2580%25B3Meta-trifluoromethylbenzenesulfonyl%2520chloride%26jtitle%3DOrg.%2520Synth.%26date%3D1981%26volume%3D60%26spage%3D121%26epage%3D126%26doi%3D10.15227%2Forgsyn.060.0121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Blackburn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">England, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gigstad, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ringeling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitors derived from 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine and related heterocycles selective for the HDAC6 isoform</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">5450</span><span class="NLM_x">–</span> <span class="NLM_lpage">5454</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.10.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1016%2Fj.bmcl.2014.10.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=5450-5454&author=C.+Blackburnauthor=C.+Barrettauthor=M.+Brunsonauthor=J.+Chinauthor=D.+Englandauthor=K.+Garciaauthor=K.+Gigstadauthor=A.+Gouldauthor=J.+Gutierrezauthor=K.+Hoarauthor=R.+S.+Rowlandauthor=C.+Tsuauthor=J.+Ringelingauthor=K.+Wagerauthor=H.+Xu&title=Histone+deacetylase+inhibitors+derived+from+1%2C2%2C3%2C4-tetrahydropyrrolo%5B1%2C2-a%5Dpyrazine+and+related+heterocycles+selective+for+the+HDAC6+isoform&doi=10.1016%2Fj.bmcl.2014.10.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.10.022%26sid%3Dliteratum%253Aachs%26aulast%3DBlackburn%26aufirst%3DC.%26aulast%3DBarrett%26aufirst%3DC.%26aulast%3DBrunson%26aufirst%3DM.%26aulast%3DChin%26aufirst%3DJ.%26aulast%3DEngland%26aufirst%3DD.%26aulast%3DGarcia%26aufirst%3DK.%26aulast%3DGigstad%26aufirst%3DK.%26aulast%3DGould%26aufirst%3DA.%26aulast%3DGutierrez%26aufirst%3DJ.%26aulast%3DHoar%26aufirst%3DK.%26aulast%3DRowland%26aufirst%3DR.%2BS.%26aulast%3DTsu%26aufirst%3DC.%26aulast%3DRingeling%26aufirst%3DJ.%26aulast%3DWager%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DH.%26atitle%3DHistone%2520deacetylase%2520inhibitors%2520derived%2520from%25201%252C2%252C3%252C4-tetrahydropyrrolo%255B1%252C2-a%255Dpyrazine%2520and%2520related%2520heterocycles%2520selective%2520for%2520the%2520HDAC6%2520isoform%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D5450%26epage%3D5454%26doi%3D10.1016%2Fj.bmcl.2014.10.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Andaloussi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Meer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sijm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulie, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Esch, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smits, R. A.</span><span> </span><span class="NLM_article-title">A novel series of histamine h4 receptor antagonists based on the pyrido[3,2-d]pyrimidine scaffold: Comparison of hERG binding and target residence time with PF-3893787</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2663</span><span class="NLM_x">–</span> <span class="NLM_lpage">2670</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.02.091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1016%2Fj.bmcl.2013.02.091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=23558237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1ejt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=2663-2670&author=M.+Andaloussiauthor=H.+D.+Limauthor=T.+van+der+Meerauthor=M.+Sijmauthor=C.+B.+Poulieauthor=I.+J.+de+Eschauthor=R.+Leursauthor=R.+A.+Smits&title=A+novel+series+of+histamine+h4+receptor+antagonists+based+on+the+pyrido%5B3%2C2-d%5Dpyrimidine+scaffold%3A+Comparison+of+hERG+binding+and+target+residence+time+with+PF-3893787&doi=10.1016%2Fj.bmcl.2013.02.091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A novel series of histamine H4 receptor antagonists based on the pyrido[3,2-d]pyrimidine scaffold: Comparison of hERG binding and target residence time with PF-3893787</span></div><div class="casAuthors">Andaloussi, Mounir; Lim, Herman D.; van der Meer, Tiffany; Sijm, Maarten; Poulie, Chris B. M.; de Esch, Iwan J. P.; Leurs, Rob; Smits, Rogier A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2663-2670</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In this work we describe the optimization of a lead compd. based on the quinazoline template to give a new series of potent pyrido[3,2-d]pyrimidines as histamine H4 receptor antagonists.  The pyrido[3,2-d]pyrimidine ligands have significantly reduced hERG binding compared to clin. stage compd. PF-3893787 while showing good affinities at the human and rodent histamine receptors.  The receptor residence time of several of these new compds. was detd. for the human H4R and compared with JNJ7777120 and PF-3893787.  The pyrido[3,2-d]pyrimidines showed residence times lower than JNJ7777120 but comparable to the residence time of PF-3893787.  Overall, the pyrido[3,2-d]pyrimidines show an excellent in vitro profile that warrants their further investigation in relevant models of human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5XgYab9jbM7Vg90H21EOLACvtfcHk0lgwrL6yWzP06A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1ejt7g%253D&md5=0c91102c3dab92c3f012c12c1a715380</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.02.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.02.091%26sid%3Dliteratum%253Aachs%26aulast%3DAndaloussi%26aufirst%3DM.%26aulast%3DLim%26aufirst%3DH.%2BD.%26aulast%3Dvan%2Bder%2BMeer%26aufirst%3DT.%26aulast%3DSijm%26aufirst%3DM.%26aulast%3DPoulie%26aufirst%3DC.%2BB.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DSmits%26aufirst%3DR.%2BA.%26atitle%3DA%2520novel%2520series%2520of%2520histamine%2520h4%2520receptor%2520antagonists%2520based%2520on%2520the%2520pyrido%255B3%252C2-d%255Dpyrimidine%2520scaffold%253A%2520Comparison%2520of%2520hERG%2520binding%2520and%2520target%2520residence%2520time%2520with%2520PF-3893787%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D2663%26epage%3D2670%26doi%3D10.1016%2Fj.bmcl.2013.02.091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Asakawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirayama, N.</span><span> </span><span class="NLM_article-title">Autogpa: An automated 3D-QSAR method based on pharmacophore alignment and grid potential analysis</span> <span class="citation_source-journal">Int. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span><span class="refDoi"> DOI: 10.1155/2012/498931</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1155%2F2012%2F498931" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=1-9&author=N.+Asakawaauthor=S.+Kobayashiauthor=J.+Gotoauthor=N.+Hirayama&title=Autogpa%3A+An+automated+3D-QSAR+method+based+on+pharmacophore+alignment+and+grid+potential+analysis&doi=10.1155%2F2012%2F498931"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1155%2F2012%2F498931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F498931%26sid%3Dliteratum%253Aachs%26aulast%3DAsakawa%26aufirst%3DN.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DGoto%26aufirst%3DJ.%26aulast%3DHirayama%26aufirst%3DN.%26atitle%3DAutogpa%253A%2520An%2520automated%25203D-QSAR%2520method%2520based%2520on%2520pharmacophore%2520alignment%2520and%2520grid%2520potential%2520analysis%26jtitle%3DInt.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D2012%26spage%3D1%26epage%3D9%26doi%3D10.1155%2F2012%2F498931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span>Molecular Operating Environment (MOE), 2013.08; <span class="NLM_publisher-name">Chemical Computing Group Inc.</span>: <span class="NLM_publisher-loc">Montreal, Canada</span>,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">; </span>H3a 2r7.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Molecular+Operating+Environment+%28MOE%29%2C+2013.08%3B+Chemical+Computing+Group+Inc.%3A+Montreal%2C+Canada%2C+2017%3B+H3a+2r7."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Operating%2520Environment%2520%2528MOE%2529%252C%25202013.08%26pub%3DChemical%2520Computing%2520Group%2520Inc%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Battles, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langedijk, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furmanova-Hollenstein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaiwatpongsakorn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costello, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwanten, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vranckx, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vink, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaensch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonckers, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koul, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnoult, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peeples, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roymans, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLellan, J. S.</span><span> </span><span class="NLM_article-title">Molecular mechanism of respiratory syncytial virus fusion inhibitors</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span><span class="refDoi"> DOI: 10.1038/nchembio.1982</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1038%2Fnchembio.1982" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=26641933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFemsbrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=87-93&author=M.+B.+Battlesauthor=J.+P.+Langedijkauthor=P.+Furmanova-Hollensteinauthor=S.+Chaiwatpongsakornauthor=H.+M.+Costelloauthor=L.+Kwantenauthor=L.+Vranckxauthor=P.+Vinkauthor=S.+Jaenschauthor=T.+H.+Jonckersauthor=A.+Koulauthor=E.+Arnoultauthor=M.+E.+Peeplesauthor=D.+Roymansauthor=J.+S.+McLellan&title=Molecular+mechanism+of+respiratory+syncytial+virus+fusion+inhibitors&doi=10.1038%2Fnchembio.1982"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanism of respiratory syncytial virus fusion inhibitors</span></div><div class="casAuthors">Battles, Michael B.; Langedijk, Johannes P.; Furmanova-Hollenstein, Polina; Chaiwatpongsakorn, Supranee; Costello, Heather M.; Kwanten, Leen; Vranckx, Luc; Vink, Paul; Jaensch, Steffen; Jonckers, Tim H. M.; Koul, Anil; Arnoult, Eric; Peeples, Mark E.; Roymans, Dirk; McLellan, Jason S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">87-93</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Respiratory syncytial virus (RSV) is a leading cause of pneumonia and bronchiolitis in young children and the elderly.  Therapeutic small mols. have been developed that bind the RSV F glycoprotein and inhibit membrane fusion, yet their binding sites and mol. mechanisms of action remain largely unknown.  Here we show that these inhibitors bind to a three-fold-sym. pocket within the central cavity of the metastable prefusion conformation of RSV F.  Inhibitor binding stabilizes this conformation by tethering two regions that must undergo a structural rearrangement to facilitate membrane fusion.  Inhibitor-escape mutations occur in residues that directly contact the inhibitors or are involved in the conformational rearrangements required to accommodate inhibitor binding.  Resistant viruses do not propagate as well as wild-type RSV in vitro, indicating a fitness cost for inhibitor escape.  Collectively, these findings provide new insight into class I viral fusion proteins and should facilitate development of optimal RSV fusion inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowEnQ0xJnoFLVg90H21EOLACvtfcHk0lgIN2rvOJdtwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFemsbrK&md5=c126990069d3f23d95d06693fe90a061</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1982%26sid%3Dliteratum%253Aachs%26aulast%3DBattles%26aufirst%3DM.%2BB.%26aulast%3DLangedijk%26aufirst%3DJ.%2BP.%26aulast%3DFurmanova-Hollenstein%26aufirst%3DP.%26aulast%3DChaiwatpongsakorn%26aufirst%3DS.%26aulast%3DCostello%26aufirst%3DH.%2BM.%26aulast%3DKwanten%26aufirst%3DL.%26aulast%3DVranckx%26aufirst%3DL.%26aulast%3DVink%26aufirst%3DP.%26aulast%3DJaensch%26aufirst%3DS.%26aulast%3DJonckers%26aufirst%3DT.%2BH.%26aulast%3DKoul%26aufirst%3DA.%26aulast%3DArnoult%26aufirst%3DE.%26aulast%3DPeeples%26aufirst%3DM.%2BE.%26aulast%3DRoymans%26aufirst%3DD.%26aulast%3DMcLellan%26aufirst%3DJ.%2BS.%26atitle%3DMolecular%2520mechanism%2520of%2520respiratory%2520syncytial%2520virus%2520fusion%2520inhibitors%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D87%26epage%3D93%26doi%3D10.1038%2Fnchembio.1982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Hotard, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaikh, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teng, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plemper, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowe, J. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, M. L.</span><span> </span><span class="NLM_article-title">A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis</span> <span class="citation_source-journal">Virology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">434</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span><span class="refDoi"> DOI: 10.1016/j.virol.2012.09.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=10.1016%2Fj.virol.2012.09.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2012&pages=129-136&author=A.+L.+Hotardauthor=F.+Y.+Shaikhauthor=S.+Leeauthor=D.+Yanauthor=M.+N.+Tengauthor=R.+K.+Plemperauthor=J.+E.+Croweauthor=M.+L.+Moore&title=A+stabilized+respiratory+syncytial+virus+reverse+genetics+system+amenable+to+recombination-mediated+mutagenesis&doi=10.1016%2Fj.virol.2012.09.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.virol.2012.09.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virol.2012.09.022%26sid%3Dliteratum%253Aachs%26aulast%3DHotard%26aufirst%3DA.%2BL.%26aulast%3DShaikh%26aufirst%3DF.%2BY.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DYan%26aufirst%3DD.%26aulast%3DTeng%26aufirst%3DM.%2BN.%26aulast%3DPlemper%26aufirst%3DR.%2BK.%26aulast%3DCrowe%26aufirst%3DJ.%2BE.%26aulast%3DMoore%26aufirst%3DM.%2BL.%26atitle%3DA%2520stabilized%2520respiratory%2520syncytial%2520virus%2520reverse%2520genetics%2520system%2520amenable%2520to%2520recombination-mediated%2520mutagenesis%26jtitle%3DVirology%26date%3D2012%26volume%3D434%26spage%3D129%26epage%3D136%26doi%3D10.1016%2Fj.virol.2012.09.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Cramer, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunce, J. D.</span><span> </span><span class="NLM_article-title">Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">5959</span><span class="NLM_x">–</span> <span class="NLM_lpage">5967</span><span class="refDoi"> DOI: 10.1021/ja00226a005</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00226a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;key=1%3ACAS%3A528%3ADyaL1cXltVCqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=1988&pages=5959-5967&author=R.+D.+Cramerauthor=D.+E.+Pattersonauthor=J.+D.+Bunce&title=Comparative+molecular+field+analysis+%28CoMFA%29.+1.+Effect+of+shape+on+binding+of+steroids+to+carrier+proteins&doi=10.1021%2Fja00226a005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative molecular field analysis (CoMFA).  1.  Effect of shape on binding of steroids to carrier proteins</span></div><div class="casAuthors">Cramer, Richard D., III; Patterson, David E.; Bunce, Jeffrey D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5959-67</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Comparative mol. field anal. (CoMFA) which represents ligand mols. by their steric and electrostatic fields was used to analyze the affinity of 21 steroids to corticosteroid- and testosterone-binding globulins and then to predict the binding consts. of 10 more, structurally diverse, steroids.  QSAR obtained with CoMFA parameters had greater predictive, and also correlative, power then QSAR obtained by other parameters combinations.  The predicted affinities of the addnl. 10 steroids were highly correlated with the actual binding data with the poorest predictions being for steroids that were most dissimilar from the original 21 steroids analyzed.  The CoMFA methodol is characterized by inherent generality, ease of use, superior anal. power, and predictive utility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkkJZS5v2zRrVg90H21EOLACvtfcHk0ljGBHrRlMcXjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXltVCqsbs%253D&md5=8829e9efd71a65faa7c9397c9eb13cc7</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fja00226a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00226a005%26sid%3Dliteratum%253Aachs%26aulast%3DCramer%26aufirst%3DR.%2BD.%26aulast%3DPatterson%26aufirst%3DD.%2BE.%26aulast%3DBunce%26aufirst%3DJ.%2BD.%26atitle%3DComparative%2520molecular%2520field%2520analysis%2520%2528CoMFA%2529.%25201.%2520Effect%2520of%2520shape%2520on%2520binding%2520of%2520steroids%2520to%2520carrier%2520proteins%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1988%26volume%3D110%26spage%3D5959%26epage%3D5967%26doi%3D10.1021%2Fja00226a005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i98"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01568">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_01711"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01568">10.1021/acs.jmedchem.6b01568</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Detailed procedure for the metabolism study of <b>1a</b> and <b>8p</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01568/suppl_file/jm6b01568_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (MFS) for compounds presented in the article (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01568/suppl_file/jm6b01568_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01568/suppl_file/jm6b01568_si_001.pdf">jm6b01568_si_001.pdf (467.62 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01568/suppl_file/jm6b01568_si_002.csv">jm6b01568_si_002.csv (4.0 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01568&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01568%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-6" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01568" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799950f5b992362","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
